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FACS fluorescence-activated cell sorting 
FCS foetal calf serum 
FDC follicular dendritic cell 
FITC fluorecein isothyocyanate 
FR framework region 
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KLH keyhole limpet haemocyanin 
L antibody light chain 
LPS lipopolysaccharide 
mAb monoclonal antibody 
MHC major histocompatibility complex 
mRNA messenger ribonucleic acid 
NP 4-hydroxy-3-nitrophenyl acetyl 
OD optical density 
OVA ovalbumin 
PBS phospate buffered saline 
PE phycoerythrin 
Ph-OX phenyl oxazolone 
PNA peanut agglutinin 
PNP p-nitrophenyl acetyl 
QM quasi monoclonal 
RAG recombination activating gene 
RCF recombinant C fragment from tetanus toxin 
RT-PCR reverse transcription polymerase chain reaction 
S.C. subcutanously 
Taq Thermus aquaticus 
TD Tdependent 
TdT Terminal deoxynucleotidyl transferase. 
TI T independent 
TNP trinitrophenyl 
V(D)J variable (diversity) joining regions 
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Abstract 
The production of high affinity antibodies is critical for providing effective 
protection against microbial agents. During the T cell dependent response to 
antigen, secondary diversification of the B cell receptor occurs. This provides a 
varied pool of B cells which can be selected and expanded resulting in affinity 
maturation of the response. This diversification is currently ascribed to somatic 
hypermutation. Both the molecular basis and the triggers for hypermutation 
have been studied in vitro. 
Recently the possibility that another process, receptor revision, might 
provide an additional means of diversification has emerged. Receptor revision 
involves the secondary rearrangement of the B cell receptor in the periphery, as 
yet no purpose for this process has been revealed. Experiments are described 
which investigate a potential contribution of receptor revision to affinity 
maturation. A pure population of transgenic B cells are adoptively transferred 
into chimaeric hosts and the affinity maturation of these cells is monitored in 
isolation. The development of the transfer system is documented and results 
presented which show no evidence for a role for receptor revision in affinity 
maturation. 
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Chapter 1 Introduction 
1.1 Antibodies and the adaptive immune response. 
Antibodies have 2 main functions: to recognise and bind pathogens and to 
recruit other cells and molecules of the immune system to destroy them. They 
have the capacity to bind strongly to an almost infinite number of foreign 
antigens, an ability that results from the complex nature of the genetic locus 
encoding these soluble proteins. The finding that B cells were responsible for the 
soluble factors that combat disease was a landmark discovery (reprinted in (1)). 
The further finding that individual B cells express only a single specificity, and 
that clones of T and B cells are expanded by antigen contact with receptors on 
the cell surface, paved the way for the study of the adaptive immune response 
(2). 
The ability to secrete molecules that specifically recognise a pathogen is a 
feature of the adaptive immune response. Adaptive immune responses are a 
feature of vertebrates, and rely on the split nature of B and T lymphocyte 
receptor genes. When randomly recombined and expressed as protein these 
genes give rise to a highly diverse B and T lymphocyte repertoire (3). The 
development of the adaptive immune system is thought to have occurred 
subsequent to the arrival of the recombination activating genes (RAG1 and 2) in 
the genome, soon after the divergence of jawed and jawless vertebrates in 
evolution (4). 
The RAG genes are proposed to have entered the vertebrate genome 
through a transposition event as they have striking similarities to a transposable 
element (4). RAG recombinase allows the joining of antibody gene segments to 
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form a gene that can be transcribed and translated into functional protein. Gene 
duplication events resulted in the generation of multiple gene segments in the 
antibody coding locus. The incorporation of RAG genes into the vertebrate 
genome enabled harnessing of gene segments into a mechanism, which allows 
the generation of diversity required for the adaptive immune system. 
1.2 Generation of antibody diversity 
Antibody diversity is essential to ensure that the body can combat the multitude 
of antigens presented to it. In humans the antibody repertoire consists of about 
1011  different antibody molecules. This diversity is generated through a variety 
of mechanisms as the B cell develops in the bone marrow (reviewed in (3)). B 
cells develop from a putative common lymphoid progenitor, to pro-B, pre-B and 
the immature B cell stages (5), during which time antibodies are generated and 
expressed on the cell surface as B cell receptors (BCR). 
Antibody molecules are made up of two protein chains: one heavy (H) 
chain and one light (L) chain (of which there are 2: K and X). Each chain consists 
of a constant region, which is highly conserved, and a variable region, which is 
poorly conserved. Variable regions make contact with antigen, while constant 
regions provide the structure, and in the case of the heavy chain, perform 
effector functions. Within the variable regions there are three regions that are 
hypervariable, these are the points of contact with antigen and are termed 
complementarity determining regions (CDRs). Intervening parts of the variable 
region are structural and are termed framework regions (FRs) (Figure 1.1). 
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Figure 1.1 Antibody gene rearrangement and antibody structure 
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The variable regions of heavy and light chains, which are most important for 
antigen binding, are encoded by either three or two gene segments 
respectively. These segments are called the variable (V), diversity (D), and 
joining (J) genes. Before the variable region can be transcribed, these gene 
segments must be placed adjacent to each other in a recombination event. There 
exists a selection of V. (D) and J segments, one of each of these is chosen at 
random to make up a functional variable region (3)(Figure 1.1). 
V, D and J segments are flanked by recombination signal sequences 
(RSSs), which consist of a heptamer sequence adjacent to the V, D or J region 
followed by either a 12 or 23 base pair (bp) spacer region, followed by an A-T 
rich nonamer sequence. To ensure correct rearrangement of V genes one RSS 
can only combine with another if they have different length spacers, the so 
called 12/23 rule. At the time of recombination, extra variation termed 
junctional variation is added in the form of extra nucleotides: P nucleotides are 
added in a template dependent fashion, whereas N nucleotides are non-
templated and are inserted by terminal deoxynucleotidyl transferase (TdT). 
V(D)J rearrangement is dependent on both RAG1 and RAG2 (6). Both of these 
genes are conserved between species that undergo V(D)J recombination but are 
unrelated to each other. Mice that lack either of these genes are unable 
rearrange immunoglobulin (Ig) or T cell receptor genes and as a result have no T 
or B lymphocytes (7). 
Following the rearrangement of antibody V genes, a further level of 
diversity is added when the pairing of heavy and light chains to form functional 
antibody occurs. This is called combinatorial diversity, most heavy chains can 
pair with most light chains and different combinations may provide different 
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specificities. Once a functional antibody molecule has been produced by a B 
cell, the recombination process is turned off so that each B cell only expresses a 
single antibody specificity, a process known as allelic exclusion (reviewed in 
(8)). 
1.3 Selection of the B cell repertoire 
Checkpoints exist in the development of B cells, to ensure that the molecular 
processes described above have occurred correctly. Successful heavy chain 
rearrangements are tested at the early pre-B cell stage by pairing with the 
surrogate light chain (reviewed in (9)). Expression of this pre-BCR at the cell 
surface signals an end to heavy chain rearrangement, and leads to a phase of 
clonal expansion, followed by rearrangement of the light chain (10-12) (Figure 
1.2). The failure to complete these stages successfully results in developmental 
arrest followed by death by apoptosis (13). 
Immature B cells with successful heavy chain and K or X light chain 
pairings then undergo negative selection to remove cells that bind self-antigen. 
There are 3 possible fates for autoreactive cells in the bone marrow, they can be 
eliminated by apoptosis (deletion) (14, 15), be functionally inactivated 
(anergised) (16), or they may be given a second chance at antibody 
rearrangement, this is known as receptor editing (17). Deletion of autoreactive B 
lymphocytes was detected in bone marrow chimaeras by injecting transgenic B 
cells expressing an anti self specificity (anti-H-2K'5. Autoreactive B cells were 
absent in mice expressing H2KK  but present in non-H-2K1< mice (15). In 
contrast immature B cells are made anergic if they encounter soluble antigen. 
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They are then unable to respond to subsequent antigen exposure, due to a 
partial block in signal transduction, however, this may be reversed if the cells 
are given help from T cells (16). 
The factors involved in the cell fate decision of immature B cells are 
unknown, however, strength of signalling through the BCR, and surface BCR 
expression levels may be important (18-20). Mechanisms may also be able to 
compensate for each other. In mice with impaired apoptosis due to the over 
expression of the anti apoptotic molecule BCL-2, receptor editing was found to 
be increased (21). Also mice over expressing another anti-apoptotic molecule 
BCL-XL were found to compensate for lack of apoptosis by increasing the levels 
of anergy induced (22). 
Receptor editing is of particular interest in the context of this thesis as it is 
mechanistically related to receptor revision, which is secondary rearrangement 
of the BCR in the periphery. However, the 2 have different consequences for the 
fate of the B cell. Receptor editing is described in greater detail below. 
1.3.1 Receptor editing 
RAG expression in the bone marrow is coincident with the rearrangement of 
heavy and light chains in pro and pre-B cells. If immature B cells in the bone 
marrow recognise self-antigen they can maintain expression of RAG 1 and RAG 
2 and alter their BCR through a process known as receptor editing (17). This 
phenomenon was first detected in the bone marrow of transgenic mice carrying 
autoreactive BCRs (17, 23, 24). Tiegs et al. (17) used a mouse with a transgenic 
BCR specific for H-2K k,b major histocompatibthty complex (MHC) molecules (3- 
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83 transgenic mouse) to investigate events involved in tolerance in the bone 
marrow. Upon encountering a membrane bound Kb  or  Kk  protein, some 
immature B cells modified their receptors by RAG dependent secondary 
rearrangement. Elevated levels of RAG 1 and RAG 2, along with the Ig 
rearrangement excision products, were detected using a PCR assay. This 
resulted in expression of a non-transgenic antibody light chain, which was 
detected by fluorescence activated cell sorting (FACS). They coined the term 
receptor editing. It had previously been believed that light chain rearrangement 
was blocked by the expression of a functional antibody on the surface, but 
discovery of circular DNA excised by nested K rearrangements suggested that 
light chain rearrangement could continue (25). 
Receptor editing is now a well-studied phenomenon and has also been 
shown to occur at the heavy chain locus (26, 27) and in B cell development in 
normal, non-transgenic mice (28). Its role in the generation of the repertoire in 
mice is considerable. Casellas et al. (29) found that about 25% of all antibody 
molecules are produced by gene replacement by examining the make up of 
expressed antibody chains in a mouse that contains one pre-rearranged K chain 
and a second allele that has an easily detectible human CK constant region. This 
suggests that the receptor editing process plays a major role in the shaping of 
the antibody repertoire. 
To facilitate receptor editing, primary rearrangements at the K locus are 
well suited for further recombination as the rearranged VKJK is flanked by 
unrearranged VK and JK segments (Figure 1.3). 
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Figure 1.3 Schematic representation of receptor editing at the 
light chain locus. 
Vin 	VK2 	VK1 	 Jicl-5 	 C  
I I,IIID 
First V(D)J Recombination D ring Development) 
VKn 	Vx2 	VK1 JK JK J1( Jx 	C K 
W - F 101 
Subsequent rea ngemen are possible 
Receptor revision at the kappa light chain locus. Following RS recombination 
lambda can also be rearranged and a similar phenomenon has been observed 
for the heavy chain. (see text for details) 
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In the heavy chain things are somewhat more complicated, as the presence of 
the D segment means that there is no longer a RSS present to allow RAG 
recombinase to recognise the DNA (30). However, receptor editing can still 
occur at the heavy chain locus due to the presence of RSS-like sequences 
embedded in the coding region, which allow secondary V(D)J rearrangement to 
displace the V gene segment from the DJ segments and replace it with a new 
one (31, 32). Secondary D to J joining can also replace primary rearrangements 
by deletion or inversion (30). 
1.4 T dependent and T independent antigens 
B cells that have successfully rearranged non-autoreactive BCRs in the bone 
marrow, upregulate 1gM and are exported to the periphery where they are 
ready to encounter antigen. Histological studies have shown that B cells interact 
with specific T cells at the border of the B cell follicle within 2 days of 
immunisation (33). However the site of initial antigen encounter by naïve B 
cells is still unclear. A subset of dendritic cells (DCs) that captured antigen 
rapidly after immunisation has been discovered, which may be involved in 
activation of T and B cells at the follicular border (34). 
The type of response generated by B cells is dependent on the nature of 
the antigen encountered. B cell responses can be broadly divided into those that 
are T cell dependent (TD) or T cell independent (TI) based on the response of B 
cells in Nude mice, a congenitally athymic strain that do not have any T cells. 
Antigens that elicit an antibody response in Nude mice are termed TI, those that 
do not are termed TD. 
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TD antigens are protein based; they can be processed and presented by B 
cells as MHC class II bound peptides. These are recognised during cognate 
interaction with CD4 T cells (35), which then provide help to B cells in the form 
of secreted cytokines and molecular costimulation (through CD40) resulting in B 
cell activation. B cell activation in a T dependent fashion initiates a host of 
characteristic processes (reviewed in (36)): germinal centres (CC) form, somatic 
hypermutation is induced and affinity maturation of the antibody response 
ensues. The development of B cell memory has also been reported to be a TD 
phenomenon (37), however this may not always be the case (38). 
TI antigens are carbohydrate and lipid based. They can be divided into 2 
subsets - TI-1 and TI-2, which have different characteristics. TI-1 antigens are 
typified by bacterial lipopolysaccharide (LPS), which contains multiple 
repeating epitopes. They are intrinsically mitogenic for B cells and can induce a 
polyclonal, non-antigen specific response, as they do not necessarily activate 
through the BCR. However, antigen specific responses to TI-1 antigens are also 
possible. TI-2 antigens also possess repeating epitopes, typified by bacterial 
capsular polysaccharides, and can hence also activate B cells in the absence of T 
cells. However, they are different from TI-1 antigens in that the response to 
them is always antigen specific. Activation by TI-2 antigens is dependent on the 
molecule Bruton?s  tyrosine kinase (Btk) (39). During B cell activation with a TI-2 
antigen small numbers of membrane bound antigen clusters induce membrane 
association of Btk molecules, which induce a calcium flux, recruiting 
transcription factors and resulting in activation of the B cell. Hence antigen 
specific immune responses can be elicited to TI-2 antigens (39). 
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Model TI-2 antigens have carbohydrate backbones and cannot be 
processed and presented to T cells, however some proteinaceous viruses have 
repeating epitopes allowing TI activation but may also be processed and 
presented by B cells recruiting T cell help. This is exemplified in mice infected 
with certain viruses e.g. rotaviruses. Although infection of mice with viruses 
normally elicits a TD response, in the absence of aiE T cells a class switched TI 
response can be elicited (40). Antibody responses of the IgG2a, IgG2b or IgA 
but not IgGi isotypes were detected. Help for B cells to class switch in this case 
is proposed to come from cytokines secreted by activated DC, natural killer 
(NK) cells or macrophages. Although the classification of TD and TI may be 
useful for model antigens, it appears that real pathogens, which interact with 
the immune system differently, may not be as easily classified. 
1.5 Isotype switching 
The Ig heavy chain can alter its constant region by rearrangement, a process 
known as isotype switching. Switching to different isotypes results in different 
effector functions for antibodies and hence is useful in enabling the immune 
system to use the most effective mode of action against different pathogenic 
targets. Isotype switching is typically associated with TD immune responses, 
however, limited switching can also occur in response to some TI antigens. 
There are 5 classes of immunoglobulins in rodents and man: 1gM, IgD, 
IgG, IgE and IgA. Naïve B cells express 1gM and IgD on their cell surface, these 
are expressed by default and are generated by alternative splicing of the same 
rnRNA transcript. The expression of other classes requires a recombination 
event similar to that described for the generation of antibody V regions, 
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however, the process is RAG recombinase independent. Although switch 
recombination signals are not as well defined as RSS sequences, a 4 bp sequence 
has been implicated (41). As the intervening piece of DNA is excised during 
isotype switching, a cell can switch again but only to isotypes encoded by 
downstream DNA (42). 
1gM is the first isotype secreted in response to infection, it is primarily 
involved in complement activation but also has a neutralising role. Isotype 
switching results in the secretion of other antibody isotypes. In the mouse there 
are 4 subclasses of IgG (IgGi, IgG2a, IgG2b and IgG3). The IgG subclasses 
neutralise bacterial toxins and viruses, activate complement, and opsonise 
extracellular pathogens for phagocytosis by neutrophils and macrophages. IgA 
antibodies are prominent at mucous membranes and may be responsible for 
protective immunity - the prevention of systemic infection by forming a barrier 
at susceptible sites. IgE triggers degranulation of mast cells and basophils and is 
hence associated with allergic responses, it is also prevalent in the gut upon 
parasitic infection (reviewed in (43)). 
Class switching is dependent on B cell activation by antigen, but also in 
the context of a TD response, signals through CD40 are required (44-46). 
Switching to different isotypes is also influenced by the cytokines secreted by T 
cells and other cell types (47-49). For example, switching to IgGi is associated 
with Th2 responses as switching to yl occurs in response to 1L4, which is 
secreted by these cells. Cytokines exert their influence by inducing the 
transcription of RNA molecules called sterile transcripts, which are required for 
isotype switching to occur (50). Transcription of these small RNA molecules 
may regulate accessibility to the DNA hence allowing switch recombination to 
Chapter 1 	 25 
occur. Switching occurs about 6 days after activation in a TD response, just after 
CC formation and the initiation of somatic hypermutation (51). 
In the mouse, model TD antigens elicit robust antibodies of all isotypes, 
whereas model TI-1 antigens induce only 1gM and IgG3 responses. The 
response elicited by TI-2 antigens is less easily defined. The finding that TI-2 
antigens can provide a TI antibody response does not mean that T cells cannot 
play a permissive role as this class of antigens can sometimes recruit T cell help. 
In normal mice stimulation through CD40 has been shown to synergise a TI-2 
response in vitro (52) and in vivo (53). This indicates that although that B-T cell 
interaction is not a requirement for isotype switching in an immune response to 
TI-2 antigens, that T cells may influence the response. 
In the absence of the possibility of costimulation through CD40 in CD40 
deficient (44) and CD154 deficient mice (54) TI-2 antigens can still elicit antibody 
responses of all classes. Isotype switching in this case is elicited by cytokines 
secreted by other cell types. It is now known that multiple cell types that 
participate in the immune response can secrete cytokines. Specifically IL-4, IFNy 
and TGF-O can be synthesised by both T and non-I cells. Mast cells can secrete 
IL-4, NK cells are a source of IFNy (47);, TGF-O can be made by B cells and 
macrophages (48). 
Class switched antibodies are monomeric (with the exception of IgA 
which is dimeric). In contrast 1gM, the first antibody class to be secreted is 
pentameric. In order to make up for the shortfall in avidity of monomeric 
antibodies, B cells undergo the process of affinity maturation (55). This results 
in the generation of high affinity class switched antibodies. 
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1.6 Affinity maturation 
Serum antibody elicited following immunisation with TD antigen increases in 
affinity for antigen during the course of an immune response (56-58). The 
secondary B cell repertoire, which is derived from the B cells triggered in the 
primary response, also consists of cells with improved antigen binding 
characteristics. This improvement in the affinity of BCRs and secreted antibody 
for antigen is known as affinity maturation and is dependent on somatically 
induced variation of antibody genes, and the subsequent selection of high 
affinity antibodies. 
Somatic hypermutation has long been known to contribute to affinity 
maturation and is a well-studied phenomenon, although many interesting 
questions about it still remain. During the process of somatic hypermutation 
point mutations, but also rare deletions and insertions are introduced into the 
variable region DNA of the heavy and light chains. These are responsible for 
the alteration of affinity, due to amino acid substitutions that subtly change the 
shape of the protein, affecting antigen binding sites. The mutation process is 
very effcective at creating antibodies with altered affinities for antigen. 
Increases in affinity ranging from ten to one hundred fold can result from as few 
as two amino acid substitutions in a 100 residue V region (59-61). However, the 
majority of expressed mutations in B cells do not confer higher affinity and may 
even result in loss of binding (62). Until recently somatic hypermutation in the 
GC was thought to be the only mechanism leading to somatic receptor 
diversification and affinity maturation. Receptor revision a recently reported 
means of inducing somatic variation may also play a role. 
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Variation introduced into antibody genes during an antigen dependent 
response is generated randomly in B cells. Following this generation of 
diversity, a small number of high affinity antigen binding B cells, improved in 
somatic events are selectively amplified. This is due to the improved binding of 
their receptors to the antigen presented in the GC on follicular dendritic cells 
(FDCs) and hence, more efficient recruitment of T cell help. The selection of 
high affinity variants results in an improved antibody response and is the basis 
of affinity maturation. 
1.7 The germinal centre - the site of affinity maturation. 
GCs are distinctive areas of B cell proliferation that develop in B cell follicles 
during the first week of a TD antigen response. The GC reaction has been 
proven to be pivotal in the maturation of primary antibody responses and the 
development of memory B cells through studies of human and mouse GCs. 
The first investigations into the role of CC in affinity maturation were 
made by MacLennan and Gray (63). The strong correlation between the kinetics 
of GC formation and the induction of somatic mutation, led them to suggest that 
affinity maturation took place in this compartment. Direct evidence that 
mutation occurs in GCs was provided by amplifying and sequencing V regions 
of GC B cells. These cells were either niicrodissected from individual GC (64) or 
were isolated on the basis of their affinity for peanut agglutinin (PNA) - only 
GC B cells up regulate the sialic acid modification that this lectin recognises (65). 
In this study mutations in response to the hapten 2-phenyl-oxazolone (Ph-OX) 
were detectable in GC B cells from day 12, whereas mutations did not appear in 
the non-GC B cells until 4 weeks after immunisation. Results from these 
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experiments prove that GCs are the site of affinity maturation and the location 
of most highly mutated B cells. 
Despite the fact that most mutation occurs in GC there exists some 
evidence for the occurrence of V region mutation outside the GC, but at a lower 
level. Affinity maturation has been shown to occur in lymphotoxin cx deficient 
mice, which fail to form GCs (66). Mutation was noted in response to 4-
hydroxy-3-nitrophenyl (NP), and on continued stimulation with high doses of 
antigen somatic mutations were noted, although at only 30% of the total number 
of wild type (wt) mutations. A similar phenomenon was found in mice 
transgenic for mcTLA4-Hyl, which also fail to form cc. These mice have 
somatic mutations in hybridomas generated from B cells but at a decreased level 
(67). Although these results provide evidence for somatic mutation occurring 
outside the cc they are still consistent with GCs being the principal site of 
activation of the process under normal physiological conditions. 
1.8 The germinal centre reaction 
In response to model protein antigens, GCs tend to peak in numbers at around 
10 days and persist for around 30 days (68). In addition to cycling B cells, GCs 
also contain a population of CD4 T cells that are antigen specific (69); and a 
supporting stromal network of FDCs. In addition, there is a substantial number 
of macrophages that deal with the large amount of apoptotic cell death that 
results from negative selection of low affinity mutants generated there. These 
macrophages are termed tingible body macrophages as apoptotic bodies are 
visible within them making them morphologically distinctive. 
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As mentioned, signals from T helper cells are required for GC initiation, 
however, later signals from GC T cells are also required for GC maintenance. 
MacLennan's group found that in the unusual case of an NP specific site 
directed transgenic mouse, GC could be initiated by the TI-2 antigen NP-Ficoll 
(70). However these CC rapidly disintegrated 5 days after immunisation, 
indicating that CC maintenance is dependent on T cell signals. In particular, 
CD40 on B cells and its ligand CD154, which is induced on  cells following 
activation, have been shown to be critical for the development of CC and the 
induction of somatic hypermutation. Mice defective in either of these molecules 
do not form CCs and have severely diminished IgC responses to TD antigens 
(44,45). Treatment of pre-immunised mice with anti-CD154 or anti-B7-2 
completely inhibits CC formation. Later in the response treatment with anti-
CD154 but not anti-B7-2 results in the disintegration of preformed CC indicating 
that signals through CD40 are required for both the initiation and maintenance 
of CC (71). 
In addition to CD154 and B7-2 the inducible costimulatory molecule 
(ICOS), expressed by activated T cells is involved in GC development. ICOS 
deficient mice have few CC and decreased antibody production. Conversely 
mice that over express the ligand for ICOS (B7RP-1) have enlarged lymphoid 
tissues that have plentiful GCs and plasma cells (72). 
Following antigen specific B and T cell interaction in the primary follicles. 
B cells collect in FDC networks where CC founder B cells undergo rapid 
proliferation. FDCs retain antigen-antibody complexes that are critical for the 
selection and survival of high affinity B cell that have undergone mutation of 
their V regions. CC develop to their fully formed state in around one week. 
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They can be seen to be polarised morphologically, into a light zone and a dark 
zone. Centroblasts, B cells in the basal dark zone of the GC proliferate 
extensively with a division rate of six hours, giving rise to centrocytes, which 
migrate into the apical light zone (73). It is during the proliferative stage in the 
dark zone that somatic hypermutation occurs. Subsequently selection of 
affinity-matured mutants occurs in the light zone. 
It has been proposed that cyclic re-entry from light zone to dark zone 
results in the high rate of mutations accumulated (74). Centrocytes, B cells in 
the light zone, express low levels of the anti apoptotic molecule BCL2 and high 
levels of the pro-apoptotic molecule FAS (75). This renders these cells prone to 
apoptosis unless they are positively selected. In the absence of FAS on B cells 
clonal selection in CC and the subsequent generation of the memory pool is 
impaired (76). 
The survival of GC centrocytes requires signals through the BCR from 
antigen on the surface of FDCs and from antigen specific T cells through CD40. 
Somatically mutated centrocytes are selected according to the affinity of their 
surface immunoglobulin (slg) for antigen expressed on the surface of FDCs. 
Cells with lower affinity for antigen are out-competed for FDC binding and die 
as they are not positively selected. This phenomenon has been mimicked in 
vitro. It has been shown that the tendency of tonsillar B cells to undergo 
apoptosis can be delayed by crosslinking their slg using anti Ig immobilised on 
solid supports, imitating the interaction with FDCs (77). Later in the selection 
process a signal for long-term survival is provided by T cell help in the form of 
CD40 ligation (77). Any autoreactive B cells which may have been generated by 
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the mutation process will not receive this second signal and will die preventing 
any deleterious effects of the high level mutation process (Figure 1.4). 
1.9 Somatic hypermutation 
1.9. iDiscovery of somatic hypermutation. 
Somatic hypermutation of B cells plays a key role in affinity maturation. The 
first suggestion that somatic mutation could enrich the diversity of antibodies 
was made by Burnet (2), as part of his clonal selection theory. These ideas were 
clarified by Lederberg (78) who presciently suggested that 
'The hypermutability of a patch of DNA may be a 
specially evolved solution' 
The first study to really show that this indeed may be the case was from 
Weigert et al. (79). They sequenced DNA from plasmacytomas expressing the 
same VA1 gene and found that few of them were the same. They hypothesised 
that somatic diversification by spontaneous mutation resulted in the mutants 
discovered. The final evidence for the introduction of point mutations into 
antibody V genes, was presented simultaneously by several groups in 1981. 
Specific mouse strains and specific antigens (the response to which had been 
well characterised) were employed, allowing clear distinction of the sequence of 
mutated V genes from that of the germline (80-82). 
It has been since been estimated, by analysing V region DNA sequences 
at various time points in the immune response and estimating the number of 
cell divisions which occurred in that time, that the mutation rate in the primary 
response is iO mutations per bp per generation and 10 3 per bp per generation 
in the secondary response (83). 
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Figure 1.4 Germinal centre reaction 













Mutation of proliferating centroblasts in the dark zone is followed by migration 
to the light zone and selection on the basis of affinity for antigen. 
I cells provide a rescue signal for cells that bind foreign antigen, autoreactive 
cells which fail to receive this signal die. (see text for further details) 
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This rate is significantly higher than the background mutation rate of 1012 
mutations per bp per generation. In fact, it has been hypothesised that if the 
rate of mutation was any higher that selection of high affinity mutants would be 
compromised (84). 
1.9.2 Characteristics of somatic hypermutation. 
Somatic hypermutation is an amazing phenomenon; no comparable event 
occurs elsewhere in the genome. Indeed, mechanisms are in place in most cell 
types to prevent mutation of any sort occurring. Although the timing and 
location of the process have been elucidated, the molecular mechanisms and in 
vivo triggers as yet remain unexplained. The analysis of the intrinsic 
characteristics of somatic hypermutation is important as it gives an insight into 
the molecular mechanisms involved in the mutation process. 
The most intriguing feature of somatic hypermutation in B cells is the 
specificity of this high rate mutation (4% in mammals), which is many orders of 
magnitude higher than the spontaneous rate, to the V region only (85). 
However, the nature of the mutations themselves is also of interest: 
they are normally nucleotide substitutions, with rare inversions or deletions. 
There is a preference for transitions over transversions and there is a coding 
strand bias, also different nucleotide sequences have varied mutability resulting 
in intrinsic hot and cold mutation spots. 
The 5' boundary of mutation is within the leader intron of the Ig V region 
gene. Mutations extend over 1.5kb with a slow decline in frequency beyond the 
V-J join and there is no defined 3' boundary (85) (Figure 1.5). Mutations are 
mainly seen to occur in the three CDRS, which are the contact areas for antigen. 
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Figure 1.5 Distribution of mutations over the antibody coding region. 
1 
1 k 	2 k 
Mutations are introduced over the entire V region DNA, starting at the leader 
sequence and continuing over the rearranged V region into the downstream 
intronic region. (From ref. 83) 
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Mutations in CDRs are more likely to affect antigen binding affinity and are 
consequently more likely to be selected explaining the prevalence of mutations 
in these regions. Approximately 30% of total mutations are silent, these being 
distributed equally between CDRs and FRs as they are not selected for, 
indicating that the mutation mechanism itself does not discriminate between 
these two regions (86) 
The mutation process was at first thought to occur randomly along the V 
region. However it was noticed that certain sequences of DNA carried 
mutations more frequently than others. These regions are called hot and cold 
spots and their discovery has given a further insight into process. The question 
arose as to whether hotspots were due to antigenic selection, or due to local 
nucleotide sequence. The occurrence, however, of frequently repeated silent 
mutations, which are not selected for, suggested that intrinsic hotspots of 
mutation might exist (87). 
Nucleotide substitution preferences have been determined by analysing 
somatic mutation in passenger transgenes, which are not translated due to the 
presence of translational termination codons within the coding region 
(upstream, downstream and non-productively rearranged alleles can also be 
used for the same purpose). For this reason there is no antigenic selection and 
all mutations can be seen in an equal light, allowing intrinsic hotspots to be 
distinguished from those that are selected. Data shows that mutations are not 
random for either base substitution preferences or distribution. They also 
showed that the effect of skewing by antigenic selection can be considerable; key 
mutations that increase affinity were frequently found (88, 89). 
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The mutation mechanism, as well as displaying preference for certain 
sequences, also displays a preference for the type of mutation. A bias for 
transitions (Fume (A or G) to Purine or Pyrimidine (T or C) to Pyrimidine) over 
transversions (Purine to Pyrimidine or vice versa) is an intrinsic property of the 
mutation mechanism with a 59% transition frequency as opposed to 33% 
frequency anticipated on a random basis (90, 91). There also exists clear 
evidence of a strand bias to the mutation process; on the coding strand Gs and 
As are mutated at a higher frequency than on the non-coding strand. (92). This 
strand bias made it seem unlikely that an error prone DNA polymerase was 
involved (85), as this would target both strands equally due to the nature of the 
replication process. However, the recent discovery that mutation cannot occur 
in the absence of DNA polymerase iota in a Burkitt's lymphoma cell line may 
conflict with this (101). 
The intrinsic features of somatic mutation discussed above have helped 
to shed some light on the mechanism of mutation. These, along with the now 
known cis-acting sequences required for the process, have led to the 
development of possible models to explain what is happening and how it 
happens. 
1. 9.3 Cis-acting DNA sequences 
The elucidation of the mechanism of somatic hypermutation has been aided by 
the investigation of the local regions of DNA, which, acting in cis, are required 
for the process. Following the discovery by Hackett (93) that chromosomal 
location was of no importance, the requirement for V region DNA itself has 
been investigated. It was shown by replacing the V region with various 
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heterologous sequences including human 0 globin or prokaryotic gpt and neo 
genes, without affecting somatic mutation, that the V region coding DNA 
sequence is not of importance (94). This study demonstrates that non-
evolutionarily selected sequences can still display features of mutation similar to 
that which occurs in the V region. 
The requirement for the V region promoter has been investigated, as a 
link between mutation and transcription was suspected. This was considered 
due to the lack of mutation in unproductively rearranged and non transcribed V 
genes, which had been allelically excluded. It has been shown that the VK 
promoter can be replaced by the P globin promoter with little change in the 
resulting mutation frequency, indicating that the promoter does not target the 
mutation mechanism to the V region (95). It has since been shown that perhaps 
all that is required for mutation is an active promoter, resulting in transcription 
of the gene, and that specificity is provided in another fashion (85). More 
recently mutation of the heavy chain has been shown to correlate with 
transcription (96). In this study passenger transgenes were placed under the 
control of either an RNA polymerase I or II promoter or no promoter at all. The 
mutation frequencies correlated with the levels of transgene-specific pre-mRNA 
expressed in GC B cells isolated from the transgenic mice. 
In the search to find out what targets mutation to V regions Sharpe et 
al. (89) investigated the surrounding region of DNA, and found that elements 
located between 1kb and 9kb 3' of the CK gene were necessary for 
hypermutation of the V region. They studied the response to Ph-OX in a 
K transgene with 9kb 3' of the C region and found that mutation was still 
correctly targeted to the V region. However, a shorter transgene with only 1kb 
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3' of the C gene was not the target for somatic mutation. The 3' enhancer has 
since been located to this downstream region and has been found to be essential 
for somatic mutation (97)(Figure 1.6). 
The K intron enhancer and the closely linked matrix attachment region 
(MAR) are also critical for the process (98). It was thought that this could be due 
to the role of enhancers as activators of transcription. However, removal of the 
intron enhancer did not affect transcription as determined by RNA quantitation. 
Thus the intron enhancer might be required for factor recruitment with 
transcription being activated by the 3' enhancer instead. This is thought 
especially likely as the intron enhancer has binding sites for topoisomerase II, 
which might be involved in creating single stranded nicks in the DNA. These 
could be required in the mutation process (90). 
It therefore appears that both enhancer elements in the kappa locus are 
required to activate full mutation although there is dispute over which enhancer 
is more important (92, 95). Enhancers appear to provide specificity, targeting 
mutation to the V region. Their action could be direct, by recruiting a factor 
involved in hypermutation, or indirect, by affecting transcription or chromatin 
structure (95). In the search to find the method of targeting mutation to the V 
region specifically, the promoter and the V region DNA itself have been deemed 
unimportant. 
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Figure 1.6 Location of the immunoglobulin enhancers. 




A rearranged murine ic locus, illustrating the location of the intron enhancer , the 
nearby matrix attachment region and the 3' enhancer 
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1.9.4 Mechanism of the mutation process 
The intrinsic features of somatic mutation along with the results of transgenic 
analysis have allowed the formulation of several models to explain the process 
of somatic hypermutation. These models have been changed and updated as 
more information has been discovered regarding the involvement of cis-acting 
sequences and other features. Recently models involving DNA mismatch repair 
enzymes have been prevalent due to research in a number of knockout animals. 
However, the conclusion is that mice that lack DNA repair enzymes have 
pleiotropic defects due to elevated mutation levels throughout the genome and 
that results from these mice are misleading (99, 100). 
In the last 2 years significant progress has been made towards the 
elucidation of the molecular mechanism of somatic hypermutation. And indeed 
in a very recent study the 'mutator' itself may have been discovered (101). In 
2000 the activation induced cytidine deaminase (AID) was found to required for 
both class switching and somatic hypermutation in mouse B cells (102). This 
was the first report of a gene that was required for somatic mutation. The 
requirement for AID was discovered following augmented class switching in a 
B lymphoma with induced over expression of AID, which is expressed 
specifically in GC B cells (103). 
AID deficient chimaeras were subsequently made and it was observed 
that mice suffered from hyper 1gM syndrome, in the absence of class switching, 
and also that they did not accumulate mutations in their V region genes (102). 
AID deficiency has subsequently been reported as a cause for autosomal hyper 
1gM syndrome in humans, (104). Despite the fact that AID deficient B cells 
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cannot undergo class switch recombination (CSR) and somatic hypermutation, B 
cells develop normally and their activation is not impaired as they form GCs 
and secrete antigen specific 1gM. It was proposed that CSR and somatic 
hypermutation relied at least in part on a common molecular mechanism (102). 
The role of AID in somatic hypermutation has been confirmed in vitro in 
two mutating cell lines: BL2 (105) and RAMOS (106). The centroblast like 
RAMOS cell line, which undergoes somatic hypermutation was found to have 
levels of mutation correlating with levels of AID mRNA in different clones. By 
transfecting these cells with AID expressing vectors, mutation rates in low AID 
expressing clones were increased. Also transfection of hybridomas, which do 
not normally mutate as they represent a later stage in B cells differentiation, 
with an AID expressing vector, induced mutation in these cells. AID has also 
been shown to be required for gene conversion in chickens (107) implicating it in 
all B cell specific modifications of Ig genes. 
The mode of action of AID is not yet fully elucidated. Initially it was 
proposed to act as an RNA editing enzyme that modified an RNA molecule 
coding for a protein common to both the CSR and somatic mutation 
mechanisms (108). AID has homology to the mammalian RNA editing enzyme 
APOBEC-1, which alters ribo-cytidine to uridine in apolipoprotein B RNA. It 
also has a cytidine deaminase RNA editing capacity. 
More recently a role for AID in DNA cleavage, which has been 
implicated in CSR and somatic hypermutation, has been examined (109-111). It 
has however now been reported to function in a post cleavage step as cells 
lacking AID still accumulate DNA lesions in target sequences for somatic 
mutation (112). Most recently AID has been proposed to play a direct role in the 
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causation of mutation of DNA within the immunoglobulin locus itself. AID 
deaminates dC in DNA to dU; it has been proposed that uradil-DNA 
deglycosylase then excises these uracils resulting in gaps in the DNA. These are 
replicated over resulting in the introduction of transversions in chickens. 
Inhibition of uracil-DNA deglycosylase shifts the pattern of V gene mutation 
from transversions to transitions, implicating AID in the alteration of DNA 
(113). 
Despite the ongoing investigation into the role of AID in somatic 
mutation, it now appears that a more directly associated molecular component 
has been discovered (101). Much research had been performed into a role for 
error prone polymerises in somatic hypermutation (reviewed in (114)). 
Although most of the investigations into specific polymerises gave negative 
results, pol has been implicated in 2 studies as its absence resulted in 
decreased mutation rates (115, 116). 
The recent finding that DNA polymerase iota is required for somatic 
hypermutation in a Burkitt's lymphoma cell line is very interesting (101). Pol 
iota (t) is a member of the Y family of DNA polymerases, which are specialised 
for copying DNA lesions and have high error rates. Its function was 
inactivated, in the same fashion as that of AID was in the BL2 line (105), by 
insertion of neomycin and hygromycin resistance genes in the place of exons 
land 2 or 3 and 4 respectively. The BL2 line can be induced to mutate by 
crosslinking 51gM in the presence of a T helper cell line. In the pol iota 
disrupted cell lines this treatment failed to induce mutation, directly implicating 
it in the mutation mechanism. 
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These recent results support a model whereby single stranded nicks 
introduced into the DNA are repaired in a templated but error prone fashion by 
one or more error prone polymerises. This idea was first proposed by Brenner 
and Milstein in 1966 (117). Due to the recent progress in finding molecules 
involved in the mutation process it appears that we may be close to solving one 
of the most obstinate mysteries remaining in immunology: the molecular 
mechanism of somatic hypermutation in B cells. 
1.9.5 Triggers of the mutation process 
Although the effects and characteristics of this high level directed mutation have 
been investigated, the factors required for induction of mutation in vivo are still 
unclear. Somatic mutation occurs in the TD immune response and it has been 
shown that LPS stimulation of B cells is insufficient (118). The participation of 
CD4 T helper cells is required for full activation of mutation in GCs in vivo. To 
demonstrate this, nude mice, which neither have T cells nor mutate, were 
reconstituted with different levels of CD4 T cells and GC cells were isolated by 
microdissection and their V regions sequenced. Mutations were found to 
accumulate in GC in proportion to the number of helper T cells present 
implicating these cells in the activation of mutation in GC (119). 
These results have lead the way to experiments performed in vitro, which 
aimed to isolate the specific molecular interactions involved. Kallberg et al. (120) 
discovered that cognate T cell help and crosslinking of slg were required to 
sustain mutation in vitro of B cells primed in vivo. However, as previously 
shown (118), LPS stimulation or CD40 ligation were shown to be insufficient. 
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CD40:CD154 interactions while sufficient for class switching and proliferation 
are insufficient for mutation induction in B cell lines (121, 122). In the human 
system Denepoux et al. (123) demonstrated that crosslinking of a Burkitt 
lymphoma cell line with Ig and co-culturing with activated cloned T cells 
induced mutation. 
Mutation was first triggered in naive cells in vitro in 1997 by Banchereau 
and co- workers (124). Human tonsillar slg D CD23 cells mutated following 
crosslinking of their membrane Igs in the presence of activated T cell clones 
however activation through CD40 in the presence of cytokines IL 2, 4 and 10 
was insufficient. This demonstrates that secreted T cell factors are insufficient 
and suggests that the process may be contact dependant. Huang et al. (125) 
subsequently demonstrated mutation initiation in normal human IgD+ B cells in 
the presence of activated CD4+ T cells in a contact dependant manner. 
Recently Zan et al. (126) have demonstrated the induction of both 
mutation and class switching in human IgM+ IgD+ B cell line. Previous cell 
lines used to investigate mutation have been unable to switch. They found that 
crosslinking of the slg was required along with T cell contact through 
CD40:CD154 and CD80:CD28. This experiment would be even more convincing 
if it could be repeated with normal naive cells. Experiments described in this 
thesis and published (127) address this and show that signals via CD40 and the 
BCR are sufficient to induce mutation in naive cells in vitro as long as cell 
proliferation can be maintained. 
All of the above experiments have demonstrated a dependence on signals 
through the BCR and from the T cell. Neither of these requirements is 
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surprising as both of these signals are necessary for B cell activation in an 
immune response. 
1.10 Receptor revision 
1.10.1 Discovery of receptor revision 
Receptor revision is a second process that may play a role in affinity maturation. 
It involves the secondary rearrangement of variable genes on rearranged Ig loci 
in the periphery (Figure 1.3), allowing the B cell to alter the specificity of its BCR 
(Reviewed in (30, 128, 129)). This is a relatively new idea as it was thought that 
B cells could express only a single receptor, selected during development in the 
bone marrow. 
The term receptor revision refers specifically to secondary V(D)J 
rearrangements that occur in the periphery, as opposed to receptor editing 
which refers to the same process if it occurs during development in central 
lymphoid organs. Until recently secondary V(D)J rearrangement was thought 
to be restricted to the bone marrow. Han et al. and Hikida et al. (130, 131) 
proved otherwise in two papers published side by side in the journal Science. In 
both papers RAG protein and mRNA were detected in activated B cells from 
splenic and Peyer's patch GC (and subsequently in draining lymph nodes (132)), 
suggesting a role for these proteins in V(D)J recombination in the periphery. 
Functional studies followed with the demonstration of RAG activity in GC B 
cells. Kelsoe's group (133) detected intermediate products of V(D)J 
recombination in the B220 10 subset  of GC B cells recovered from immunised 
C57BL/6 mice; a population which is already destined to die, thus 
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'the improbable genetic experiment of receptor revision is 
confined to B cells that are destined for programmed cell 
death'. 
These results were concurrent with those of Nussenzweig's group (134), 
who showed VJK  and VDJH rearrangements in splenic B cells from mice with 
targeted heavy and light chain alleles (V B1-8 DJH2 and V383 Jk2) / cultured in 
vitro with LPS and 1L4. Hikida et al. (135) also detected excision products 
reflecting VU to lxi rearrangement in parallel with RAG expression in mature 
mouse B cells from the same gene targeted mice, activated in vitro with LPS and 
IL-4. Similar rearrangement was also seen in cells in the draining lymph nodes 
of immunised mice; In situ PCR localised these cells to GCs. Although 1L4 has 
been used to induce RAG expression in vitro , it has since been shown that 1L7 
may be the critical cytokine in the induction of RAG expression in GC in vivo as 
RAG expression is unperturbed in the GC of 1L4 deficient mice whereas 
blocking the 1L7 receptor with anti 1L7 antibodies greatly decreased RAG 
expression in GC (136). 
In the bone marrow receptor editing is a tolerance mechanism. It is 
activated in an attempt to rescue cells with auto-reactivity which otherwise 
would be clonally deleted. The function of receptor revision in the periphery 
was not quite as clear. As mentioned, Kelsoe's group favoured the idea that 
receptor revision in GCs was a method of increasing diversity. However, the 
possibility that it might be involved in peripheral tolerance, possibly of new 
specificities generated by somatic mutation, had not yet been ruled out. 
Nemazee's group investigated this question (137) by measuring V(D)J induction 
as a function of antigen receptor signalling. In their system receptor revision 
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was measured by the presence of X expressing B cells in a K light chain 
transgenic mouse (3.83 transgenic) - indicating rearrangement of the 
endogenous light chain. They found that tolerance was unlikely to induce V(D)J 
recombination in mature splenic B cells as BCR ligation inhibits recombination 
induced by IL-4 and LPS in splenic B cells in vitro. In vivo, immunisation of Ig 
transgenic mice with ligands of varying avidities for the BCR showed that low 
avidity antigen could induce strong V(D)J recombination whereas non-binding 
or high affinity antigen could not. If secondary rearrangements in the periphery 
were in response to self antigens we might expect to see the opposite occurring: 
V(D)J recombination in the presence of a signal through the BCR. Autoreactive 
B cells in the periphery are normally removed by deletion when they encounter 
membrane bound antigen (138). 
In human tonsillar B cells Meffre et al. (139) showed that mature B cells, 
expressing non-transgenic antibodies, undergo peripheral V(D)J recombination. 
The presence of TgK  signal breaks, intermediates in V(D)J rearrangement, had 
been determined indicating kappa light chain rearrangement in GC B cells. 
However, RAG expression and that of terminal deoxynucleotidyl transf erase 
(TdT) - another protein required for efficient antibody assembly - was halted 
following receptor crosslinking. They propose that B cells, which have already 
attained high avidity for the prevalent antigen by mutation, would not need to 
revise the V region of the receptor and hence RAG is switched off. These cells 
receive a strong signal through their BCRS having bound antigen, which is 
probably held on the surface of FDC. B cells with receptors that do not have 
strong affinity for antigen are given another chance, before they die by neglect, 
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to alter the entire V region and hopefully provide a useful specificity. These 
cells continue to express RAG. 
Although clonal selection implies that cells selected to go into the GC 
should retain their specificity, new recombination might function to rescue B 
cells that make deleterious mutations. Or perhaps it could act as an alternative 
mechanism for producing high affinity antibodies in the CC. Although, as Han 
(133) says, this is an unlikely genetic experiment, any high affinity recombinants 
that do arise would be preferentially selected for and clonally expanded. It does 
appear to be worth the risk. 
At this stage the V(D)J recombination machinery had been shown to be 
active in vivo (133,134) and regulated by signalling through BCR in vitro in 
human tonsillar B cells (139). The presence of intermediates of the 
recombination process indicated kappa light chain rearrangement. In transgenic 
mice actual V(D)J recombination had been shown to occur in response to low 
affinity antigen by detecting newly rearranged lambda light chains from the 
endogenous locus in a K transgenic system (137). 
The above experimental evidence supports the idea that V(D)J 
recombination in mature B cells exists to increase the diversity of the antibody 
pool and to increase recognition of foreign antigen and not to prevent 
recognition of self as it does in the bone marrow. In the bone marrow antigen 
encounter leads to RAG expression whereas in the CC BCR ligation turns off 
RAG expression. How can this be the case? Benschop et al. have investigated 
the responses of immature and mature B cells following BCR ligation (140) and 
found that immature B cell responses require a much smaller increase in 
intracellular free calcium than does the induction of mature B cells responses. 
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Thus the cells are intrinsically different in their response to signalling through 
the BCR. Sandel and Monroe have also demonstrated that the bone marrow 
microenvironment provides signals that block antigen induced deletion and 
promote RAG expression (141). In the periphery the absence of these signals 
allows immature, but not mature B cells, to default to apoptosis as a result of 
BCR engagement, explaining the different responses of these cells to BCR 
ligation in the presence of RAG. The cellular constituent of the bone marrow 
dull 	pos 
microenvironment was defined subsequently as a novel Thyl , DX5 cell 
that is found in close association with immature B cells in vivo (142). 
It is difficult to show directly the result of revision, a newly rearranged 
antibody, without using transgenic systems where the specificity of the BCR is 
already known. Transgenic systems attract criticism due to the fact that the B 
cells may be subjected to unnatural pressures to alter their receptor specificities. 
However, much evidence now exists in transgenic and non transgenic systems 
that RAG is expressed in GC and that it can cause the secondary rearrangement 
of V genes in the periphery. 
Subsequent investigations into receptor revision in the periphery can be 
divided into those that focussed on RAG expression, and those that directly 
examined peripheral rearrangements and their prevalence in vivo. The latter 
can be further subdivided into those which employed transgenic systems and 
those that selected a more physiological system with a diverse B cell repertoire. 
Transgenic systems allow easier determination of secondary rearrangements on 
the basis of loss of expression of the transgenic receptor. Non-transgenic 
systems require the employment of sequencing of hybridomas generated from 
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individual B cells to determine the temporal relationship between the onset of 
somatic mutation and the rearrangement of receptors to localise revision to CC. 
Both approaches are discussed in subsequent sections, separating investigation 
into rearrangements at the heavy and light chain loci. 
1. 10.2 RAG expressing cells in the periphery 
The RAG expressing cells in previous studies were found to be localised to GC 
and to express GL-7, a marker of CC B cells (130, 131). These cells could be 
mature B cells that re-induce RAG expression during an antigen driven immune 
response or they might reflect an accumulation of immature cells B cells that 
continue to re-express RAG having recently emerged from the bone marrow 
(143). This is supported by the fact that as well as being expressed on GC B cells 
GL-7 is also a marker of immature B cells. RAG expressing cells were also 
found to express lambda 5, a component of the pre-BCR (130). A number of 
groups have investigated the source of RAG expressing cells using mice that co-
express RAG and green fluorescent protein (GFP), which can be used as a 
marker of RAG expression by flow cytometry. Several RAG/GFP transgenic 
mice have been used in these experiments. One mouse employed has bacterial 
artificial chromosome (BAC) containing GFP under the control of the RAG2 
promoter (144). A second possesses a site directed RAG/GFP fusion gene in 
which the GFP gene has been inserted into the RAG2 locus (145); a third uses 
similar technology for the RAG1 locus (146). 
The BAC system was employed first by Yu et iii. (147). They found that 
cells of an immature phenotype (transitional B cells (148)) continued to express 
RAG in the spleen, as indicated by GFP expression. They also found that RAG 
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was not re-induced following immunisation in mature B cells. However, the 
transitional B cells represented between 5 and 30% of B cells in the spleen 
making their contribution not insubstantial. RAG expressing cells in the spleen 
were found to have V(D)J recombination intermediates, detected by PCR, 
indicating recent gene rearrangement. To determine whether these GFP 
positive cells could form GC they were adoptively transferred to RAG1 deficient 
hosts and mice immunised with the hapten NP conjugated to a protein carrier, 
GFP positive cells (and similarly transferred GFP negative cells) formed GC and 
made antigen specific IgGi indicating that they can respond to antigen in vivo. 
Again, however, RAG expression was not re-induced in GFP negative cells and 
those that were GFP positive lost expression. Re-induction of RAG expression 
in vitro with 1L4 and LPS as previously reported (134, 137) also failed. 
Yu et al. conclude that RAG expression is not re-induced in the periphery 
following immunisation. These results limit the RAG expressing cells 
determined in other experiments to a small number of immature cells that may 
enter the GC before they have turned off RAG expression. These results appear 
to be contradictory to those of other groups who found re-induction of RAG in 
splenic cells in vitro under the specified conditions. This may be reconciled 
with the findings of Hertz et al. by speculating that low affinity antigen might 
slow down the maturation of immature cells resulting in the continued 
expression, rather than the proposed re-induction of RAG (147). 
Further investigations into RAG expression in the periphery were 
performed in the site directed RAG2/GFP mice in which the expression of RAG 
is proposed to be more physiological. 2 studies found that the immunisation 
process alone could have an effect on the numbers of transitional B cells in the 
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spleen (143, 149). This occurs due to a lymphopoietic burst of immature B cells 
from the bone marrow about 5 days after immunisation. This burst occurs in a 
non-antigen specific fashion, as the adjuvant alum also has this effect if used on 
its own, and may account for the perceived re-induction of RAG detected by 
PCR in previous studies. (143). Gartner et al (149) further demonstrated that 
bone marrow cells were the only one to express GFP in the spleen following 
adoptive transfer of splenic and bone marrow B cells to RAG 1 deficient hosts. 
These results were confirmed in the RAG1 /GFP system (146). 
Despite the strong evidence against RAG re-expression in mature B cells, 
transitional B cells, present in the spleen, have been shown to continue to 
express RAG and undergo V(D)J rearrangement (147). These cells have also 
been shown to form GC when immunised following adoptive transfer to RAG 
deficient hosts. They may account for the perceived re-induction of RAG 
reported previously and more importantly may play a role in an antigen specific 
immune response. 
1. 10.3 Receptor revision in murine Ig transgenic systems 
In murine Ig transgenic systems, receptor revision has been demonstrated in B-i 
B cells and in MRL/lpr mice. Both B-i B cells and B cells from MRL/lpr mice 
are prone to autoinimunity, which may be important when interpreting results 
obtained from these mice. B-i B cells are a self renewing population of B cells 
that differ from conventional B cells (B-2 cells) in that they are predisposed to 
autoantibody production and reside mainly in the peritoneum. Qin et al. (150) 
show that these cells can express RAG1 and RAG2 and undergo secondary 
V(D)J rearrangement of their Ig heavy and light chain genes. Also, using a 
Chapter 1 	 53 
novel genetic mechanism, they show that the rearrangements detected in the 
periphery occurred in situ, rather than having occurred in the bone marrow. 
The mice used in this experiment express a heavy and light chain site directed 
transgene (V 1-8  Hi, 3.83id). B-i B cells were found to express BCRs other than 
those encoded by the transgenes, as detected by loss of binding with an anti-
idiotypic (Id) antibody. When idiotype (Id) negative cells were sorted by flow 
cytometry they were found to express RAG1 and 2 and to contain intermediates 
in the recombination process. In contrast conventional B-2 B cells most of which 
are Id positive did not have either RAG expression or V(D)J recombination 
intermediates. 
To determine whether V(D)J recombination was ongoing in these cells 
rather than having occurred recently in the bone marrow, Ku80 deficient mice 
were employed. These mice are unable to repair the double stranded breaks 
introduced by V(D)J recombination and the cells die by apoptosis. B-i cells 
were absent in the peritoneal cavity of V 1-8  Hi 3.83Ki Ku80" mice. As the B-i 
compartment is maintained by self renewal, the absence of these cells in the Ku 
80 deficient mice indicates the occurrence of secondary V(D)J rearrangement in 
an ongoing fashion. RAG levels and the presence of reaction intermediates 
were also examined in C57BL/6 and autoinimune prone NZB mice both of 
which were also found to undergo secondary V(D)J rearrangement in B-i B 
cells. This is strong evidence for the ongoing rearrangement of V genes in the 
periphery. 
Peripheral light chain rearrangement in vivo has also been 
demonstrated in mice with site directed transgenes specific for single stranded 
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DNA on the MRL/lpr background. These mice have defects in FAS ligand 
(CD95) resulting in defects in apoptosis (151). In normal mice, B cells that 
possess transgenic antibodies recognising single stranded DNA are silenced. In 
the same mice on an MRL/lpr background these cells have been shown to 
undergo secondary V(D)J rearrangement, possibly in an attempt to avoid 
autoreactivity. The sequencing of hybridomas generated from the spleens of 
these mice allowed a comparison of mutation patterns in cells that had 
undergone secondary rearrangement. This confirmed that the secondary 
rearrangement had occurred after the onset of somatic hypermutation in the 
periphery and resulted in the generation of more anti-self specificities (anti 
double stranded DNA and anti cell nuclei). 
In this case it is possible that a normally beneficial mechanism has been 
turned into a pathogenic process (152) due to the impairment of negative 
selection in these mice. However, interestingly in this study receptor revision 
was also found to rescue B cells that had lost the ability to generate a functional 
antibody due to the inactivation of a light chain by a non-sense mutation 
introduced by somatic hypermutation, indicating one of the possible benefits of 
peripheral revision. 
Autoreactive B cells should be deleted in the periphery by signals 
through FAS from FAS ligand expressing T cells. The newly generated 
autoreactive specificities of these cells would probably not be detected in normal 
mice, however they are detected here due to the defects in the regulation of 
apoptosis. The results in autoreactive systems may not give an insight into the 
normal survival of revised cells but might give us an idea of the frequency of its 
occurrence in the absence of negative selection. It also allows us to see that the 
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random generation of new specificities can result in the generation of auto 
reactive specificities at high level. 
The results in autoimmune prone systems concur with a report in a non-
autoimmune Ig transgenic mouse model. Magari et al investigated the 
contribution of receptor revision to the generation of high affinity anti p-
nitrophenyl acetyl (pNP) antibodies in a mouse with a site directed transgenic 
heavy chain specific for the hapten NP. Immunisation of the mouse with pNP, 
which is recognised with low affinity by the transgenic receptor, led to the 
generation of high affinity antibodies, comprised of heavy chains not encoded 
by the transgene and newly rearranged lambda light chains. RAG2 mRNA 
expression and lambda recombination intermediates were detected in pNP 
immunised mice but not in non immunised mice. These results were 
reproduced in transfers of sorted lambda negative B cells to RAG1 deficient 
animals, indicating that the lambda expressing cells that bound pNP with high 
affinity were produced de novo in response to pNP immunisation. 
All results in transgenic models appear to support the occurrence of 
receptor revision in peripheral B cells, however, as always in transgenic systems, 
there is strong selection for diversification events. Especially in the case of 
autoimmune mice where there is a defect in negative selection, there is an 
abnormal bias for this process to be detected. Potential autoreactive specificities 
will remain due to defects in apoptosis, which removes these cells in normal 
mice. However, these results do show that mechanistically, receptor revision 
can occur. The results of studies in non-transgenic systems may prove more 
informative. 
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1. 10.4 Receptor revision in non-transgenic systems; murine and human. 
Due to abnormal pressures for diversification of the B cell repertoire in mice that 
possess predominantly one BCR, the occurrence of receptor revision may be 
exaggerated. In systems where the repertoire is already diverse this pressure 
does not exist, however, receptor revision has still been detected. Firstly in a 
study of B cells from rheumatoid arthritis (RA) synovial tissue, heavy chain 
revision was detected at a frequency of around 8% (153). The secondary 
rearrangements were proposed to have occurred in situ due to the detection of 
RAG expression and the presence of blunt ended double stranded DNA breaks 
synonymous with the process. Somatic mutation was also shown to have 
occurred in these B cells. Synovial tissues of some RA patients contain CC - 
sites of cell proliferation, where this mutation may have occurred. Although 
receptor revision was found to occur at a high level, RA patients may be prone 
to dysregulated B cell diversification events leading to an increase in the 
detection of the event in these patients. It is unclear whether these cells 
contributed to autoimmune specificities causing disease in this mice. 
In a similar study in MRL mice, which also have defects in apoptosis, 
splenic B cells have been shown to undergo peripheral rearrangement of their 
heavy chains. This is based on a comparison of the accumulated somatic 
mutation and secondary rearrangements between neonatal and 4 month old 
MRL mice with non-MRL mice on the same genetic background (154). 
The above studies are in autoimmune models, in normal non-
autoimmune humans, one important study detected receptor revision at the 
heavy chain locus in tonsillar B lymphocytes (155). Following sequencing of 
hybridomas generated from these individuals, 7 out of 141 sequences 
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investigated had hybrid VH segments, indicating the joining of 2 VH  genes in a 
secondary rearrangement event. These hybrid joins are the only ones detectible 
by PCR as complete VH  or JH  replacement may be mistaken for germline 
rearrangements. As a result this may be an underestimation of the actual 
number of secondary rearrangements in these individuals. Although the 
investigation of somatic mutation places the secondary rearrangement event 
temporally after its onset in the CC, RAG expression was not investigated and 
the possibility that these rearrangements are due to homologous recombination 
remains. 
In contrast to the above results which suggest a high level of receptor 
revision, in another human study (156) Goossens et al. state that receptor 
revision plays no major role in the shaping of the receptor repertoire after the 
onset of somatic hypermutation. A similar technique of cloning and sequencing 
of B cells was employed, however, this time light chain rearrangements were 
investigated. They estimate the frequency of revised cells at below 3% by 
comparing single X cells before and after CC X formation. 
1. 10.5 Conclusions 
There is now a body of evidence in murine Ig transgenic systems and non-
transgenic mouse and human systems, where the repertoire is not restricted, to 
suggest that receptor revision at both the heavy and light chain loci can occur. It 
is most easily detectible in autoimmune models where there may be a defect in 
apoptosis. This means that where receptor revision does lead to the generation 
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of an autoreactive specificity that it may not be removed in the normal fashion. 
However revision has also been detected in normal mice and humans. 
There exists an apparent contradiction between the information gained 
from RAG/GFP transgenic mice which failed to show the re-induction of RAG 
expression in mature cells, with data on V(D)J rearrangement in splenic B cells. 
In order to reconcile these differences we must assume that either RAG re-
expression in the periphery is a very rare event and not readily detectible, or 
that the cells that express RAG in the periphery are recent immigrants from the 
bone marrow that are continuing to express it. Although immature RAG/GFP 
expressing cells have been shown to be able to make an antigen specific immune 
response, it remains to be shown directly whether these cells are the ones that 
undergo receptor revision. 
There 4 possible consequences for a cell that has undergone receptor 
revision (128). Due to the difficulties in rearranging a functional receptor, most 
cells are likely to undergo cell death due to the absence of Ig on the cell surface. 
Following that, of B cells that do generate a functional receptor, most are likely 
to have lower affinity for the antigen. If the theory that receptor revision 
provides useful specificities is correct these should continue to rearrange, as 
they do not receive a signal through their BCR. Some are likely to generate an 
autoreactive specificity. In normal individuals these should undergo deletion or 
anergy, however, these are more likely to remain present in an autoimmune 
model that has defects in apoptosis, and may explain the detection of revised B 
cells in these systems. Finally, a rare serendipitous event may result in the 
generation of a useful specificity that will be selected and clonally expanded. 
We aimed to investigate this latter possibility, to determine whether receptor 
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revision in the periphery can contribute to affinity maturation of the immune 
response. 
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Aims of this study 
Triggers of Mutation 
The first aim of this study was to investigate signals involved in triggering 
somatic mutation in B cells. Although CD4 T cell help and signals through slg 
have been demonstrated to be required(119, 120), the specific molecular 
interactions were still undetermined. We have demonstrated that high levels of 
mutation can be initiated in vitro when naive B cells are cultured with anti-
CD40 antibody, anti-IgK antibody and anti CD38 antibody. Anti-CD40 antibody 
mimics at least part of the interaction between B cells and T cells. Anti K 
antibody provides a signal through slg mimicking antigen recognition. Anti 
CD38 antibody is mitogenic for B cells and CD38 deficient mice have also been 
shown to have defects in antibody responses to TD antigens implicating CD38 
in humoral immune responses. 
In order to confirm that the above signals were indeed important for 
mutation initiation in vivo, mutation levels were determined in immunised 
CD40 and CD38 deficient mice. The levels obtained were compared with those 
of unimmunised and immunised wild type mice. 
Receptor revision 
The aim of the second part of this study is to investigate the hypothesis that 
receptor revision is involved in affinity maturation. George and Gray (157) have 
proposed the idea that receptor revision in the GC collaborates with somatic 
hypermutation in contributing to affinity maturation. It has already been 
demonstrated that receptor revision can rescue B cells that have lost the ability 
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to express antibody due to the introduction of a non-sense mutation (151). 
Therefore It is also possible that secondary V(D)J recombination could allow B 
cells that have lost the ability to bind antigen by deleterious mutation, to have a 
second chance at expressing a useful specificity. Receptor revision might allow 
BCRs to undergo large structural changes, unlike somatic mutation, which only 
allows small changes to be introduced. The proposed mode of collaboration 
between the 2 mechanisms is described below. 
A particular antibody that has been selected in the primary immune 
response can explore the local area on the affinity landscape by somatic 
mutation. Large changes in structure could only be caused by receptor revision, 
which changes the entire V region. This newly formed antibody, which may not 
have been selected in the primary response is now exposed to the 
hypermutation machinery, which may allow greater increases in affinity to 
occur. However, often useless specificities will be created. This idea allows 
receptor revision and somatic mutation to play complementary roles in affinity 
maturation. 
To explain this idea a hypothetical example is given below. A highly 
simplified affinity landscape is shown (Figure 1.7). All possible antigen binding 
sites are shown on the X axis, with the most similar adjacent to each other. On 
the Y axis the affinity of binding sites for a nominal antigen is shown. A 
particular antibody that has been selected during the primary response (A), will 
be altered by point mutation, allowing the immune system to explore the local 
area around A, by making small alteration in the shape of the antigen binding 
site (green). Mutations conferring higher affinity are selected for, allowing A to 
climb the hill until it reached a maximum A'. As mutations conferring lower 
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affinity are lost due to absence of positive selection in the CC, the antibody 
cannot undergo changes to increase affinity if they involve a period of loss of 
affinity. Thus the antibody may be stuck at a local optimum (A'), unable to 
increase its affinity further. 
Receptor revision might allow an antibody to take large leaps through the 
affinity landscape (red). In most cases this will land the antibody in a locale 
where the affinity is lower (B). However occasionally the leap will generate 
antibody on the side of a higher hill (C), which can then use point mutation to 
climb to the top of that hill (C'). Inhibition of recombinase activity by high 
affinity interactions ensures that this process is switched off when it is not 
needed. 
Figure 1.7 Affinity landscape demonstrating the potential effect of 
receptor revision and somatic mutation on receptor affinity 
affinity 
potential antigen binding structures 
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Receptor revision has been shown to occur in peripheral B cells in 
response to low affinity antigens (137). However it has not been shown directly 
whether newly gained specificities may contribute to affinity maturation of the 
response to low affinity antigens. To do this a cohort of transgenic B cells were 
transferred to adoptive hosts. These hosts were then immunised with antigens 
recognised with low affinity by the transgenic B cells. The results of 
experiments performed with two site directed transgenic mice are presented 
here. 
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Chapter 2 Somatic hypermutation. 
Introduction 
Selection of B cells that have undergone mutation of their IgV regions is a cause 
of affinity maturation. The molecular basis for somatic hypermutation of V 
genes is still elusive. Neither the mechanism involved nor the molecular 
triggers have been fully elucidated despite intensive investigation. In this 
chapter we describe an in vitro system to investigate the molecules involved in 
the initiation of somatic hypermutation. We found that hypermutation could be 
triggered in vitro in mouse B cells by stimulating through three cell surface 
molecules: CD40, CD38 and Ig (127). In the absence of any one of these stimuli, 
mutation remains off. The requirement for these signals in vivo was 
investigated in mice deficient in CD40 and CD38. CD40 was found to be 
obligatory for the induction of mutation, however mice deficient in CD38 had 
normal levels of somatic mutation, indicating that its role in vitro is provided by 
other signals in vivo. 
The investigation of somatic mutation in normal mice can be complicated 
by the fact that many V gene sequences are highly related. This makes it 
difficult to distinguish between somatically mutated sequences and naturally 
occurring allelic variation. For this reason a transgenic mouse was employed in 
this study. ELK transgenic mice possess a Vi< Oxi transgene, which provides 
specificity for the hapten Ph-OX, the response to which has been well 
characterised (158-160). The transgenic construct also carries the 3'kappa 
enhancer and the intron enhancer, downstream regulatory elements known to 
be required for the targeting of mutation to V genes (89). The constant region 
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employed is of rat origin allowing amplification of the transgenic V region only, 
using a primer specific for this sequence. 
The problem of distinguishing V genes in CD40 and CD38 deficient 
mouse strains, which do not carry immunoglobulin transgenes, was overcome 
by employing a method first documented by Jolly et al. (161). This method takes 
advantage of the fact that somatic mutations spill over into the region flanking 
the 3' side of VDJH segments (Figure 1.6). By PCR amplifying the abundantly 
used J558 family, the VDJH 3' sequence can be compared in different mouse 
strains. Any one mouse can only carry 2 germline variants of the J558 JH4 
flanked sequence used in this analysis; this variation was readily eliminated to 
allow enumeration of the number of mutations introduced. 
The stimuli used in cultures of B cells from ELK mice were designed to 
mimic signals delivered to B cells during TD responses. Anti Ig was used to 
mimic antigen-antibody interactions, anti-CD40 to mimic CD154 costimulation 
from T cells, and Th2 supernatant as it contains cytokines released from 
activated T cells. We also tested an antibody to CD38, NIMR-5, which has been 
documented to cause proliferation of murine B cells (162). B cell proliferation is 
commensurate with the induction of mutation in CC B cells. 
The results presented in the first part of this chapter were attained in 
collaboration with Siggridur Bergthorsdottir, a previous lab member. 
Investigation into the proliferative effect of anti-CD38 was performed by myself 
alone. 
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Results 
2.1 Splenic B cells stimulated in vitro undergo somatic hypermutation 
B cells from ELK transgenic mice, isolated by CD43 MACS depletion of other 
cell types, were stimulated in vitro with antibodies to various cell surface 
molecules. We chose molecules that we had reason to believe might be 
important in the initiation of somatic mutation in vivo. 1x106 B cells per well 
were plated in 24 well tissue culture plates. The following stimuli were added 
singly or in combination: LPS, anti-CD38 supernatant (provided by Dr Michael 
Parkhouse, IAH, Pirbright, Surrey), anti-CD40, and anti kappa light chain. 
Supernatants from alloreactive T cell clones, as a source of cytokines were also 
used. LPS stimulation alone is known not to induce somatic mutation and was 
used as a negative control(118). Culture medium and stimuli were replenished 
after 4 days and B cells maintained in culture for 7 days. After harvesting cells, 
RNA was prepared, mRNA transcripts from the VKOx1 transgene amplified by 
RT-PCR, cloned and sequenced. The sequences were compared with the 
germline VKOxl sequence and the number of mutations enumerated. 
Representative results from one experiment are shown in Figure 2.1 and 
summarised for 4 experiments in Table 2.1 (see appendix for sequence data). 
Mutation of cultured B cells was only detected in the presence of the three 
stimuli: anti-CD38, anti-CD40 and anti-kappa. Removal of any one of these 
stimuli resulted in a statistically significant reduction in the number of 
mutations introduced. 
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Figure 2.1 Mutation frequency in the VKOX 1 transgene of cultured 
transgenic mouse B cells 
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* P = 0.01 
The frequency of mutations obtained in the Vic Ox transgene following 7-day culture 
of the B cells with combinations of anti x (anti Ig), anti-CD40, and anti-CD38. Only 
the combination of all three stimuli was statistically, significantly different from the 
LPS control (using Fischer's exact test). This result is representative of three other 
experiments. 
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Table 2.1. Frequency of somatic mutations in the VkOX1 transgene in 
splenic B cells stimulated in vitro. 
Stimulus' 	Number of 	Number of 	Number of 	Frequency of p5 
sequences2  mutated mutation S3 mutations4 
sequences 
anti-CD38 	 20 	9 	 20 	1/290 	0.016 
anti-CD4O 
anti-Ig 
anti-CD38 15 6 6 1/725 0.73 
anti-CD4O 
anti-CD38 14 4 6 1/676 0.52 
anti-Ig 
anti-cD40 22 9 10 1/627 0.56 
anti-Ig 




anti-CD38 8 0 0 <1/2320 0.65 
LIPS 12 3 3 1/1140 - 
1  Cultures are the same as those from which the sequences in Figure 2.1 were derived. 
2  Number of independent sequences used for analysis. 
Total number of mutations in all mutated sequences. 
Number of mutations in all sequences divided by the total number of base pairs sequenced. 
Probability using Fisher's exact test that the difference in mutation frequency between LPS and 
triple stimulus is due to chance. 
Chapter 2 	 69 
Z2 The pattern of mutations observed is consistent with that of somatic 
hypermutation induced in vivo. 
The mutations incorporated into the VKOxltransgene by the three stimuli were 
analysed for hallmarks of somatic mutation. The pattern of mutations was 
scattered throughout the V region, with over half in the FR. In vivo, under 
antigenic selection, accumulation of mutations is normally focussed on the 
CDRs with fewer in the FR. CDRs are important for specificity as they are the 
sites that come into contact with antigen, mutations do not normally accumulate 
in FRs as they are required to maintain antibody structure and function. In our 
study, the absence of antigenic selection resulted in a broader distribution of 
mutations and also in equal accumulation of silent and replacement mutations 
(data not shown). 
One of the hallmarks of the mutation process is an increased number of 
transitions compared with transversions. This is believed to be an intrinsic 
property of the hypermutation machinery, which is as yet unresolved (90). 
Transitions are purine (A or G) to purine or pyrimidine (T or C) to pyrimidine 
mutations whereas transversions are purine to pyrimidine or vice versa. In a 
previous study transitions have been found to occur with a frequency of 59%, 
significantly more frequent that the 33% expected by chance (91). In our data set 
53% of the mutations are transitions. Even taking into account errors that may 
be attributable to Taq infidelity, which also favours transitions, the proportion 
of such mutations is 43%, some 10% greater than the expected frequency (Table 
2.2). 
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Table 2.2. Nature of base substitutions observed in cultured B cells 
Mutations' 	 Observed (%) 	Expected  (%) 
Transitions 
Total 56.3 33.3 
C—T 18.8 9.3 
A—G 25.0 8.0 
G--->A 6.3 7.4 
T—C 6.3 7.0 
Transversions 
Total 43.7 66.6 
A—T 12.5 8.0 
25.0 7.4 
G—C 6.3 7.4 
Mutations found in the 9 mutated sequences derived from the anti-Ig, anti-CD40, anti-cD38 
cultures. 
Expected number of mutations was calculated by multiplying the frequency of a particular 
nucleotide (mutation target) in the germ-line sequence by the total number of observed 
mutations and dividing this by 3 (as mutation to any of the other 3 nucleotides has the same 
theoretical probability) 
2.3 The rate of mutation in cultured B cells is within the normal range. 
Calculation of the rate of mutation in this culture revealed that it is in the range 
previously estimated for somatic hypermutation in vivo. The mutation 
frequency in the triple stimulation culture is 3.4x10 3 per base pair. We 
estimated using the halving of CFSE (5 carboxy-fluorescein diacetate 
succinimidyl ester) fluorescence that cell in this culture pass through 6 
generations (see appendix). Thus the rate of mutation is 5.8x10 4 per base pair 
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per generation. This is 10-fold lower that the maximum quoted rate in vivo of 
-3 	 -4 5x10 (163). It has been argued that a rate of 3x10 mutations per base pair per 
generation is more accurate and indeed most calculated figures are below 1x10 4 
(164, 165). 
24 Somatic mutation in CD40 and CD38 deficient mice. 
To see whether CD40 and CD38 play a role in the induction of hypermutation in 
vivo we immunised CD40 and CD38 deficient mice and analysed the 
accumulation of mutations in their V genes. 3 mice of each type were 
immunised intraperitoneally (i.p.) with lOOtg of alum—precipitated Ph-OX- 
chicken serum albumin (CSA), together with 10 Bordetella pertussis / and 
boosted 2 weeks later. Spleens were harvested 4 days after boosting and 
genomic DNA isolated from pooled splenocytes. The J-C intron flanking the 3' 
border of VHJ558 genes, one of the most regularly employed gene families, was 
sequenced following the method of Jolly et al (161). This method involves 
analysis of the region flanking the 3' side of VDJH segments taking advantage of 
the fact that hypermutation extends into the I-C intron (85). 
The advantage of this approach over sequencing of V regions themselves 
is that the problem of uncertainty over definitively identifying the germline 
counterpart of the putatively somatically mutated genes is avoided. JH  to C 
rearrangements were amplified using primers specific for the IgH intronic 
enhancer and a conserved sequence in FR3 of the VHJ558  family. The region 3' 
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Of JH4 is generally heavily mutated in CC B cells (161). For this reason PCR 
products from JH4  to C rearrangements were gel purified, cloned and 
sequenced. The data are summarised in Table 2.3. As expected, in the light of 
the absence of CC in CD40" mice, no somatic mutation was detected (44, 166). 
In contrast the J-C intron of B cells from immunised CD38 deficient mice 
was heavily mutated. This indicates that CD38 is not necessary in vivo for the 
induction or maintenance of somatic mutation. Although in vitro, CD38 
induced proliferation of B cells, was required for the growth and detection of 
somatically mutated B cells, it appears that CD38 is not required for the 
proliferation of B cells in CC. 
Table 2.3. Frequency of somatic mutations in the VHJ558 J/C intron in 
immunised CD40 and CD38 knockout mice 
Mice/Immunisation 	Number of 	Number of 	Number of Frequency of 
sequences' mutated mutations2 mutations3 
sequences 
Wild-type/non-immune 13 12 24 1/4660 
Wild-type! immune 11 8 53 1/169 
CD4O-/-!immune 13 3 5 1/1820 
CD38-/-/immune 12 7 38 1/198 
Number of independent sequences used for analysis. 
Total number of mutations in all mutated sequences. 
Number of mutations in all sequences divided by the total number of base pairs 
sequenced. 
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Z5 CD38 supernatant causes proliferation of CD38 deficient splenocytes 
in culture 
The antibody to CD38 used in the experiments described was in the form of 
supernatant (a gift from Dr M Parkhouse, Surrey) from the NIMR-5 secreting 
hybridoma. The hybridoma itself was not made available to us. To investigate 
whether the strong proliferative effect we and others (167) had found it to have 
on B cells was specific, splenocytes from CD38 deficient mice were stimulated in 
vitro under various conditions. As a comparison anti-CD38 antibody was 
purified from the supernatant using protein C sepharose. Purified B cells were 
stimulated in vitro and their proliferation measured after 48hr by measuring H3-
thyidine incorporation over 16 hr. Anti-CD38 supernatant was able to induce 
strong proliferation of CD38 deficient mice, indicating that its effect was not 
mediated via CD38. In contrast purified anti-CD38 antibody failed to induce 
proliferation (Figure 2.2). 
2.6 CD38 supernatant but not purified anti-CD38 antibody causes division 
of CFSE labelled cells in vitro. 
The proliferative properties of anti-CD38 supernatant were further tested by 
analysing cell division using CFSE. B cells purified from C57BL/6 mice were 
purified using MACS CD43 depletion of other cell types. Cells were USE 
labelled and placed into culture at 106  cells/mi. Cultures were treated with LPS, 
CD38 supernatant or purified anti-CD38 antibody. After 6 days cultures were 
analysed by light microscopy and by FACS. Cultures stimulated in the 3 
different ways appeared very different by microscopy. 
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Splenocytes from CD38 deficient mice were stimulated in vitro with anti-CD38 
supernatant or purified anti- CD38 antibody. LPS and CD40 were used as 
positive controls for stimulation. H3 thymidine incorporation over 1 6hrs was measured 
after 48 hrs as an indication of cell proliferation. Shown are the means of one 
experiment performed in triplicate +1- the standard error of the mean. Data shown 
are representative of two independent experiments. 
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In cultures stimulated with LPS cells or purified anti CD38 antibody were 
present singly, however with anti CD38 supernatant cells were present in tight 
clusters, similar to those induced by CD40 stimulation of B cells. By FACS, 
firstly purified anti CD38 antibody was tested to ensure that still bound to CD38 
expressing lymphocytes. Cell division as measured by reduction in the 
fluorescent marker CFSE, was induced by both LPS and anti-CD38 supernatant 
but not by purified anti-CD38 antibody (Figure 2.3), indicating that its effect is 
not mediated by the antibody but by a component of the supernatant. 
2.7 The proliferative effect of CD38 supernatant can be abrogated by the 
presence of polymyxin B. 
CD38 supernatant but not purified anti CD38 antibody can induce proliferation 
of B cells in culture. To investigate the contaminating factor in the supernatant 
that maybe responsible for this proliferation, cells were stimulated with anti-
CD40, anti-CD38 supernatant or LPS in the presence of polymyxin B sulphate. 
Polymyxin B inhibits LPS function by binding it and hence preventing its 
activation of B cells. After a 48hr stimulation H3 thymidine incorporation over 
16hrs was measured. Increasing concentrations of polymyxin B inhibited anti-
CD38 supernatant induced proliferation of B cells (Figure 2.4). In this 
experiment LPS induced proliferation was low, however, its induction of B cell 
proliferation is still inhibited in a similar fashion. As a control CD40 induced 
proliferation was measured this was unaffected by polymyxin B except at a 
concentration of 100tg/nil where polymyxin B appears to be toxic to cells. 
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Figure 2.3 CFSE profiles of stimulated B cell cultures 
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Purified B cells were CFSE labelled and placed in culture with LPS, CD38 
supernatant or the purified antibody. 7 days later cultures were harvested and analysed 
by FACS. Shown from the top are CFSE labelled cells after 24hr in culture, LPS 
stimulated cells, cells cultured in the presence of CD38 supernatant, or purified anti 
CD38 antibody. Data shown are from one experiment and are representative of 2 
experiments performed. 
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Purified B cells were stimulated in vitro with anti-CD40 antibody (black), LPS (blue), 
anti-CD38 supernatant (red) or 11-4 (green) in the presence of polymyxin B sulphate at 
a rangeof concentrations. After 48 hrs H3 thymidine was added and its incoropration 
into dividing cellsover 16 hrs measured. Shown are the means of one experiment 
performed in triplicate+/- the standard error of the mean. Data shown are representative 
of three independent experiments. 
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This leads us to conclude that the proliferative effect of CD38 supernatant was 
caused by bacterial contamination. 
Discussion 
Background 
We have derived an in vitro system to define the signals that will initiate 
somatic mutation in naïve splenic B cells. We find that three signals are 
required to allow detection of somatic mutation in vitro. These signals are anti-
CD40, anti-Ig, and anti-CD38. In the absence of any one of these signals 
mutation remains off. By immunising CD40 deficient mice we have shown that 
CD40 is required in vivo. In contrast CD38 is not required in vivo as CD38 
deficient mice mutate normally. 
These three stimuli were chosen as they mimic signals that B cells may 
receive in the context of a TD immune response. The GC reaction and somatic 
hypermutation only occur during responses to TD antigens. This implicates T 
cells in all of these processes. Although the identity of signals inducing these 
processes is unknown, CD40 is implicated as CD40 deficient mice fail to class 
switch and form M. Activated T cells express CD154, which provides signals 
through CD40 on B cells during cognate interaction when the T cell receptor 
binds antigen bound to MHC class II on B cells. Subsequently CD40 also 
provides survival signals to CC B cells, which are prone to apoptosis (77) 
allowing entry into the memory pool (168). Signals via the BCR are critical for 
the activation of B cells and hence induction of mutation, but also to provide 
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survival signals during the selection of high affinity B cell mutants with antigen 
presented on FDCs (169). 
It is clear that signals from T cells and through slg are required for the 
initiation of somatic mutation in vivo. Indeed, it has previously been shown that 
somatic mutation initiated in vivo can be maintained in vitro with anti Ig and 
helper T cells (120). Until now the exact nature of the signals derived from T 
cells was unknown. 
The third stimulus used to initiate mutation in our in vitro system was 
anti-CD38. CD38 is a type II glycoprotein expressed on many cell types 
including T and B lymphocytes. It has ecto-enzymatic activity, catalysing the 
conversion of nicotinamide adenine dinucleotide (NAD) to cyclic adenosine 
diphosphoribose (cADPR)(170). However, it has also been implicated in B cell 
activation (171). Mice deficient in CD38 have deficiencies in antibody responses 
to TD protein antigens and it is thought to modulate BCR mediated B cell 
activation (172). As TD, but not TI antibody responses are diminished in CD38 
deficient mice we thought it might play a role in the GC where somatic 
mutation is known to take place. The role of CD38 in the induction of somatic 
hypermutation was investigated along with other molecules known to be 
important in TD antibody responses. 
Significance of the results 
The difference in the mutation frequency between LPS (1/1140) and the triple 
stimulus (1/290) cultures is statistically significant. The rate of mutation in the 
LPS stimulated culture is similar to the Taq error rate (-1/1200) as LPS alone is 
known not to trigger mutation despite its mitogenic effect on B cells, indicating 
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that proliferation alone does not induce mutation (118). In the absence of CD38 
intermediate levels of mutation were achieved, however these were not 
statistically significantly different from the LPS rate. This may indicate that 
CD40 and slg alone can initiate mutation but that in order for these mutations to 
be detected at high level that strong cellular proliferation is required; this is 
provided by anti-CD38 supernatant. One interesting finding in this system was 
that the addition of Th2 cytokines to the triple stimulus culture inhibits the 
accumulation of mutations, we think because they drive the differentiation of B 
cells into plasma cells. This may concur with a study by Razanajaona et al. (124) 
where CD154 transfectants failed to induce mutation in the presence of a 
mixture of cytokines. 
This study is the first report of the induction of mutation in naïve splenic 
B cells using defined stimuli. In previous investigations into the triggers of 
mutation, cell lines have been employed (123, 126, 173). Although the 
information gleaned from these experiments is useful it does not necessarily 
apply to normal naïve B cells. In one study mutation was initiated at low level 
in human tonsillar B cells (124) in the presence of T cell clones. The results of 
this experiment are consistent with results presented here, however the 
molecular nature of the cellular interaction was not dissected. We have shown 
that the signal from T cells is through CD40 on B cells. 
Pattern of mutations induced in vitro. 
The mutation induced in this system using the three stimuli detailed had the 
hallmarks of somatic mutation induced in passenger transgenes in vivo (89). The 
term passenger transgene is used to describe a transgene that is not expressed 
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and therefore not affected by antigenic selection. The use of such transgenes has 
allowed a distinction to be made between the intrinsic properties of the 
mutation machinery and those imposed by antigenic selection of the most 
effective mutants. Reported properties for a VkOxl passenger transgene 
include a clustering of mutations in the CDRs, accumulation of mutations at 
hotspots and a transition over transversion preference (88). Of these, the 
mutations induced in our system had a transition over transversion preference 
and an accumulation of mutations could be seen in the CDRs, however, we did 
not note an increase in the serines at codon positions 26,31 or 77 which are 
intrinsic hotspots for this gene (62). Despite this the rate at which mutations 
were introduced into the V region DNA was within the range expected in vivo 
(-5.8x10 4). This data supports our belief that we have induced somatic 
mutation as it occurs in vivo. 
Interpretation of the role of these signals 
We have shown that CD40 is required for the induction of mutation in vivo. 
CD40 deficient mice do not form GC as signals through CD40 are required for 
CC formation. Hence it could be argued that the reason we do not detect 
somatic hypermutation in CD40 deficient mice is due to the lack of proliferation 
and antigenic selection in the absence of GC, and not due to the absence of a 
specific on signal for mutation to occur. Indeed immunised CD40 deficient mice 
have mutation levels elevated 2.6 fold (1/1820) above those of a non- immune 
mouse (1/4660). Although this is still 10 fold lower that the level achieved in an 
immunised mouse (1/200), it may imply that B cells in CD40 deficient mice 
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maybe able to undergo low levels of somatic hypermutation when stimulated 
through the BCR. 
The role of stimulation through the BCR in the induction of mutation is 
undisputed. However, our finding that stimulation with anti-CD38 supernatant 
along with other stimuli can induce high level mutation is novel. The role of 
CD38 in this culture system is thought not to be as a specific trigger for 
mutation, but as an inducer of cell division. We believe that CD38 supernatant 
in combination with other stimuli, drives extensive cell division, allowing the 
detection of mutated sequences. In vivo, GCs are the sites of B cell proliferation, 
this proliferation is not CD38 dependent as CD38 deficient mice undergo 
normal somatic mutation of their antibody V regions. However, the strong 
mitogenic effect of CD38 supernatant used in these experiments is thought to be 
important. 
Subsequent to the publishing of a paper in the Journal of Immunology 
reporting our findings (127) the nature of the proliferation induced by anti-
CD38 supernatant was investigated more closely. We were unable to detect any 
mitogenic role for purified anti-CD38 antibody, NIMR-5, as was described by 
Santos-Argumendo et al. (167, 174). Also anti-CD38 supernatant was found to 
be mitogenic for CD38 deficient B cells. This confirms our suggestion that the 
role of CD38 supernatant in these cultures was simply to induce cell 
proliferation. 
The contaminating factor in these cultures is thought to be of bacterial 
origin due to the abrogation of proliferation in cells treated with anti CD38 
supernatant in the presence of the LPS inhibitor polymyxin B sulphate. It would 
be interesting to determine whether LPS could replace CD38 supernatant in the 
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triple stimulus culture. Attempts were made to address using a CD154 
transfected fibroblast system, however these experiments were unsuccessful. 
Conclusions 
This study was the first demonstration of the initiation of hypermutation in 
splenic B cells using defined stimuli. Antibodies to CD40 and Ig mimic B cell 
encounter with antigen and interaction with T cells. We believe that anti-CD38 
supernatant, which drove B cell proliferation in this system may play a role in 
mimicking the division of B cells in the GC, however this signal is dispensable in 
vivo. This is also the first formal demonstration that CD40 deficient mice do not 
undergo somatic hypemutation of V regions. 
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Chapter 3 Development of an adoptive transfer system to detect 
receptor revision in QM B cells. 
Introduction 
The detection of RAG gene expression and activity in GC, has led to speculation 
that secondary rearrangement of BCRs in the periphery can contribute to 
repertoire diversity (130, 133, 175). It is now known that in transgeriic and non-
transgenic mouse models and in humans, B cells can undergo receptor revision 
(151, 155, 176). This can lead to the generation of autoreactive specificities (150), 
however it might also lead to the generation of useful specificities that could be 
recruited to the immune response. 
We sought to find out whether B cells, which had undergone secondary 
V(D)J rearrangement in the periphery might contribute to affinity maturation, 
which up until now has been solely attributed to somatic hypermutation. To do 
this a pure population of B cells with the same BCR was required so that any 
changes in specificity could be attributed to alterations in those cells rather than 
to expansion of existing specificities. Two mouse systems with targeted 
insertions of rearranged antibody genes were used as a source of identical B 
cells to investigate this: the QM mouse (Chapter 3 and 4) and the 3.83 knock-in 
mouse (177)(Chapter 5). 
Quasi-monoclonal (QM) mice were chosen as a source of identical B cells 
to investigate receptor revision at the heavy chain locus. QM mice carry a 
targeted heavy chain gene that results in most of its B cells recognising the 
hapten NP (178). As it has a disrupted kappa chain, it requires the 
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rearrangement of endogenous lambda light chains in order to make functional 
antibody. In this mouse secondary rearrangement of the heavy chain generates 
B cell diversity (179). It is not known what triggers this but it could be low level 
cross reactivity with a self antigen. There is a strong selective pressure for non-
NP specificities and about 25% of QM BCRs no longer express the idiotypic 
receptor due to rearrangement and selection. This makes the QM mouse 
immunocompetent and it is capable of responding to a variety of antigens, 
model and otherwise. 
To obtain a pure population of B cells, those cells that have undergone 
central editing need to be removed by cell sorting. The remaining identical B 
cells are then transferred to an adoptive host. Experiments are described in this 
chapter detailing the difficulties encountered and problems solved during the 
setting up of an adoptive transfer system to investigate affinity maturation of 
transferred QM cells. Firstly the repertoire of the site directed transgenic, QM 
mice was investigated. 
Results 
3.1 The B cell repertoire of the QM mouse includes cells that have 
undergone central editing. 
QM mice express a site directed transgenic BCR, which can be detected on the 
cell surface using an anti idiotypic antibody. Receptor editing during 
development results in loss of Id expression in about 25 % of B cells. This is 
thought to be induced by cross reactivity between the NP specific receptor and 
self antigens which initiates receptor editing, a tolerance mechanism. However, 
Chapter 3 	 86 
it is also possible that there is cross reactivity with antigens derived from the 
gut. The latter possibility was suggested to us by Dr Alain Lamarre (Zurich, 
Switzerland) and would mean that unweaned mice might have fewer of Id 
negative B cells. To test this, spleen and bone marrow samples from unweaned 
mice (younger than 3 weeks), 6 week old mice and 3 month old mice were 
stained with anti QM idiotypic antibody (R2.438.8(178)) and a monoclonal 
antibody (mAb) against the B cell marker B220. 
Mice of all ages examined had similar levels of Id positive B cells (76.5 to 
79%) in both spleen (Figure 3.1) and bone marrow (not shown). This indicates 
that editing in response to ingested antigens is not likely to be a primary 
generator of Id negative cells as cells were detected at the same level in mice 
that had not been exposed to ingested antigens. It is, however, still possible that 
milk antigens or commensal bacteria might be involved in the induction of 
central editing. 
3.2 QM mice can make antibody responses to diverse antigens. 
It has previously been reported that QM mice can provide neutralising antibody 
responses to several viruses (180). This response is presumably provided by Id 
negative cells, which have edited centrally. To see if centrally edited cells can 
provide a response to haptens and model antigens, QM mice were immunised 
i.p. with trinitrophenyl acetyl-ovalbumin (TNP-OVA), dinitrophenyl acetyl 
(DNP)-OVA, Ph-OX-CSA, recombinant C fragment (RCF) of tetanus toxin and 
M13 bacteriophage, antigens which were readily available to us. Following a 
day 10 boost mice were bled on day 14 and serum ELISAs performed. 
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To see if levels of Id negative cells were effected by exposure to ingested 
antigens, spleens were harvested from mice before and after weaning 
and splenocytes stained with antibodies to B220 and the QM Id. 
Stained splenocytes are shown on the left. On the right are 
histograms showing levels of ld cells on the gated B cell population. 
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Responses varied greatly between mice probably due to varying responder 
frequency in the limited QM repertoire, however, for all antigens tested, at least 
1 mouse in 2 provided an impressive response similar to, if not greater than, that 
of a wt mouse (Figure 3.2A). 
Further evidence of the response of centrally edited cells was gained 
visually, by immunising mice with allophycocyanin (APC), a fluorescent 
antigen. Mice immunised with APC in phosphate buffered saline (PBS) plus iO 
Bordetella pertussis were killed 3 weeks later and cell suspensions generated 
from spleen samples. Cells were stained with APC to illuminate antigen specific 
cells and also with a mAb to B220. Mature, B220 B cells, along with the B220 
compartment reported by Hayakawa et a! (181) and others can be seen, 
illustrating the expansion of antigen specific cells in these mice (Figure 3.2B). 
This also illustrates the need to remove cells of other specificities in order to 
carryout our investigation into receptor revision. 
3.3 The response of centrally edited cells in the QM mouse has normal 
kinetics 
Despite the fact that the QM mice have a limited repertoire (-25% of that of a wt 
mouse) we had shown they could respond to a range of model antigens. We 
wanted to test whether the kinetics of this response was similar to a normal 
mouse. We also investigated the response of the mouse to NP, the antigen 
recognised by 75% of its B cells. QM and wt mice were immunised i.p. with NP-
OVA and DNP-OVA, blood samples were taken at intervals for analysis by 
serum ELISA. 
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Figure 3.2 Antigen specific lgG levels in QM mice immunised with 
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A Immunised mice were boosted on day 10 and blood samples taken on day 
14 for serum ELISA. Shown are lgG levels of mice immunised with TNP, DNP, 
Ox, RCF and M13. QM levels are indicated by red boxes, wt levels are indicated 
by black circles with negative control levels in green. 
B QM mice were immunised and boosted with APC. 2 weeks later spleens 
were harvested and analysed by flow cytometry for CD1 9 expression, NP 
binding and APC binding. Data shown is from one mouse and representative 
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The DNP response in a QM mouse is similar to that in a wt mouse without any 
delay in the kinetic of the response (Figure 3.3). This indicates that the limited B 
cell repertoire in QM mice does not substantially compromise their ability to 
make an antigen specific antibody response. High levels of NP specific 
antibody are constitutive in these mice. Unimmunised mice have the same 
levels as a wt immune mouse and levels do not increase following a normal 
immunisation protocol. Following investigation of immunisation conditions it 
was determined that using Bordetella pertussis as an adjuvant did raise the 
response above constitutive levels (Data not shown). 
As a further indication of an antigen specific response we counted the 
numbers of GCs in DNP and NP immunised mice 10 days after immunisation. 
While those immunised with DNP-OVA had normal CC numbers (22.87+!- 4.8 
SD per section n=3) mice immunised with NP either with, or without Bordetella 
pertussis had reduced GC numbers (9.75+/-2.87 SD n=4). This indicates a 
difficulty in activating QM B cells with NP in a TD fashion within the mouse. 
Similar findings have been made by the MacLennan lab (Dr Ian MacLennan, 
Birmingham, personal communication). This is probably due to the high 
numbers of B cells with the same specificity, as QM cells transferred to other 
hosts can make GC. These results indicate: 1) That QM B cells do not respond 
normally upon immunisation with in the QM mouse; 2) that a mouse with a 
limited repertoire can produce detectible immune responses to diverse antigens. 
To ascertain whether these specificities are generated by receptor revision and 
not by expansion of existing cells we need to follow the response of a cohort of 
identical B cells. This requires the adoptive transfer of QM Id positive B cells to 
an adoptive host. 
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Figure 3.3 Kinetics of the response of QM and C57BL16 mice to 
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Day 0, 4,7,10. 
QM and C57BL16 mice were immunised with NP-Ova and DNP-Ova. Blood 
samples were taken and serum lgG ELISAs performed. 
WT responses are depicted in the 2 graphs on the left and QM responses on the 
right. NP responses are depicted in the top 2 graphs with DNF ones below. 
In all cases day 0,2,4,7,and 10 responses are represented by green, yellow, blue, 
red and black respectively 
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3.4 QM cells can be sorted on the basis of Idiotype expression by flow 
cytometry 
We have shown that QM mice can provide good serum antibody responses to a 
range of antigens, however this is probably attributable to Id negative cells. 
Centrally edited cells, undergo V(D)J rearrangement in the bone marrow 
resulting in loss of Id expression. Receptor revision is the secondary 
rearrangement of antibody V genes in the periphery and its role, if any is 
unproven. In order to ascertain whether receptor revision of mature Id positive 
cells can contribute to affinity maturation of an immune response we needed to 
obtain a pure Id positive population of B cells, which is not possible in an intact 
mouse. This was achieved by FACS sorting and performing adoptive transfers 
of sorted cells. Spleens were harvested from QM mice and cell suspensions 
made. To increase sorting efficiency B cells were enriched by MACS CD43 
depletion. Remaining B cells (-90% pure) were stained with fluorescein 
isothyocyanate (FITC) conjugated anti-QM Id and anti-B220 conjugated to 
phycoerythrin (PE), before being sorted on the basis of Id expression using in 
turn both a MoFlow and FACS Vantage flow cytometer. 
QM mice have small spleens and typically yield only 2 or 3 x iO 
lymphocytes (normal mice yield around 8x107) this is compounded by the fact 
that only about 25% of these lymphocytes are B cells, probably due to the 
difficulty in rearranging the lambda light chain. On top of this -25% of these B 
cells are Id negative. This means that obtaining good yields following sorting is 
difficult. Removal of all non-Id positive cells proved problematical. Non-B cells 
provided the largest contaminating population, however, as these would be 
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predicted not effect our experiment in any way we did not worry unduly. Id 
negative B cells were reduced to -4% of B cells (Figure 3.4). To account for this 
contamination of our 'pure' B cell population, Id negative cells were also 
collected and used in control experiments. 
3.5 RAG -/- mice are not suitable hosts for adoptively transferred B cells 
During the development of an adoptive transfer system for the receipt of a pure 
population of sorted B cells, RAG-/-  mice were selected initially as a potential 
adoptive host. Numerous groups (143, 149) have employed these mice, 
primarily as they have no mature lymphocytes. This allows uncomplicated 
determination of the response of transferred cells. Following preliminary, 
unsuccessful transfers of C57BL/6 splenocytes to C57BL/6-RAG 2 mice it 
was decided to irradiate the mice to provide space for transferred cells. 
Although RAG-/-  mice have no mature lymphocytes due to their inability to 
rearrange B and T cell receptors, early progenitors, developmentally blocked at 
the early pro B cell stage, reside in the spleen. These cells might compete with 
transferred splenocytes for space. Two mice in each group were irradiated in 
200 rad increments up to 600 rads, 24 hours later 5x106 splenocytes from 
C57BL/6 mice were injected through the tail vein and mice were immunised i.p. 
with DNP conjugated to keyhole limpet haemocyanin (KLH). Following a day 
10 boost mice were bled and spleens harvested on day 14. Serum antibody 
responses and transferred cell numbers in the spleen were assessed. 
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Splenocytes were harvested from QM mice and stained for QM Id and B220 
expression. CD43 depletion by MACS enriched for B cells, then Id positive 
and negative cells were sorted using a FACS Vantage flow cytometer. 
On the left whole cell populations are shown, these are then gated on B cells 
to estimate the proportions of Id positive and negative cells in each sorted 
population. From the top are shown:- the pre sort population, ld sorted cells 
and IT sorted cells. Data shown is from one sort and is representative of at 
least 20 sorts performed. 
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Cell suspensions were stained for T and B cells using mAbs to CD3 and 1gM 
respectively. These markers were selected as they are absent on the immature 
cells present in RAG-/-  mice. T cell numbers approached normal levels (-40% of 
the spleen) when irradiated at 200 or 400 rads, indicating reconstitution of the 
spleen with transferred T cells. B cell numbers, however, remained very low 
(<2% of the spleen) indicating that RAG deficient mice are not a good host for 
transferred mature B cells (Figure 3.5). 
Interestingly, transferred B cells, although they do not fill up the resting B 
cell compartment, do provide antigen specific serum 1gM (but not IgG) antibody 
responses. This finding was further investigated by staining tissue sections with 
antibodies to 1gM, T24 and with PNA, a lectin that binds to GCs. As intimated 
by the FACS results, B and T cell areas were absent or paltry, also, there were no 
GCs. IgM plasma cells, however, were present in abundance explaining the 
presence of serum 1gM ELISA (Figure 3.6). This phenomenon was subsequently 
reported and explained by Agenes et al. (182). 
It was suggested to us by Dr Paul Garside (P. Garside, Glasgow, UK, 
personal communication) that transferring B cells first, followed by T cells 48hrs 
later might improve B cell reconstitution. To investigate this, mice were given 
300rads of irradiation, as this appeared to have given the best results in the 
experiments described above (Figure 3.5). 2 mice in each group were then given 
either a) lx iU B cells and 2.5x106 carrier primed T cells 48 hours later or b) lx 
107 splenocytes. Mice were then immunised 24hrs post transfer with NP-OVA. 
Serum ELISA results similar to previous experiments were obtained, there were 
good 1gM levels but no IgG response to NP (data not shown). 
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RAG-'- mice were irradiated in 200 rad increments up to 600 rads. 24 hr later 
5x106 wt splenocytes were transferred and mice immunised with DNF-KLH. 
Following a day 10 boost, mice were bled and spleens harvested on day 14 for 
FACS analysis. Splenocytes were stained with anti-CD3 and anti-lgM antibodies 
to detect T and B cells respectively and compared with a wt and and RAG 1  
mouse (A). 
The percentage of the spleen accounted for by each cell type was counted and is 
represented in B.Black dots indicate T cell percentages in each of two mice per 
group. B cell percentages are represented by red diamonds. 
Dashed lined indicate the normal % of cells in a wt mouse. 
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A Serum 1gM levels were measured in irradiated mice that received 5x1 06 wt 
splenocytes. Mice that were unirradiated are depicted in blue, those that received 
200rads; yellow; 400rads,pink; 600rads, green and negative control, red. 
Serum lgG levels: positive control,blue. 
B.Spleen sections from (L to R) wt, unirradiated RAG-/- with 5x1 06 splenocytes 
and RAG-/- stained with anti-Thy-1 FITC (green) and anti- 1gM Texas red. B and T 
cells can be seen, note the 1gM + plasma cells in the middle picture. 
C.B and T cell levels in RAG mice that received either B cells first and T cells 
48 hr later or splenoctes, presented as percentages of the spleen. B cells are 
represented as red circles, T cells as black squares. 
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Reconstitution of the spleen was measured by FACS analysis (Figure 3.6). In 
one of the two mice in which B cells were transferred first there appeared to be 
an increase in splenic B cell levels, however full reconstitution was not achieved. 
We decided that in order to have the correct environment for GC formation and 
affinity maturation, normal B and T cell areas were required, and so the RAG-/ 
 
-
mice were not suitable for this experiment. 
3.6 Analysis of CD401 mice as a potential adoptive host. 
The experiments we had performed with RAG' mice demonstrated the need to 
find a suitable adoptive host to receive QM Id + cells. RAG' mice appeared to 
have the advantage of having no complicating host cells, this however, limits 
their use as a physiologically relevant model in the failure to reconstitute them 
successfully. Other potential adoptive hosts come with the complication that 
they carry their own endogenous lymphocytes; hence we would need a way to 
distinguish the response of host cells from that of the transferred cells. Other 
groups have used congenic strains with an allotype marked heavy chain (33) 
mice with cell surface or clonotypic markers (183), or haemopoietic markers 
(182). We decided to use CD40' mice as they possessed several advantages 
over other potential hosts and they were also readily available to us. 
Transferred cells can be detected by FACS on the basis of expression of 2 cell 
surface markers - the QM Id but also, in the case of loss of expression of this, 
they express CD40 which is lacking in the knockout host. 
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A second advantage of this system is that CD40' mice are unable to 
make class switched antibody responses. This is due to a) the absence of CD40 
on DCs, which is required for the activation of T cells and b) the absence of 
CD40 on B cells themselves, which needs to be ligated by T cells during cognate 
interaction to induce class switching in response to TD antigens. This means 
that adoptively transferred CD40 B cells will be the only cells in the mouse able 
to produce IgG, thus allowing us to monitor their response by isotype specific 
ELISA. However, to circumvent the lack of CD40 on DCs and allow priming of 
helper T cells these mice must be supplemented with CD40 DC (Figure 3.7). 
CD40' mice which have received wt B cells fail to make a class switched 
response, however, if splenocytes are transferred the CD40 DCs in the spleen 
enable the CD40 B cells to respond (Figure 3.8). As QM cells need to be sorted, 
DCs need to be added separately. Immunisation of CD40' mice with DCs 
while activating the T cells and causing their migration to B cell follicles, does 
not result in class switching of CD40 1  B cells (S. Fillatreau and D. Gray in press 
and Figure 3.8) confirming that IgG can come from the transferred CD40 B cells 
alone. 
Bone marrow derived DCs were generated in vitro in a 7 day culture 
with GM-CSF. These DC were pulsed with NP-OVA at 100tg/m1 for 1 hour at 
37°C before being harvested. 
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Figure 3.7 Immunisation of CD40' mice with pulsed CD40 
DCs allows activation of transferred CD40 B cells. 
0040+ 
c. . 
CD40+ 	Cultured in vitro with 
	
DC 4 pulsed with antigen 
c GMCSF to generate DCs 
Sorted QM+ 
B cells from spleen 
A schematic diagram illustrating the transfer protocol to CD40 mice. 
Bone marrow derived dendritic cells, cultured in vitro were pulsed with 
antigen and used to immunise CD40-1- mice. Sorted QM ld cells were 
simultaneously transferred. 
Chapter 3 	 101 
Figure 3.8 Antibody responses in CD40' mice that received 
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CD40 mice received either 1 .5x107B cells (blue) or 5xl07splenocytes 
(red) and were immunised with DNP-KLH 1 week later. Blood samples were 
taken on day 10 for serum lgG ELISA. The positive and negative controls 
are indicated by a black and green line respectively. 
CD40 1- mice that received 4x106 QM B cells were immunised with 
NP-OVA pulsed DC and blood samples taken on day 14. 1gM levels are 
shown on the graph on the left and lgG levels on the right, in both graphs red 
lines indicate experimental mice with black and green lines for positive and 
negative controls respectively. 
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2x106 DC derived from C57BL/6 mice and 4x106 QM B cells were mixed and 
injected i.v. to CD40' mice which had been backcrossed for 7 generations onto 
the C57BL/6 background. Although 1gM was produced by host B cells, 
indicating the success of the immunisation by DC, IgG was not produced by co 
transferred QM B cells (Figure 3.8). This experiment was repeated 3 times, 
altering the quantity of antigen and length of pulse with similar results. CC 
were not formed but most tellingly transferred cells could not be detected by 
FACS. At the time this result was assumed to be related to sub-optimal 
activation of transferred cells, however, it later became clear that it was graft 
rejection due to incomplete backcrossing of the QM mice. 
3.7 Development of a chimaeric mouse with CD40 on DC but not B cells. 
Assuming that our failure to detect a response from transferred B cells in 
CD40 1  mice was caused by DC and B cells not interacting at the correct 
location, it was decided to make a mouse in which CD40 + DC and CD40-I- B 
cells coexisted. A bone marrow chimaera system was under development in the 
lab to allow complete substitution of B cell and DC compartments. This work is 
presented as a collaboration with many lab members, most notably Simon 
Fillatreau. 
During the development of this system allogeneic transfers were made so 
that reconstituted cells could be distinguished from those of the host. This 
allows us to be sure that the chimaera is comprised only of transferred cells. 
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The procedure is illustrated in Figure 3.9, briefly, host C57BL/6 mice were 
lethally irradiated. 24hrs later they were reconstituted with 5x106 bone marrow 
cells, depleted of mature T cells, from BALB/c mice. Mice were left 8 weeks to 
reconstitute and then analysed. Splenocytes were analysed by FACS to 
determine the MHC class II haplotype of B cells and DC. BM cells were also 
cultured and non adherent cells analysed by FACS to define the haplotype of 
borne marrow DC precursors. Representative data is shown for splenic B cells 
and bone marrow precursors using either mAbs AF6 (anti IA') or MKD6 (anti 
IA d)  although both populations (and also splenic DCs) were stained with the 
two antibodies. The splenic B cells, DC and bone marrow DC precursors in the 
reconstituted chimaeras were derived only from cells in the transferred bone 
marrow, without any contribution from host cells, confirming complete removal 
of the host immune system by irradiation. 
The chimaera used for the adoptive transfer of QM B cells has CD40 
deficient B cells and CD40 sufficient DC. To generate this chimaera C57BL/6 
mice were irradiated and reconstituted with a mixture of jtMT and CD40' bone 
marrow (these are referred to as tMT/CD40 chimaeras). tMT bone marrow, 
lacking B cells provides T cells and CD40 + DC, CD40-I- bone marrow provides 
the B cell compartment. 
To confirm the absence of CD40 B cells from the host, and hence validate 
our model, we stimulated B cells in vitro with anti-CD40 antibody. Stimulation 
through CD40 causes B cell proliferation and would amplify any contaminating 
host cells. 
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Figure 3.9 Development of a bone marrow chimera system allowing 
complete substitution of B cell and dendritic cell compartments. 
A 
Lethal irradiation (1250cGy) 
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by FACS to determine cells to define the allotype 
the allotype of B cells 	of BM precursors 
and DC 
C571316 	BALB/c 	 C57131-6 	BALB/c 
0.1% 1.1% 1.2% 95.3% 	= O5% 215%-J 37, 2.% 
317% 21 r 57•5% .7%1..%.L% 
1 102
BAL/c to 	
01  to,  101  101  to,  
à5 Bl 	 BALB/c to C57B16 
MKD6f21Z 
8.9% AF6  
CD19 
 HI-3 -j.4 52-2% 
A.Schematic diagram of the development of the chimaera system. 
B. Analysis of splenic B cells with anti lAd  antibody MKD6 and CD19, showing staining 
patterns on a C57BLi6 mouse, a BALB//c and a BALB/c to C57BLJ6 reconstituted chimaera. 
C Analysis of non adherent bone marrow precursors with anti anti lAb  AB AF6 and anti 
CDilc (1-11-3), showing staining patterns on a C57BLJ6 mouse an BALB/c mouse and 
reconstituted chimaera. 
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Spleens were taken from CD40', C57BL/6 mice and reconstituted chimeras. 
As a control for the sensitivity of the assay CD40' cells were also spiked with 
either 10% or 1% CD40 B cells. Cells were stimulated for 48hrs at which time 
proliferation was measured by H3 thymidine incorporation. Resulting counts 
are shown in Figure 3.10 alongside FACS data confirming absence of detectable 
CD40 on B cells in reconstituted chimaeras. Control cultures demonstrate that 
CD40 B cells can be detected even if they represent only 1% of the cells in the 
assay. This gives us confidence in stating that reconstituted chimeras contain no 
B cell or DC contribution from the host, and that we have achieved complete 
substitution of the B cell and DC compartments. 
It was determined that reconstitution with 20% CD40 1  bone marrow 
and 80% MT bone marrow gave the most physiological levels of all cell types 
involved. This was determined by histological analysis of spleen sections. T cell 
priming was also assessed by re-stimulating T cells in vitro and assaying 
proliferation and cytokine production. We aimed to maximise levels of DC 
from the MT host, while still allowing reconstitution of the B cell compartment 
within a 2 month period. 10% CD40' bone marrow and 90% [tMT bone 
marrow resulted in unreliable reconstitution of the B cell compartment. 
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Figure 3.10 Analysis of chimaeras reconstituted with .MT and 
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C57BLi6 hosts were irradiated and reconstituited with 80%1iMT bone marrow 
and 20%CD40 bone marrow. 
A To confirm absence of CD40 B cells, spleens were harvested from chimaeras 
8 weeks after reconstitution and stimulated with anti CD40 antibody (FGK-45). 
Proliferation was measured by H3 thymidine incorporation after 48 hrs and plotted 
(LtoR) CD40,CD401contaminated with 1% C57BL16, CD40contaminated with 
10% C57BL16, C57BLJ6, reconstituted chimaera, chimaera with no FGK. 
B. FACS staining of reconstituted chimaeras, compared with C57B1J6 and 
CD40 mouse. 
Chapter 3 	 107 
3.8 Mixed bone marrow chimaeras make good adoptive hosts for 
transferred CD40 B cells 
We planned to use jiMT/CD40 chimaeras as adoptive hosts for transferred 
QM B cells but first, to validate the system, C57BL/6 B cells were transferred. 
Mice immunised with 2 model antigens, NP-OVA (not shown) and DNP-KLH 
to confirm that transferred B cells could make an antigen specific antibody 
response (Figure 3.11). Blood samples were taken at 7 day intervals and assayed 
for total IgG and IgGi by serum ELISA (Figure 3.12). Mice were given either 
1x106 (not shown), 1x107 or 5x107 B cells. The response was greater and faster in 
those which received more cells, presumably due to increased responder 
frequency, however, all mice made some antigen specific antibody response. 
DNP-KLH immunised mice were sacrificed on day 16 and splenocytes 
stained for CD40 B cells. CD40 B cells can be easily distinguished from the 
CD40 1  B cells of the host by FACS. The mice with increased numbers of CD40 
cells proved to be those that had made the greater antibody response, 
illustrating clonal expansion in these animals. Sections were also cut and 
stained for GC. GCs were formed indicating that transferred cells can make a 
TD immune response. In contrast chimaeras that did not receive transferred 
cells had no GC and no IgG. These results indicate that transferred cells can 
make a TD response, produce IgG distinguishable from host produced 1gM and 
make GC. Grafts of CD40 B cells also proved to be very stable, in mice tested 
grafts were still present after 3 months. 
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Figure 3.11 Chimaera strategy - a mouse with CD40 on DCs but not B 
cells allows detection of the response of transferred CD40 B cells. 














A schematic diagram illustrating the construction of AMT/ CD40 chimaeras 
and their subsequent transfer with CD40 B cells and immunisation. 
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A 
tMTICD40 chimeras received either 1 X 07 or 5x1 07  C57BL16 B cells and 
were immunised 24 hr later with DNP-KLH. Mice were bled and serum ELISAs 
performed to detect lgG and IgGi. A lgG (left) and lgGi (right) serum ELISA 
graphs. Blue lines represent mice that received 5x107  cells whereas red 
lines represent mice that received 1x107 cells. Negative and positive controls 
are represented by green and black lines respectively. B Spleens were harvested 
and cells stained for CD40 and B220. B cells were gated and CD40 B cells 
given as a percentage of total B cells in the table (left). On the right a 
representative dot plot is shown indicating the B cell (1) and CD40+B cell (2) 
populations. Gating on B cells (1) CD40 expression is shown in the histogram 
below. 
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39 Adoptively transferred QM cells are rejected by hosts on a C57BL/6 
background 
Initially we had attributed the failure to detect transferred QM cells in CD40 1  
mice to poor priming resulting from the DC immunisation protocol required 
(section 3.6). However, similar results were obtained with grafts of QM B cells 
to the verified tMT/CD40 chimera system. Transferred cells were not 
detectable by FACS and GC were not formed (data not shown). Results were 
replicated in carrier-primed chimaeras. This indicates to us that grafts were 
being rejected. 
In order to be satisfied with results obtained from adoptive transfer 
experiments we had to be sure that transferred cells QM cells were being 
activated in the host and forming GCs, the sites of affinity maturation. To do 
this, grafts need to be stable for at least 3 weeks. To measure rejection of cells 
QM B cells were transferred to C57BL/6 mice. 1x107 QM splenocytes were 
transferred and mice immunised i.p. with NP-OVA. Transferred cells were 
identified by FACS at regular intervals ,with antibodies to B220 and the QM Id. 
Analogous C57BL/6 to C57BL/6 transfers were performed as a control, in this 
case cells were marked with the intracellular fluorescent stain CFSE. Numbers 
of QM cells dropped dramatically post transfer to C57BL/6 mice, some cells 
were present at day 2 but levels were not above background on day 6 (Figure 
3.13). Control grafts were still present on day 14. Although we were aware that 
QM mice were not fully backcrossed, short term transfers were thought 
possible. 
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Figure 3.13 QM cells are not tolerated in C57BL/6 hosts 
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lxi 07  QM or C57BL/6 splenocytes were transferred to C57BL/6 mice or 129xB6 
Fl mice. 24 hr later mice were immunised with NP-OVA. On day 2, 6, 10 and 14 
spleens were harvested and splenocytes stained with anti B220 and anti QM Id 
for analysis by FACS. 
In A representative FACS plots are shown for 1 of 2 mice In each group. Top: 
positive and negative control - QM mouse and C57BL/6 mouse. Bottom (L to R): 
day 2 and day 6 QM to C57BL/6 transfers and C57BL/6 (CFSE) to 129xB6F1. 
B The percentage of B cells which were QM or CFSE positive was 
calculated and is presented graphically. Green symbols represent background 
QM staining. Red symbols indicate QM to B6 transfers, blue symbols represent 
C57BL16 to 1 29xB6 Fl transfers with QM to 1 29xB6 Fl transfers represented by 
black symbols. 
B 
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Grafts of USE labelled QM cells to QM hosts were also rejected (data not 
shown) indicating that QM mice are not syngeneic, complicating the search for a 
suitable host. 
QM mice were generated on a 129 background and crossed 3 or 4 
generations to C57BL/6. As they were not tolerated by mice on a C57BL/6 
background we decided to investigate 129xC57BL/6 Fl (128xB6 Fl) as 
prospective hosts for transferred QM cells. Grafts were well tolerated with cells 
present at levels similar to those of C57BL/6 transfers (Figure 3.13). These mice 
were used as hosts for the generation of chimaeras in future experiments. 
3.10 Construction of a bone marrow chimaera using 129xB6 Fl mice. 
We decided to use 129xB6 Fl mice as hosts for the generation of CD40' tMT 
chimaeras. Although the CD40 and jtMT mice are both on a C57BL/6 
background, during reconstitution from the transferred bone marrow, 
precursors will be exposed both to 129 and C57BL/B6 antigens on the host 
stroma. This should tolerise them to QM antigens and avoid the rejection 
problems encountered with transfers to C57BL/6 hosts. 
C57BL/6 mice are irradiated for 47minutes for the generation of 
chimaeras, as illustrated in figures 3.9 and 3.10, this successfully removes all 
traces of host B cells and DC. 129xB6 Fl mice require a significantly higher dose 
than this as leakage of host cells was detected at this level. We were reticent to 
irradiate for a longer period as prolonged exposure to ionising radiation causes 
gut lesions in mice. However, if the dose is split in 2, the deterministic effects of 
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irradiation can be minimised while still effectively depleting host lymphocytes 
and haemopoietic cells. A titration of radiation dose was performed to find the 
level at which host tissue is removed without adverse effects to the mice. 
To ensure removal of all CD40 positive cells, after a 2 month 
reconstitution period, mice were immunised with NP-OVA and blood samples 
taken for IgGi serum ELISA. Splenocytes were also analysed by FACS for 
CD40 B cells. ELISA results closely mimic FACS data, those mice that have 
CD40 B cells make a response that is proportional to the number of cells 
present (Figure 3.14). Two doses with a 2 hour gap between them was found to 
be required to completely remove all traces of host B cells. Identical results 
were obtained from mice that had received either doses of 35+40 min or doses of 
35+45 mm, it was decided to err on the side of caution and select the higher 
irradiation dose for generation of 129xB6 Fl host chimeras to ensure complete 
removal of host lymphoid tissue. 
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B 	Irradiation 	Irradiation % of B 
condition dose cells 
- minutes CD40+ 
1 50 7.17 
303 
2 55 2.89 
1.90 
3 60 18.16 
1.41 
4 35+35 2.99 
1.55 
5 35+40 1.49 
1.34 
6 35+45 1.13 
1.02 
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1 29xB6 Fl mice were irradiated at various doses and reconstituted with JAMT and 
CD40 bone marrow. 8 weeks later mice were immunised with NP-OVA, after a day 
10 boost, spleens were harvested and stained for B220 and CD40 expression. 
A Representative FACS plots are shown of a CD40 mouse and a reconstituted 
chimaera. Gating on B cells a histogram is shown of CD40 B cells. B The percentage 
of B cells which were CD40 for each of 2 mice per condition was determined and is 
plotted (top) against irradiation condition, which is shown in the table. Antigen specific 
IgGi ELISAs were performed, titres are shown (bottom.)The OD 405 is plotted against 
irradiation condition. 
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Discussion 
The development of an adoptive transfer system for the transfer of mature 
splenic B cells has been described. Ideally we wanted to be able to distinguish 
transferred B cells from host B cells so that they could be visualised by FACS 
and their response determined by ELISA. The progression of experiments 
leading to the development of a mixed bone marrow chimaera as an adoptive 
host is described. Many different types of hurdles were encountered but each in 
turn lead to a fuller understanding of the requirements for an appropriate, 
physiological experimental system. 
RAG-I- mice as adoptive hosts for transferred B cells. 
Initial transfers of C57BL/6 B splenocytes to RAG' mice were performed to 
assess their suitability as a host for mature B cells. Having no mature 
lymphocytes these mice proffer an easy method of distinguishing transferred 
cells. All ELISA responses can be attributed to transferred cells and simple 
markers for mature lymphocytes allow their detection by FACS. We had 
thought that transferred cells would proliferate and reconstitute the missing 
lymphocyte compartments in the spleen, just as in normal mice, B cells which 
die are replaced by new ones from the bone marrow. However it became 
immediately obvious that mature B cells did not reconstitute the B cell 
compartment of the spleen, whereas transferred mature T cells almost fully 
replenished the splenic T cell compartment. In repeated experiments, despite 
irradiation of the host, transferred B cells failed to proliferate and instead a small 
but reproducible number of them differentiated into plasma cells. This was 
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mirrored in the ELISA results where antigen specific serum 1gM but not IgG 
was detected. Immunofluorescent analysis of spleen sections exemplifies these 
results well; no B cell areas can be seen, but 1gM plasma cells are clearly visible 
along with small I cell areas. 
These results seemed difficult to explain without further investigation, 
however at this time a report by Agenes and co workers was published detailing 
similar findings in great depth. (182). They find that when resting lymph node 
B cells are transferred to B cell deficient hosts (RAG2) that the number of 
donor B cells recovered is very low, that they have an activated phenotype, and 
that serum 1gM levels are the same as in normal mice. They attribute this to 
independent homeostasis of a peripheral pool of activated B cells. 
In mice that received 1x107 lymph node cells on day 0, only 1x105 cells 
were recovered on day 3, however, this improved slightly with 1x106 cells 
recovered on daylo. The number of cells recovered remained stable for 4 
months. Cells were found to turn over, however transferred B cells were unable 
to reconstitute normal B cell numbers. Many of these cells had an activated 
phenotype suggesting that some donor B cells differentiate from a resting to an 
active state or that pre-activated cells in the transferred population proliferate. 
In either case, the surviving population is different from the resting B cell 
compartment in normal mice. Similar findings have been reported for a mouse 
with an inducible RAG2 mutation; a small population of activated cells remain 
while normal B cells disappear with time (184). 
These results mean that RAG hosts are unsuitable for the transfer of 
mature B cells. The reason for this might be that in a lymphopeonic setting it is 
Chapter 3 	 117 
important to attain protective immunity. This is done by immediate 
differentiation to plasma cell rather than reconstitution of the B cell 
compartment. Or perhaps mature B cells, although they have the ability to 
divide are lacking other unknown factors that allow the reconstitution of a niche 
in an inimunodeficient host. The importance of the adoptive host is stressed by 
Freitas: 
"B cell survival is not predetermined by intrinsic 
properties of the cell but rather it is dependent on the host 
environment and the presence of other competitor 
populations "(185) 
Many other labs have used RAG deficient mice as hosts for the adoptive 
transfer of B cells. Much of the work investigating the expression or re-
expression of RAG in the periphery involved the transfer of B cells from either 
RAG2-GFP (143, 149) or RAG-1-GFP (146) fusion gene targeted mice, or mice 
carrying a bacterial artificial chromosome (BAC) encoding GFP instead of RAG2 
(147) to RAG1 deficient mice. We feel that transferred cells should be able to 
take part in a normal immune response and that this should be ensured by 
monitoring their response to antigen. Although some information can be 
determined by transferring cells to RAG deficient animals for our purposes we 
felt a more physiological system was required. 
Other adoptive hosts investigated. 
Our results with transfers to RAG hosts led us to investigate the use of other 
mice, which have their own complement of B cells. However, this can cause 
other difficulties. If host B cells are present it makes the identification of 
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transferred cells more complex. We needed a strategy for the detection of the 
response of transferred cells by ELISA, to assess affinity maturation, and a cell 
surface marker for their detection by FACS. It is important that transferred cells 
should be distinguishable from host cells in the event of loss of Id expression. 
As discussed before there are at least 3 well-documented systems for 
identification of transferred cells. However, CD40' mice were available to us 
and had the advantage of lacking the cell surface marker but also of being 
unable to class switch. This allows the detection of the response of transferred 
cells by class switched isotype ELISA. 
CD40 1  mice have the added advantage that CD40 deficient B cells are 
unable to make TD responses as they cannot receive signals from CD154 on T 
cells. They do not form GCs, nor do the B cells proliferate in response to 
antigen. This gives transferred CD40 cells a large selective advantage. This 
selective advantage helps to counteract the stress cells are put under when 
manipulated ex vivo. Cell sorting limits the number of cells that can be 
transferred so this selective advantage is beneficial. Adoptively transferred cells 
are also in the position of being extra cells in a mouse that has already filled all 
its lymphocyte niches. We were reticent to create space for cells by irradiating 
hosts as we found this to non specifically activate cells and disturb lymphoid 
architecture. Hence the use of CD40 deficient mice is ideal. 
Although it has been reported that B cells transferred to full 
immuriocompetent hosts are lost soon after transfer (186), we have had modest 
success, with transferred cells still detectable after 16 days. However, in hosts 
where other B cells are CD40 deficient CD40 + B cells can be detected after 3 
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months. This led to the development of two systems based on the use of CD40 
deficient B cells as compromised competitors for survival factors with 
transferred cells. The first one relied on the immunisation of CD40' mice with 
CD40 + DC as these are required to activate T cells so they can provide 
costimulation for CD40 B cells. Our second system removed the requirement 
for external administration of DC, by generating a mouse with DC and B cells 
compartments provided by different transgenic mice. This allows DC to be 
CD40 sufficient in the context of CD40 deficient B cells, an ideal host for 
adoptive transfer of a pure population of transgenic CD40 B cells. 
Mixed bone marrow chimaeras have been used by other groups to 
investigate competition between cohorts of B cells for space during 
reconstitution (185). However chimaeras where DC and B cell compartments 
are from different sources have not been documented. They were developed in 
our lab initially, to allow dissection of the factors involved in T cell migration to 
B cell follicles (S. Fillatreau and D. Gray in press). They have also been used to 
investigate cognate interaction between B and T cells where B cells, but not DC, 
are class II deficient. The real benefit of this system is that it allows the isolation 
of a genetic deficiency to the B cell compartment alone, allowing dissection of 
the role of B cells in the context of a functioning immune system. 
At this stage our experiments were complicated by the rejection of QM 
cells by hosts on the C57BL/6 background. Although we were aware that the 
QM mice were not fully backcrossed we had though that grafts would be stable 
long enough for our purposes but this proved not to be the case. 
Chapter 3 	 120 
This meant that as well as providing a means for the cells to be distinguished by 
FACS and their response by ELISA, the adoptive host needed to accept QM 
grafts. The use of 129xB6 Fl hosts means that transferred bone marrow cells 
used for reconstitution are educated in the presence of stroma expressing 
antigens of both 129 and C57BL/6 origin. Surprisingly these mice are 
particularly radio resistant and it took some time to find irradiation conditions 
that removed all host cells. However, these mice were tolerant of QM grafts. 
Chimaeric hosts provide an environment for the activation, selection and 
expansion of transferred CD40 B cells. Cells are able to class switch and form 
GCs. Their antibody responses can be distinguished from those of the host as 
they can class switch and produce IgG and its subclasses. Cells can also be 
visualised by staining with an anti-CD40 antibody and analysed by FACS. This 
chapter details the development of this system as a suitable adoptive host for 
our requirements. In subsequent chapters experiments investigating the 
response of transferred cells are described. 
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Chapter 4 Receptor revision in QM B cells 
Introduction 
In chapter 3 the development of an adoptive host for the receipt of a pure 
population of QM B cells is described. In this chapter a series of experiments to 
investigate whether a pure population of splenic QM Id cells might produce a 
serum antibody response to antigens other than NP, the hapten recognised by 
the site directed BCR is described. It has already been reported that centrally 
edited Id - cells in the QM mouse can provide neutralising antibody responses to 
several viruses (180). We have also shown that they can provide a response to 
model antigens (section 3.2, 3.3). We wanted to know whether de novo 
rearrangements of the BCRs of mature splenic QM B cells could provide a serum 
antibody response to other antigens. 
QM mice were chosen as a source of transgenic cells specifically because 
they recognise the hapten NP. Haptens when conjugated to protein carriers 
elicit a TD immune response which has been well characterised (187, 188). Since 
haptens are small and only contain one epitope, the antibody response can be 
measured in ELISA by conjugation of the hapten to a different carrier, allowing 
an uncomplicated measure of serum antibody titres. The other site directed 
transgenic mouse used in this study, 3.83K1 (Chapter 5), requires the use of a 
complex antigen - M13 bacteriophage, the response to which is less well 
defined. 
The QM mouse undergoes secondary rearrangement of its antibody 
heavy chain. It is the heavy chain that provides the specificity for antigen as all 
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combinations of site directed transgenic heavy chain with endogenous lambda 
light chains result in NP specificity (178). There is strong selective pressure in 
this mouse for the expansion of other specificities. This is substantiated by the 
25% of B cells in the spleen that no longer express the idiotypic antibody due to 
central editing. As the QM heavy chain is known to undergo rearrangement the 
QM model is a good choice for investigating the effects of receptor revision at 
the heavy chain locus on affinity maturation. 
In experiments performed by Nemazee and co-workers receptor revision 
in 3.83 transgenic mice was detected in response to antigen recognised with low 
affinity by the transgenic BCR. High affinity or non-binding antigen did not 
induce receptor rearrangement (137). We have adopted this antigen system in 
our investigation of affinity maturation in 3.83 mice (Chapter 5). However, 
there is not a known hierarchy of antigens recognised by the QM receptor. In a 
recent publication (176) pNP (p-nitrophenyl acetyl) was used as an antigen 
recognised with low affinity by the QM receptor. In the experiment described 
here it was decided to use the homologues of NP: DNP and TNP, as potential 
low affinity antigens. TNP has been previously used as an antigen recognised 
with low affinity by the QM BCR (Gaspal and Lane poster presentation at 
Keystone B cell symposium 2001). No reactivity to TNP or DNP was detected 
by ELISA using serum from NP immunised C57BL/6 or QM mice, indicating 
that if there is any cross reactivity between antigens that it is very low. 
Consequently these antigens (TNP and DNP) are ideal candidates for induction 
of receptor rearrangement. 
In chapter 3 the development of a mixed bone marrow chimaera 
adoptive transfer system was described. Here, the results obtained from the 
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transfer of mature sorted QM Id B cells into chimaeric hosts are reported. Mice 
were immunised with NP, DNP or TNP and serum antibody responses 
measured by ELISA. Strong antibody responses were detected to NP, however, 
there was no response to DNP. A small, delayed response to TNP was detected 
in some mice. The implications of these findings are discussed. 
Results 
4.1 QM cells grafted to chimaeric hosts undergo cell division when 
immunised with NP-OVA. 
It is critical to the experiment that adoptively transferred cells should be 
responsive to antigen and capable of normal B cell immune responses. To 
determine whether transferred cells become activated after immunisation of 
host mice, we examined their cell division using the fluorescent stain CFSE. 
This dye stably binds cytoskeletal actin following activation by cellular 
esterases. When a cell divides USE is apportioned equally between the 2 
daughter cells, resulting in halving of the fluorescence, consequently cell 
division can be examined by FACS (189, 190). QM and C57BL/6 splenocytes 
(1x107) or sorted QM Id B cells (1x106) were USE labelled and transferred to 
129xB6 Fl host chimaeras reconstituted with CD40' and tMT bone marrow 
(for simplicity these will be referred to as chimaeras in the remainder of this 
chapter). Mice were immunised 24hr later with NP-OVA alum. After 7 days 
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mice were sacrificed and splenocytes analysed by FACS (Figure 4.1). 
QM cells divided well with many having gone through at least one cell 
division, this was even more impressive on day 14 with very few cells 
maintaining full levels of fluorescence (not shown). Sorted B cells behaved 
similarly to splenocytes, indicating that sorted cells maintain the ability to 
respond to antigen. In contrast, much fewer C57BL/6 B cells underwent cell 
division, this is unsurprising as few of them should recognise NP. It is difficult 
to estimate exactly how many divisions cells have completed, as after about 3 
rounds the loss of fluorescence causes cells to blend into host cells, however, we 
are content that transferred QM cells respond to antigen in a normal fashion. 
4.2 Transferred QM cells form germinal centres which can be detected by 
immuno fluorescence 
It is important that transferred CD40 B cells are able to form CC in the chimera 
system. The formation of GC is critical in any system designed to investigate 
affinity maturation, and other processes in the normal B cell response to antigen. 
In GC, high affinity B cells are selected on the basis of competition for antigen 
captured on FDC networks and expanded. Also, RAG expression in the 
periphery has been localised to GC and to cells with a GC like phenotype (130). 
To confirm that CC can form in this system, 1x1O7QM or C57BL/6 
splenocytes were transferred to chimaeras. Mice were immunised with NP-OVA 
24hr later and spleen sections taken for immunofluorescent analysis on day 7 
and 14. 
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1 X 07 C57BL/6 or QM splenocytes or 1 X 0 6  sorted QM B cells (all CFSE labelled) 
were transferred to 129xB6fl host chimaeras. 24hr later mice were immunised with 
NP-OVA. After 7 days spleens were harvested and cells stained with anti-B220 
conjugated to PE before analysis by FACS. Shown, from top to bottom are mice that 
received C57BL/6 splenocytes, QM splenocytes and QM sorted B cells. For the 
mice that received splenocytes 200,000 events in the lymphocyte gate were collected, 
for the mice which received B cells 500,000 events were collected gating on both 
lymphocytes and B cells. In all cases CFSE is on the X axis and B220 on the Y axis 
Data shown is representative of two mice per group on each day. Similar results 
were obtained on Day 14. 
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GCs were not detected on day 7 but on day 14 CC numbers similar to control 
levels were detected. The anti QM Id antibody is faintly visible on sections and 
it is possible to discern whether CC are composed of QM Id cells or not. When 
QM splenocytes were transferred and mice were immunised with NP all CC 
were QM Id , in contrast all CC in the mice that received C57BL/6 cells were 
QM Id -. QM Id + plasma cells are also clearly visible (Figure 4.2), indicating 
differentiation of transferred cells into plasma cells. 
4.3 Transferred, unsorted QM splenocytes can mount a response to two 
chosen antigens. 
We have shown that centrally edited cells can mount a response in the QM 
mouse. As a final control we wanted to show that centrally edited cells were 
activated and expanded after transfer to chimaeras, and that these cells could 
mount a serum antibody response detectible by ELISA. This would confirm that 
the selection and expansion of a small number of antigen specific cells is 
possible and that our detection method is sensitive enough to measure an 
antibody response from these cells. In turn this would confirm that if cells were 
to undergo revision and provide a useful specificity, that the machinery is 
present to incorporate them into an immune response and that we could detect 
this response. 
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Figure 4.2 GC formation by OM cells in chimaeras 
C57BL/6 to 129xB6F1 
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1 X 07 C57BL16 or QM splenocytes were transferred to 129xB6 Fl host chimaeras. 
Mice were immunised after 24hr with NP-OVA andl4 days spleens harvested and 
sections cut for immunofluorescent analysis. Sections were stained with PNA Texas 
red and anti-QM Id FITC (top), to stain idiotype positive GC,or 1gM texas red and anti 
QM Id FITC (bottom) to illuminate QM positive plasma cells. On the left C57BL/6 
transfers to chimaeras are shown with OM transfers on the right. 
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QM splenocytes were isolated and 1.5x107 cells injected intravenously 
(i.v.) to chimaeric hosts. Typically 25% of the QM spleen is comprised of B cells, 
therefore we estimate that mice received —3.75x106 B cells. Mice were 
immunised i.p. with DNP-OVA or tetanus toxin RCF, blood samples taken at 
weekly intervals, and serum ELISAs for all isotypes performed. IgGi results are 
shown as a representative example, however, antibody of all IgG isotypes was 
made, although the levels are about half the magnitude of that of a wt mouse. 
FACS was also carried out to detect expansion of cells that were QM 1d, and 
CD40 . Immunofluorescent analysis of spleen sections was performed to detect 
the presence of GC (Figure 4.3). 
In QM mice around 25% of the B cells in the spleen are Id negative, this is 
very consistent (our observation). In the chimaeras that received splenocytes 
this number increases to 56% in the RCF immunised mouse and to 45% and 52% 
respectively in the 2 DNF immunised mice, this is most likely caused by 
expansion of Id negative cells rather that receptor revision of Id positive cells. 
This is probably in response to clonal expansion of selected cells following 
immunisation, however, we cannot be sure that in the absence of immunisation, 
Id negative cells would not expand. 
Spleen sections were stained with PNA and anti-QM Id to quantify GCs. 
The density of GC in experimental mice was the same as that of a wt mouse. All 
GC were QM Id - indicating that they were formed by centrally edited cells. 
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Figure 4.3 Antibody responses of unsorted QM splenocytes when 
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1 .5x1 07  QM splenocytes were transferred to three chimaeras. 24hr later 1 was 
immunised with RCF and 2 with DNP-OVA. Blood samples were taken every 7 
days and on day 21 spleens were harvested and 3 colour FACS analysis 
performed. 
A ELISAs showing levels of RCF(left) and DNP (right) specific IgGi antibody. 
Experimental mice are depicted in red with positive and negative controls in 
blackand green respectively. 
B Splenocytes were stained with B220 PerCP, CD40 FE and QM Id FITC. 
Gating on CD40 B cells (top) mice were analysed for QM Id expression. 
Numbers indicate the percentage of CD40 B cells which are ld or IT 
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These results confirm that selection and expansion of QM Id - cells in response 
to non-NP antigens can happen in this system. Even when the majority of 
CD40 + B cells recognise NP, mice can make a response to DNP and RCF, two 
selected model antigens. 
4.4 A pure population of QM Id positive splenic B cells can respond to NP 
in adoptive hosts. 
We have shown that a mix of QM Id positive and negative cells can respond to 
other antigens in an adoptive host, hence verifying our system. To see if a pure 
population of QM cells can alter its specificity by secondary V(D)J 
recombination and provide a response to other antigens, cells were sorted by 
flow cytometry before transfer to chimaeric hosts. A population of -'99% pure 
QM Id + B cells was isolated as described in section 3.4. Between 2 and 3x106 
cells were transferred to chimaeras. To account for the small percentage (-1%) 
of contaminating Id negative cells, sort purity was assessed after each sort on a 
FACS Calibur flow cytometer and the requisite number of sorted Id - cells 
transferred to control mice. 
Mice were immunised with NIP or either DNP or TNP, homologues 
which may be recognised at low affinity by the transgenic receptor and boosted 
every 7 days. All antigens were alum precipitated and 109 Bordetella pertussis 
was added. Further mice were immunised, which did not receive any 
transferred cells, to control for any host response. Due to the limited yield of 
cells after sorting, the experiment was split into 3 groups with each group 
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having at least one NP immunised mouse as a control for cell survival post 
transfer. In each group, for each mouse that received QM Id + cells, a control 
mouse received QM Id - cells (Table 4.1). This was to ensure that any response 
we detected could be attributed to de novo rearrangements rather than to 
existing centrally edited cells in our sorted population. Blood samples were 
taken and mice were boosted at weekly intervals up to day 21 when mice were 
sacrificed. Serum ELISAs were performed to assess the levels of IgG and its 
subclasses secreted by transferred cells (host cells can only produce 1gM). 
Spleen cells were analysed by FACS to ensure the presence, and assess the 
composition, of transferred CD40 B cells. 
Table 4.1 Experimental organisation. 
Cell type transferred! Expt Noll Expt No. 2 Expt No. 3 
Antigen 
QM Id 2NP 1NP 1NP 
NP 
OM ld+ 2TNP 2TNP 3DNP 
DNPorTNP 
QMld - 2NP 1NP 1NP 
2TNP 2TNP 3DNP 
No cells 1NP 2NP 
1TNP 2DNP 
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At day 7 all mice make antigen specific 1gM (data not shown) indicating 
successful immunisation with all antigens. All NP immunised mice that 
received QM Id cells make an IgG response, this is half the magnitude of that 
made by a wt mouse on day 14 (Figure 4.4) and indicates that transferred cell 
survive and respond. This IgG response is comprised of IgG2a and IgG2b, with 
no IgGi being secreted at this time. None of the NP immunised mice, which 
received QM Id - cells or no cells, have any antigen specific IgG indicating that 
the response can be attributed solely to QM Id cells. There is no IgG response 
of any type to TNP or DNP indicating a failure of transferred cells to make a 
serum response to these antigens. 
45 On day 14 serum anti-NP responses are similar to those of a wt mouse 
At day 14 the strength of the IgG response is similar to that of a wt mouse. There 
is the same contribution from IgG subtypes as at day 7 and there is still no IgGi 
(Figure 4.5). DNP and TNP immunised mice still have no antigen specific IgG. 
Interestingly, however, in the NP immunised mice a low level of IgG can be 
detected from mice that received -1% QM negative cells to control for cell 
sorting accuracy. Mice that received no cells have background levels indicating 
that the response is not coming from the host but from the transferred cells. 
When sorting QM B cells, it is difficult to obtain a purity level above 99%. 1% 
sorted QM negative cells are used to control for this, however, the QM Id - cells 
themselves are not 100% pure and contain about 1% QM positive cells. 
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Figure 4.4 Responses of QM cells day 7 post transfer 
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Between 1 and 3x106 QM B cells were transferred to chimaeras, control mice received 
either no cells or the requisite number of sorted QM - cells. Mice were immunised with 
1 OOtg of either NP, DNP or TNP conjugated to OVA with 109 pertussis. Mice were bled 
on day 7 and serum ELISAs performed for lgG and its subtypes. On the left are shown NP 
immunised mice that received QM + cells from top to bottom lgG, Gi, G2a and G2b. Mice 
in different experiments (cells sorted on different days) are coloured red, blue and yellow 
the positive and negative controls are black and green respectively. 
On the right are lgG elisas from the top NP immunised mice that received negative cells 
(7mice), DNP immunised mice that received positive or negative cells (8 mice) and TNP 
immunised mice (9mice) as they are all negative individual lines cannot be distinguished. 
Positive controls are depicted in black 
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Figure 4.5 Day 14 serum ELISA data 
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Day 14 serum antibody responses were determined by ELISA. On the left are 
NP lgG responses in mice that received QM cells, from top to bottom: lgG, Gi, 
G2a, G2b. Mice in different experiments (cells sorted on different days) are 
coloured red, blue and yellow, the positive and negative controls are black and 
green respectively. Depicted in pale blue is the day 14 response of chimaeras 
reconstituted with wt cells to control for the irradiation and reconstitution process 
On the right are lgG elisas, from the top NP immunised mice that received 
negative cells or no cells (7mice), DNP immunised mice that received positive, 
negative or no cells (8 mice) and TNP immunised mice that received positive, 
negative or no cells (9mice) -as they are all negative individual lines cannot be 
distinguished. ELISA positive controls are depicted in black, in pale blue is the 
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Although only tens of thousands of negative cells were transferred to each 
mouse and only about 100 of these cells (1%) will have NP specificity we can 
still detect their response our assay, indicating that the response of a small 
number of cells can be detected in this system. However, it also indicates that 
the mice that received QM Id - cells as a control for sort purity should be treated 
cautiously as a marker of the response of contaminating QM Id - cells in the QM 
positive population. On day 14 another control is included; 129.B6 Fl host mice 
were irradiated and reconstituted with C57BL/6 bone marrow to control for the 
irradiation and reconstitution process. Levels of IgG are similar to those of a 
C57BL/6 mouse indicating that mice recover fully from irradiation and 
reconstitution and that it does not impair the immune response. 
4.6 At day 21 a small response to TNP can be detected in mice that 
received QM Id positive cells but not in control mice 
By day 21 the NP response has surpassed that of a wt mouse and the 
composition has shifted (Figure 4.6). IgGi is now the major contributing IgG 
subclass. The response of the mice that received QM Id cells is also more 
clearly visible, with IgG1 and IgG2b being the major contributing isotypes. 
Again, there is no contribution from host cells of the chimaera, as indicated by a 
lack of response in immunised chimaeras that did not receive any cells. 
Unexpectedly, although there is no detectible response to DNP, there is a small 
IgG response to TNP from 2 mice in one group (Figure 4.7). This response is 
entirely comprised of IgGi; all other isotypes were absent. 
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Figure 4.6 Day 21 NP responses in chimaeras with transferred QM cells 
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Mice were bled on day 21 and serum ELISAs performed for lgG and its subtypes. 
On the left are shown NP immunised mice that received QM + cells. On the right 
are mice which received QM negative cells or no cells and were immunised with NP. 
From top to bottom lgG, Gi G2a and G2b. Mice in different experiments (cells 
sorted on different days) are coloured red, blue and yellow the positive and 
negative controls are black and green respectively. 
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Figure 4.7 Day 21 DNP and TNP responses. 
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Mice were bled on day 21 and serum ELISASs performed for lgG (top) and IgGi 
(below). On the left are shown TNP immunised mice that received QMId + cells. 
On the right are mice that received QMld - cells, or no cells and were 
immunised with TNP. At the bottom, day 21 DNP results from mice that received 
positive, negative, or no cells are shown (8 mice). Mice in different experiments 
(cells sorted on different days) are coloured red, blue and yellow the positive and 
negative controls are black and green respectively. 
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These mice received QM Id+  cells, there is no response from mice that received 
either QM Id - cells, or no cells, indicating that it has been most likely generated 
by QM Id cells. However, this response is only seen in one of two groups 
immunised with TNP -2 out of 4 mice. We appreciate that group numbers 
could be larger, however, as discussed before, this was made difficult by the low 
yields achieved when sorting QM cells. This is compounded by the number of 
control mice employed. 
The response to TNP detected, could have been generated by somatic 
hypermutation or receptor revision. Crossing QM mice onto a to RAG deficient 
background would make secondary rearrangements impossible, allowing a 
comparison to be made between the responses of cells that can revise and those 
that cannot. QM mice cannot be crossed to RAG deficient mice as they require 
RAG to rearrange the endogenous lambda light chain. Consequently there is no 
way of ruling out either mechanism in the QM system. This is discussed further 
in the discussion. In our system B cells are marked with CD40 and with the QM 
Id, thus in the event of loss of the Idiotypic receptor (by secondary 
rearrangement or otherwise) transferred cells can still be distinguished from 
those of the host. Analysis of the composition of CD40 B cells by FACS is 
presented in the next section. 
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4.7 Detection of transferred cells is complicated by high levels of serum Id 
positive 1g. 
QM cells transferred to the chimaeras can be distinguished on the basis of QM 
Id expression but also on the basis of CD40 expression. This means that if cells 
were to revise their BCRs and loose Id expression, they should still be 
distinguishable from host CD40 B cells because they express CD40. This should 
show whether receptor revision had occurred. On day 21 spleens were 
harvested from chimaeras and analysed by three colour flow cytometry for the 
presence of transferred cells. Splenocytes were stained for the B cell marker 
B220, for CD40 and QM Id expression. To eliminate host DCs, which can also 
express low levels of B220 and are CD40, FACS plots were gated on B220 hi  B 
cells and analysed for Id and CD40 expression. 
In previous transfer experiments to C57BL/6, or to 129xB6 Fl host 
chimaeras, QM Id + B cells could be easily distinguished from host cells at day 7 
or day 14. However, in this experiment, in which mice were boosted multiple 
times to increase our chances of detecting a response, 3 problems were 
encountered which hindered our detection of Id expression. Firstly, host 
CD40 1  B cells (but not T cells) shifted on staining with anti Id antibody making 
it difficult to distinguish truly Id + cells from background (Figure 4.8A). We 
attribute this to Fc receptor mediated binding of Idiotypic antibody, which is 
present at high levels within the host. This may be subsequently detected on 
staining ex vivo with the anti Id antibody. 
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Figure 4.8 Problems encountered when attempting to identify whether 
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Chimaeras that received transferred cells and were immunised with NP-OVA, 
boosting weekly, were killed on day 21 and spleens harvested. Splenocytes were 
stained for B220, QM Id and CD40 expression and analysed by FACS. 
A.Splenocytes gated on live lymphocytes stained with B220 and QM Id shows 
shift of host B cells with anti- Id. 
Gating on lymphocytes and B220 hi  cells (gate in A) CD40 and QM Id 
expression is examined in a OM mouse (left) and a chimaera that received sorted 
QM ld CD40 B cells (right). The vertical line indicates the cut off between QM 
positive and negative cells in a QM mouse. All of the CD40+ cells in the chimaera 
should also be QM + however expression is down regulated. 
A CD40 mouse gated on lymphocytes and 6220 hi  cells illustrating the 
autofluorescence encountered in the spleen, making enumeration of putative Id 
positive and negative cells impossible (boxes 2 and 1 respectively). 
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This phenomenon has only been detected in mice that have high levels of NP 
specific antibody from transferred cells. 
Secondly transferred QM Id + cells appear less brightly stained than they 
were when they were sorted, compounding the previous problem. This may be 
attributible to down regulated surface Ig due to cell activation (Figure 4.8B). 
Thirdly, autofluorescent cells in the spleen, which lie in the same position as 
CD40 Id positive cells on FACS dot plots, make quantitative analysis of 
transferred cells very difficult (Figure 4.8C). These autofluorescent cells are only 
noticeable when large numbers of events are collected, however, it is necessary 
to collect large numbers to detect rare transferred cells. These results are 
commented on further in the discussion. 
4.8 Transferred cells are still present on day 21 and have expanded in NP 
immunised mice. 
Despite that fact that we cannot make any conclusions on Id expression of 
transferred cells in these mice, transferred cells can still be detected on the basis 
of CD40 expression. Representative FACs plots from each group of mice are 
shown in Figure 4.9. For each antigen (NP, DNP and TNP) there is a group of 
mice that received positive cells, negative cells or no cells and there are between 
3 and 5 mice in each group. 
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Figure 4.9 CD40 positive cells in chimaeras on day 21 
QM Id 
On day 21 spleens from chimaeras were harvested and stained for B220, CD40 
and QM Id. Plots shown are gated on live lymphocytes and B220 hi  cells to 
eliminate DCs. At the top (L) is the CD40 control illustrating autofluorescence in 
the spleen. From left to right in columns are representative mice of each of the 
groups which received; no cells, QM Id - cells and QM Id + cells. In rows across, 
from the top are mice immunised with NP, DNP and TNP respectively. QM 
staining is on the X axis and CD40 staining on the Y axis. 
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In mice that did not receive transferred cells, CD40 B cell levels are not 
above background. In those which received negative cells to account for 
contamination of the positive population, only mice immunised with NP have 
CD40 cells. This is due to the fact that the negative sorted population is 
contaminated with 1% positive cells and there is a high level of selection for and 
expansion of CD40 cells in these mice. In the mice that received positive cells, 
CD40 + B cells can be detected, indicating their survival to day 21. They have, 
however, expanded in the NP immunised mouse but not in the DNP or TNP 
immunised mice. 
Forward scatter profiles of transferred cells were analysed to assess their 
activation status, by gating on CD40 cells. Transferred cells in all mice were 
larger than CD40 B cells in a wt mouse, however, in mice immunised with NIP 
cells were larger than those immunised with either TNP or DNP (Figure 4.10) 
indicating antigenic activation. 
4.9 Germinal centres were formed in mice that received QM Id cells. 
Spleen sections were cut and examined for GCs. Sections were stained with 
PNA and surface Id with anti QM antibody to reveal whether cells in the GC 
had originated from transferred QM Id cells. 
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Splenocytes of chimaeric mice that received QM sorted cells were stained for B220 
and CD40. Gating on transferred, CD40+  B cells forward scatter profiles were 
compared between mice immunised with NP, DNP or TNP (B,black,blue and pink 
respectively). WT CD40 B cell were used to assess a normal forward scatter profile 
(green) 
Profiles shown are from one mouse for each antigen and are representative of 3 - 
5 mice per group. 
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Mice that received QM Id cells and were immunised with NP formed many 
large GCs, most of which also stained for QM Id (Table 4.2). 3 out of 4 control 
mice that received sorted QM - cells also had GC but at much lower numbers. 
This is probably due to the very low numbers of QM Id cells that are present in 
the QM Id - population. This again indicates that a small number of cells can 
generate an immune response in this system, as we estimate that these mice 
receive only —100 QM Id cells. 
Mice that received QM Id cells, but were immunised with DNP or TNP 
also had some CC (Table 4.1). All of the CC in DNP and TNP immunised mice 
were QM Id . None of the mice that received QM Id - cells and were 
immunised with other antigens had any GC implicating QM Id + cells in GC 
formation. None of the mice (5/5) that were immunised in the absence of cells, 
had GC indicating that any formed were from transferred cells. 
GC numbers are shown in Table 4.1. 
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Table 4.2 	GO numbers in chimaeras that received QM B cells 
OM Id positive QM Id negative No cells 



















GCs in chimaeras that received QM positive, negative or no cells and were 
immunised with NP, DNP or TNP. QM Id positive GO numbers are in brackets. 
4.10 Immature cells from the bone marrow do not respond well to other 
antigens. 
The source of RAG expressing B cells has been attributed to immature cells 
emerging from the bone marrow (143, 147, 149). To ascertain whether these 
immature cells can revise their receptors in response to different antigens, we 
transferred bone marrow cells from QM mice to chimaeric hosts. Mice received 
6x106 bone marrow cells, which had been depleted of mature I cells (to avoid 
graft versus host disease), and were immunised 24hr later with NP, TNP or 
DNP. A very strong NP IgG response was generated on day 7 and was 
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maintained to day 21 (Figure 4.11). A very small but reproducible DNP 
response was detected on day 21 but there was no response to TNP. 
Transferred CD40 cells can be detected by FACS, however, due to the 
problems detailed in section 4.7, it is difficult to tell whether they are Id positive 
or not (Figure 4.11). Spleen sections were also analysed for the presence of CC, 
results are shown in Table 4.2. The mouse that generated the DNP response had 
higher numbers of CD40 + B cells and also had a large number of GC, only half 
of which are Id positive (Table 4.3). 
Table 4.3 GC numbers in chimaeras that received QM bone marrow cells. 
Antigen Number of 
GC 





GO numbers in chimaeras that received 6x106 QM bone marrow cells. Numbers 
in brackets indicate the number of QM Id + GO. 
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6x1 06  QM bone marrow cells were transferred to chimaeras and mice immunised 
with NP, DNP or TNP. Mice were bled on day 21 and lgG ELISAS performed 
A Antigen specific ELISAs: experimental mice are in red with positive and negative 
controls in black and green respectively. B Spleens were harvested and stained 
for B220, CD40 and QM Id. Plots shown are gated on lymphocytes and B220 hi 
cells to avoid CD40 DC and show CD40 and QM Id expression. 
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Discussion 
Background 
Affinity maturation of antibodies is currently ascribed to somatic 
hypermutation. Receptor revision, the process whereby the entire variable 
region of an antibody is changed by RAG mediated recombination, might 
provide an additional means of diversification. To investigate this we needed to 
follow the response of a cohort of B cells that had a known specificity, so that if 
this specificity was altered it could be detected. We decided to use QM B cells, 
which are specific for the hapten NP. Some of the B cells in this mouse already 
recognise antigens other than NP due to central editing of their BCRS. To obtain 
a pure population of B cells, the NP specific cells were separated from the others 
by sorting them on the basis of expression of the site directed transgenic heavy 
chain, which provides the NP specificity. These cells were then transferred into 
chimaeric hosts, which lack CD40 on B cells, allowing the selective expansion of 
transferred cells as they are the only ones that can receive signals from T cells 
through CD40. 
The discovery of RAG expression and DNA excision products, indicative 
of functional protein, in the periphery, raised the question of its function there 
(130, 133). RAG is required for the rearrangement of antibody gene segments to 
enable antibody production and was therefore thought to be active solely in the 
bone marrow during B cell development. Since its discovery in the periphery, 
there has been much speculation about the function of RAG here. It appears 
risky to generate random new B cells specificities, some of which could by 
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chance be autoreactive. Indeed, initially it was speculated by Nemazee and co 
workers that peripheral rearrangement was a tolerance mechanism just as 
receptor editing is in the bone marrow. This turned out not to be the case as 
RAG expression is turned off on the receipt of a strong signal through the BCR 
(137). This result was corroborated in human tonsillar B cells (139). These 
results along with the sequencing of human B lymphocytes revealing 'hybrid' 
VH gene segments allayed fears that the phenomenon was a transgenic artefact 
(155). 
We and others have suggested that receptor revision might play a role in 
providing useful specificities in the GC, which would be unobtainable by 
somatic mutation alone (133, 157, 175). Our working hypothesis is that receptor 
revision and somatic hypermutation play complementary roles in affinity 
maturation. Somatic mutation might have limited effects on certain antigen 
binding structures with further mutation resulting in loss, rather than gain, of 
binding affinity. 
When this work was started no evidence of a role for receptor revision 
had been documented. Research focussed on the investigation of the nature of 
RAG expressing cells with a number of reports suggesting that the cells were, in 
fact, immature immigrants from the bone marrow (143, 149). Immature cells 
express RAG to make functional antibody, if cells were to leave the bone 
marrow while still expressing RAG they might be mistaken for mature cells in 
the GC as they share some cell surface markers (GL7). This data is difficult to 
reconcile with PCR and immunohistochemical evidence of RAG expression in 
lymph nodes where bone marrow cells are unlikely to migrate (131, 132). In 
vitro experiments also directly demonstrate receptor revision in transgenic B 
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cells of splenic origin upon stimulation only in the presence of low affinity 
antigen (137). 
Irrespective of the source of RAG expressing cells we sought to find out 
whether they could contribute to affinity maturation of the immune response. 
Recently some publications have addressed the role of peripheral revision. 
Goossens and co workers (156) state that 
"Receptor revision plays no major role in the shaping of 
the receptor repertoire of human memory B cells after the 
onset of somatic hypermutation." 
They analysed VJK  and VJx joints in single X positive GC B cells for 
rearrangements at the K and X loci and found that the frequency of rearranged 
cells is less than 3%. However, Magari and co workers (176) analysed the 
production of X positive anti pNP IgG antibodies and say that their findings 
suggest that 
"Light chain rearrangement that occurs in the periphery 
can contribute to affinity maturation of antibody." 
We felt that the issue was as yet unresolved and used a novel system to 
investigate further. 
Development of a system to allow the distinction of the antibody response 
of transferred cells. 
Having developed an adoptive transfer system, which we felt provided a 
physiological environment for the receipt of sorted cells, we wanted to ensure 
that the system specifically allowed proliferation of a cohort of identical 
transgenic cells. Previous experiments investigating the source of RAG 
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expressing cells used empty vessel RAG deficient hosts (143, 147, 149). The 
ability of cells to divide in response to antigen was not investigated in all of 
these studies. We showed by USE labelling cells that when immunised with 
NP they undergo numerous rounds of cell division, confirming the suitability of 
our host. 
Secondly, to determine whether a minor population of cells might 
be able to provide a serum antibody response unsorted QM splenocytes (about 
25% of which have diverse specificities) were transferred. This was to 
determine whether if a small proportion of the transferred pure QM positive cell 
population were to alter specificity and recognise another antigen, we might be 
able to detect the response by ELISA. The responses to RCF and DNP detected 
along with the increase in QM Id - cells encouraged us that we might be able to 
detect a response from revised cells. 
Another way to do this might have been to spike sorted cells with 
transgenic cells of another specificity. This would have given us an idea of how 
many cells are required to give a detectable immune response. However, our 
results where QM Id - sorted cells which contain -1% QM Id cells give a 
detectable ELISA response on day 14 and 21 indicate that the response of a very 
small number of cells can be detected in this system. We estimate that about 100 
QM positive cells were transferred in this case. In early control experiments 
where C57BL/6 B cells were transferred to chimaeric hosts, responses were 
detected in mice that received as few as 1x106 cells. Mice were immunised with 
NP-OVA and although the number of NP specific cell must have been very low, 
an NP specific antibody response was still detected. In experiments to analyse 
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the response of QM positive cells to non-NP antigens between 2 and 3 x106 QM 
cells were transferred, all of these cells would have had the opportunity to 
interact with TNP and DNP. If receptor revision was to be induced by one of 
our low affinity antigens and be physiologically relevant we should have been 
able to detect it as we had a greatly increased number of relevant B cells. 
Our main concern when devising an experimental strategy to detect 
receptor revision was that sorting was never going to provide as pure a 
population of B cells as we would want. Contamination with B cells of other 
specificities was minimised to 1%, this required extensive optimisation of the 
sorting conditions. To control for this contamination the experiment was set up 
with an equal bias for mice receiving sorted positive and negative cells. Also 
another control group of mice, which did not receive cells, was included to allay 
any fears of a serum IgG contribution from 129xB6 Fimice, the irradiated hosts 
for the generation of bone marrow chimaeras. In the event it might have been 
more beneficial to bias the experiment more toward the mice that received 
positive cells as most of them made no response to DNP or TNP and our fears of 
the contribution of negative cells may have been exaggerated. 
Antibody responses attributable to transferred cells. 
A strong NP specific IgG response was detected in mice that received 
transferred cells and were NP- OVA immunised, indicating that cells 
transferred to chimaeras can make good antibody responses. This contrasts 
with lower levels of antigen specific Ig secreted by transgenic cells transferred to 
normal hosts by other groups (191, 192). Initially, most of the antibody 
produced by transferred cells was of the isotypes IgG2a and 2b, probably due to 
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the use of Bordetella pertussis , which is a Thi inducing adjuvant. With time, 
however, the nature of the response changed and by day 21 IgGi was the main 
contributing isotype. The mice that received sorted QM Id - cells responded to 
NP but not to DNP or TNP, leading us to conclude that the NP response was 
caused by a small number of QM + cells, present due to sorting inaccuracies. 
Due to the lack of response to DNP and TNP in mice that received negative 
sorted cells we believe that the small number of QM negative cells present in the 
QM positive population is not responsible for the TNP response detected on day 
21. 
Based on preliminary findings we had expected not to see any response 
to either DNP or TNP from sorted cells. The fact that a small TNP response was 
detected on day 21 in 2 mice that received QM Id cells but not in those that 
received QM - cells is intriguing. However, the fact that a response is detected 
in 2 mice in one experiment and not in another 2 mice in a different experiment 
does not allow an unequivocal conclusion to be drawn. 
One possibility is that the response to TNP is caused by QM positive 
cells, which having revised their receptors, are now Id negative. However, 
somatically mutated QM positive cells, or QM negative cells already present in 
the transferred population could also be responsible. The fact that mice that 
received negative cells did not provide a TNI? response implies that it is derived 
from QM positive cells leaving either revision or mutation as possible causes. 
This issue could have been resolved if we had been able to cross QM mice onto a 
RAG deficient background. Crossing to RAG deficient mice rules out a 
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contribution from receptor revision as RAG is required for receptor 
rearrangement. However, this cannot be carried out as QM B cells require RAG 
expression to rearrange endogenous lambda light chains to make a functional 
antibody. If we had still obtained a response to TNP in B cells deficient in RAG 
we could have attributed it to somatic mutation alone. 
We might have expected that affinity maturation by somatic 
hypermutation would have given us some response to the chosen antigens. 
Most of the work on somatic mutation has focussed on the molecular diversity 
generated. Those assessing affinity changes have generally generated 
hybridomas and assessed affinity by fluorescence quenching (158, 159). Affinity 
maturation of serum antibodies, however, has been described by Smith and co 
workers (193), and can cause a 1000 fold increase in affinity to antigen. Indeed 
somatic mutation can cause a complete change in specificity between haptens 
(194) or result in loss of binding (195). These facts need to be borne in mind 
when drawing conclusions from our data. 
Due to the complex nature of these experiments we chose a small 
selection of antigens against which to measure affinity maturation. In the 3.83 
system, which formed the basis for our experiment, receptor revision was 
triggered by low affinity antigen. This affinity did not induce proliferation of 
transgenic B cells nor did it increase their forward scatter (FSC) profile as 
analysed by FACS (201). The forward scatter profiles of QM cells transferred to 
chimaeras were analysed. Cells from mice immunised with NP had a larger 
FSC profile that those from mice immunised with either DNP or TNP. 
However, all transferred cells were larger than B cells from a C57BL/6 mouse. 
This may reflect the fact that these cells had been adoptively transferred and 
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were the only CD40 B cells in the mouse, or it may truly effect antigen 
activation. 
All that was required, to trigger V(D)J rearrangement in the 3.83 system 
was receptor occupancy as measured by mean fluorescent intensity of samples 
analysed by FACS. We were not able to assess receptor occupancy of QM 
receptors with DNP or TNP due to a lack of the required reagents. In this 
respect the 3.83 system is better defined. Our results obtained from the 3.83 
system are described in chapter 5, however, the nature of the antigen caused 
unforeseen complications, justifying our parallel investigation of receptor 
revision in QM mice with the better-defined hapten-carrier system. 
Analysis of germinal centre formation by transferred cells 
Immunofluorescent analysis of spleen sections revealed that CC were formed in 
mice that received QM positive cells only. Mice that did not receive cells or 
those that received negative cells did not have CC (apart from those that were 
immunised with NP). This implies that the GC observed originate from 
transferred QM positive cells. In mice that were immunised with NP most of 
the GC detected were QM Id , however, a small number were Id negative. The 
GC present in NP immunised mice that received negative cells are also QM Id+ 
indicating that they were probably formed by contaminating QM + cells in the 
negative population. We do not know why some of the CC did not express Id 
but it may indicate an unreliability of the anti QM Id antibody on sections. 
It is a possibility that the QM staining observed is not actually expression 
of QM Id on the surface of CC B cells. CC B cells are known to down regulate 
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surface Ig so in fact we may be detecting the binding of serum antibody to Fc 
receptors on B cells. It is unlikely that we are observing the binding of antibody 
to FDC networks as the staining does not have the characteristic branching 
appearance detected when immune complexes on FDC networks are stained 
with anti 1gM. Fc receptor mediated binding may explain why only NP 
immunised mice have QM positive GC. NP immunised mice that received wt 
cells are Id negative indicating that this phenomenon is not only related to NP 
immunisation but may be due to the abundance if Id positive serum present in 
this system. If this is the case it would be analogous to the situation detected 
when performing FACS analysis on the spleens of these mice. 
Mice that were immunised with TNP and DNP had low numbers of GC, 
all of which were QM Id -. Since these mice received sorted QM positive cells we 
might have expected the GC to be QM positive if those cells had been recruited 
to GC by low affinity interactions with antigen. It is known that low affinity B 
cells can form CC in the absence of competition (196, 197). However, the CC in 
DNP and TNP immunised mice are not QM positive. 
One explanation is that in mice immunised with TNP and DNP there is 
selection for B cells of other specificities to form GC. These may be the negative 
cells in the positive population, however, mice that received negative cells only, 
do not have GC implying that they were formed by QM positive cells. They 
may also be positive cells that have lost Id expression either due to secondary 
rearrangement or somatic mutation, we are unable to tell using this system. 
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FACS analysis of transferred cells 
Despite the fact that QM mice cannot be crossed onto a RAG deficient 
background allowing a comparison of the response in mice that can and cannot 
undergo receptor revision, we had hoped that analysis of Id expression by FACS 
would reveal whether cells had lost expression of the idiotypic receptor. This 
alone may have elucidated whether of the response to TNP had come from 
either QM positive or negative cells. Having transferred sorted QM Id cells, 
these would be the only ones detectible by FACS in the absence of secondary V 
gene rearrangement. However, if cells underwent receptor revision and lost 
specificity to NP we should be able to detect this by enumerating CD40 cells 
which no longer expressed the QM Id. 
As mentioned in the results section, several problems were encountered 
with FACS staining of splenocytes from experimental mice. Firstly CD40 B cells 
of the host, which should be QM negative, appear to be bound by the anti Id 
antibody making it difficult to distinguish truly positive cells. Secondly 
transferred CD40 QM Id B cells appear less brightly stained for QM Id than 
QM cells do in a QM mouse. We attribute this to activation induced down 
regulation of surface Id as most of the cells have been shown to divide in 
response to immunisation with NP (section 3.11). Thirdly, autofluorescent cells 
in the spleen, which lie in the same position as transferred cells in the dot plot 
make quantitative analysis untenable. These issues are discussed in more detail 
below. 
Chapter 4 	 159 
The staining pattern observed using the anti QM Id antibody is neither 
due to antibody batch nor the genetic background of the mice employed as both 
of these options were investigated. When comparing mice, only those that 
received QM Id cells have CD40 deficient cells that are bound by anti QM Id 
antibody. CD40 deficient cells in NP immunised chimaeras that did not receive 
QM cells do not bind QM Id. This indicates that the phenomenon is related to 
transferred QM Id cells. We propose that the high levels of QM Id antibody 
secreted by transferred cells is bound by Fc receptors on B cells (T cells are not 
shifted), this is then detected by the anti Id antibody when staining cells ex vivo. 
In fact, when examining a QM mouse the same phenomenon can be observed, 
QM Id - cells are shifted strongly to the right, however, as the positive cells are 
not activated they can be distinguished as they are brighter still. 
In previous experiments transferred cells could easily be detected at day 
7 or 14. However, in this experiment mice were repeatedly boosted resulting in 
very high NP specific serum IgG. This antigen specific serum is also of a single 
Id arising from transferred cells only. These factors may explain the binding of 
QM Id to CD40 deficient host cells in chimaeras that received transferred QM 
cells. 
Secondly, although CD40 transferred QM cells in the spleen are not 
stained much more brightly than host cells as mentioned before we believe this 
may be due to the down regulation of slg when cells are activated. We do not 
think it possible that all transferred cells have lost Id expression, which is 
another explanation for the profiles observed. All mice that received QM cells 
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and were NP immunised have high levels of QM Id + GC implying that there 
are QM Id + cells in the spleen. Also when examining Id staining by FACS the 
stain is continuous implying that there is just one population - that of positive 
cells. There is no reason for NP immunised QM cells to alter specificity by 
receptor revision as they bind the antigen with high affinity and the receipt of a 
strong signal through the BCR has been shown to down regulate RAG 
expression. The diminution of Id staining on QM Id cells means that we 
cannot clearly distinguish QM Id cells from those of the host on the basis of 
QM Id expression. 
We now realise that our aim to visualise transferred cells that may have 
revised their receptors by FACS was ambitious. Even in the absence of the 
problems encountered and discussed above the detection of a small number of 
cells that may have undergone revision may not have been possible. However if 
cells were to revise in response to antigen we might expect them to be selected 
and to expand, improving their chances of detection. 
Transfers of QM bone marrow cells to adoptive hosts 
To address directly the issue that bone marrow cells, expressing RAG are the 
cells that were detected in the spleen (143, 147) we investigated whether they 
could contribute to affinity maturation. Very strong NP responses were 
detected indicating that bone marrow cells can mount a response however, 
responses to other antigens were absent or very low. A small response, to DNP 
was detected on day 21. This implies that cells from the bone marrow, although 
they may indeed be the cells reported by others in the spleen do not make a 
Chapter 4 	 161 
significant response to antigens other than those they are already specific for. 
This may indicate that immigrant cells from the bone marrow cells cannot revise 
their receptors to any considerable level. 
Conclusions 
In retrospect, aspects of this experiment were perhaps too ambitious and needed 
to be refined more fully. Due to the delays incurred in the generation of a 
suitable adoptive transfer system a more basic analysis of the affinity 
maturation or responses was necessary. The initial experimental plan involved 
the generation hybridomas by fusion of the spleens of experimental mice. This 
would have afforded the opportunity to gain unambiguous information about 
the affinity of individual clones by using surface plasmon resonance (198, 199). 
Sequencing of clones would have elucidated the make up of the V region and 
given information about the contribution of somatic hypermutation and 
receptor revision. Further analysis of the affinity of the BCR for the selected 
antigens would also have been beneficial this however, was impossible due to 
time restrictions. 
We have however, developed a novel adoptive transfer system that has 
been demonstrated to improve the strength of the response of adoptively 
transferred cells. We have shown that a cohort of transferred cells can make 
antibodies and form GCs in response to antigens other than that recognised by 
the site-directed transgenic BCR they possess. One explanation for these results 
is that cells have undergone receptor revision of their BCRS, however, we cannot 
rule out that they may also have undergone somatic hypermutation alone. The 
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formation of unequivocal conclusions from these results is difficult and we 
would be reticent to do so in the absence of further investigation. 
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Chapter 5 Receptor revision in 3.83 B cells 
Introduction 
In splenic B cells in the 3.83 transgenic mouse, V(D)J recombination has been 
shown to be inhibited upon the receipt of a defined strong signal through the 
BCR, but not by a weak signal (137). This was interpreted to mean that B cells 
with high affinity for antigen, having no reason to alter specificity, continue to 
express the same BCR expression. Whereas B cells that only bind the antigen 
weakly are given the opportunity to bind it more strongly by receptor 
rearrangement. 
The 3.83 BCR used in this experiment was selected as source of transgenic 
B cells for experiments described in this chapter. This allows the investigation 
of affinity maturation in a B cell population known to undergo secondary 
rearrangements in the periphery, following the receipt of a defined weak signal. 
However, instead of using the 3.83 transgenic mouse as previously employed, 
we used the 3.83 knock-in mouse (3.83 KI) (177, 200) (19), kindly donated to us 
by Dr Roberta Pelanda (Denver, Colorado). In this mouse the pre-rearranged 
3.83H and 3.83K genes were targeted to the endogenous loci resulting in the 
generation of a mouse in which '-P90% of the B cells have the same specificity. 
These B cells are also able to undergo somatic hypermutation and class 
switching of the inserted Ig genes, unlike those of conventional transgenic mice 
where the transgene is randomly inserted. 
The ligand for the 3.83 BCR is the MHC class I molecule 
H2KK, it also recognises H2KtD  with lower affinity, while binding to H2Kd  is 
below detection. To facilitate antigen generation, a recombinant phage library 
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was screened for clones recognised by the BCR with the above hierarchy. Three 
phage known as 4)31,4) 11 and 4) wt, mimic the high, low, non binding properties 
of the MHC molecules (201). It is in response to 4)11, but not to 4)31 or 4)wt, that 
receptor revision was detected in 3.83 transgenic mice (137). We adopted this 
antigen system to investigate if secondary rearrangements in response to 
immunisation with 4) 11, might allow affinity maturation of the B cell response 
to this antigen. 
In addition, to evaluate the contribution of receptor revision alone to 
affinity maturation, we wanted to compare the response of pure B cells from 
RAG sufficient mice with that of RAG deficient B cells, which are unable to 
rearrange antibody genes. 3.83 KI mice were bred with RAG 2 deficient mice 
resulting in a mouse in which the only lymphocytes are B cells expressing the 
pre-rearranged 3.83 BCR. These B cells are unable to undergo further receptor 
rearrangement, however in the presence of T cells should be able to somatically 
hypermutate. These cells were used as a comparison with RAG sufficient cells 
in adoptive transfer experiments. This allows a distinction to be made between 
the contributions of receptor revision and somatic hypermutation to affinity 
maturation by comparing the affinity of serum from cells which can both mutate 
and revise with those that can only undergo mutation. 
Having developed an adoptive transfer system for the QM mice that 
allowed detection of antibody responses on the basis of IgG production, we 
decided to adopt an analogous approach for the 3.83 mice. B cells from 3.83 KI 
mice were sorted on the basis of 3.83 expression to provide a pure population. 
These cells were transferred to chimaeric hosts and mice immunised with one of 
the high affinity, low affinity or control, non-binding phage. In parallel, mice 
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received 3.83 RAG cells. IgG responses were determined by ELISA as measure 
of the response of transferred cells (Figure 5.1). Results obtained from this 
system are presented in this chapter. 



























Look for cells by FACS 
Make hybridomas 
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Results 
5.1 3.83 mice contain centrally edited cells that can be removed by cell 
sorting. 
Unlike QM mice, 3.83 mice have normal levels of B cells; this makes isolation of 
those that express the transgenic receptor cells less difficult. They also have 
lower levels of centrally edited cells, only about 10% of B cells have lost 
expression of the transgenic receptor. B cells that express the 3.83 BCR can be 
detected with the anti idiotypic antibody 54.1 (15), allowing their separation 
from B cells of different specificities. Splenocytes were harvested from 3.83 mice 
and enriched for B cells by CD43 depletion of other cells types. Cells were then 
stainedwith antibodies to B220 and 3.83 Id. Double positive and single positive 
cells were isolated using a FACS Vantage cell sorter. Typically 5% of the starting 
splenocyte culture was yielded as double positive B cells, this contrasts with 
only 1% for QM mice. Sort purity was also improved with between 0.2 and 
0.4% Id negative B cells present (Figure 5.2). 
5.2 Centrally edited 3.83 cells can respond to some antigens. 
When QM mice were immunised with a selection of model antigens they were 
able to make a response to all of those tested. 3.83 mice have a less diverse 
repertoire, 10% as opposed to 25% of their B cells express a non-transgenic 
receptor. To ascertain whether these cells could mount a serum antibody 
response to a selection of antigens, mice were immunised with NP-OVA, Ox-
CSA and RCF. 
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Figure 5.2 3.83 sort purity. 
CD43 depleted splenocytes 
-- I 
13% 	 80% 
' 	6°/.;- 
- 
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Sorted 3.83 positive B cells 
0.3% 99% 
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3.83 splenocytes were depleted of non B cells by CD43 MACS. 3.83 positive cells 
were sorted on the basis of binding B220 and 54.1 (anti 3.83 Id) using a FACS 
Vantage flow cytometer. To assess sort purity 3.83 positive and negative 
populations were analysed on a FACS Calibre flow cytometer. Shown above are 
representive examples of samples after CD43 depletion (top) and after cell sorting 
(bottom) 
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Mice failed to respond to either hapten but both 3.83 mice immunised made 
responses to RCF (Figure 5.3). This indicates that a small number of centrally 
edited cells can provide a serum antibody response and reinforces the need to 
remove cells of non-transgenic specificity in order to examine responses only 
those cells that express the transgenic Id. The failure to respond to either hapten 
may be related to the greatly reduced diversity of B cells in the repertoire of 
these mice. 
5.3 3.83 mice crossed to a RAG deficient background contain B cells of a 
single specificity 
Unlike QM B cells, which require RAG expression to generate functional 
antibody. 3.83 KI mice can be crossed to RAG deficient mice as they carry 
insertions of both heavy and light chain antibody genes. 3.83 KI mice were 
mated with BALB/c RAG 2 mice to produce mice homozygous for both 
heavy and light chain genes and the disrupted RAG gene. To examine the make 
up of cells in the spleen, splenocytes from 3.83 RAG mice were stained for 3.83 
expression with anti 3.83 Id (54.1 (15)), B cells and T cells were stained with 
monoclonal antibodies to B220 and CD3 respectively. 
The RAG-deficient 3.83 KI mice have no mature T cells due to their 
inability to rearrange T cell receptor genes. All B cells are Id positive (data not 
shown), unlike 3.83 KI mice in which about 10%  of the B cells are Id negative. 
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Figure 5.3 Response of 3.83 mice to immunisation with RCF. 
3.83 mice were immunised with 100.tg of alum precipitated RCF and boosted 10 
days later. On day 14 blood samples were taken and serum antibody responses 
analysed by ELISA. lgG responses to RCF of two immunised 3.83 mice are shown 
above in red. The response of a BALB/c mouse is depicted in black and the negative 
control is depicted in green. 
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5.4 Survival of 3.83 cells, transferred to BALBIc mice. 
To confirm that 3.83 cells could survive transfer to mice on a BALB/c 
background, 1x107 3.83 splenocytes were injected i.v. into BALB/c mice and 
immunised 24hr later. Immunisation for the 3.83 system is performed 
subcutaneously (s.c.) in the hind legs with 50i.g of phage emulsified in complete 
Freund's adjuvant (CFA). On day 2,6,10,16 and 24 post transfer 2 mice were 
sacrificed and spleens and draining lymph nodes examined for the presence of 
transferred cells by FAGS. Cell numbers slowly decline from a maximum of 
about 0.8 % of B cells on day 2 to 0.2 % on day 24 (Figure 5.4), indicating that cell 
stably survive adoptive transfer. Equal ratios of positive cells were found in the 
lymph nodes and the spleen. 
5.5 Analysis of recombinant M13 Phage, ligands for the 3.83 BCR. 
Recombinant M13 phage, which express mimotopes recognised by the 3.83 BCR, 
were a gift from Dr Valerie Kouskoff (Denver, Colorado). The mimotope is 
expressed as a pill fusion, this is the minor coat protein of the phage and is 
present in four copies per phage particle. Phage are isolated from infected 
bacterial cultures by polyethylene glycol (PEG) precipitation. To confirm the 
identity of the 3 phage types (31, 011 and Owt, high, low, and non binding 
respectively) and their behaviour in our hands, we performed several tests. 
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Figure 5.4 3.83 B cells survive transfer to BALB/c mice. 
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1 X 07 3.83 splenocytes were transferred to BALB/c hosts and mice were immunised 
24hr later. On day 2,6,10,16 and 24,2 mice were sacrificed and spleens harvested 
for analysis of transferred cells. BALB/c mice that did not receive any cells were also 
Immunised and used as negative controls. A Splenocytes were stained with 
antibodies to B220 and the transgenic B cell receptor. The percentage of 3.83 
positive cells was assessed and is depicted in B. The percentage of B cells that 
were Id positive in the lymph nodes of analysed mice is represented in blue. Spleen 
results are represented by red dots and immunised BALB/c mice are represented 
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The binding of the 3 phage by 3.83 B cells was assessed by measuring 
mean fluorescent intensity by FACS. 3.83 splenocytes were incubated with 5 
serial 10 fold dilutions of phage starting at 100 p.g/1x106 3.83 cells for 20min on 
ice. Cells were washed and phage binding detected with rabbit anti-M13 
antibody and an anti-rabbit FITC secondary. B cells were co stained with anti-
B220 conjugated to PE. The mean fluorescent intensity of binding of 031 to 3.83 
B cells was —7 fold greater that of 411 and Owt (Figure 5.5). However, in 
published experiments (201) the low affinity binder, 011 binds more strongly 
than we detected, so to further assess 41 1 binding ELISAs were performed. 
Plates were coated with purified 3.83 antibody and phage serially diluted (1 in 
2) down the plate. Phage binding was detected with rabbit anti M13 antibody 
and horseradish peroxidase (HRP) conjugated goat anti rabbit Ig. Similar 
results were obtained with a failure to detect significant 011 binding by the 3.83 
antibody. In all experiments the phage concentration was normalised by 
performing phage ELISAs (Figure 5.6). DNA digests allow the distinction of 011 
(low affinity) and 031 (high affinity) phage by the liberation of a 400bp band 
from 0 31 following digestion of phage DNA with BSPH1, however no similar 
test was available for 0 11 (Figure 5.5). 
Having investigated all available options and analysed phage from 2 
different sources, we felt we had no option but to accept that the mimotope was 
expressed in the phage given to us and continue with our experiments. 
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Figure 5.5 Analysis of M13 Phage. 
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A 1 X 06  3.83 splenocytes were incubated with serially diluted phage, phage binding 
was revealed with ant- Ml3antibody and a fluorescent labelled anti-rabbit secondary. 
B cells were co-stained with anti B220 and analysed by FACS. Mean fluorecscent 
intensities of phage staining were calculated and are plotted on the Y axis against 
phage concentration on the X axis. 4)31,11 and wt binding are represented by 
black red and green lines respectively. 
B Phage binding to purified 3.83 antibody was analysed by ELISA. 3.83 was 
coated on plates overnight. Phage was serially diluted down plates and binding 
detected with anti M13 and an anti rabbit HRP secondary. 0111 and wt are 
represented in black red and green respectively. 
C Replicative form phage DNA was isolated from each of the 3 phage and digested 
overnight with BSPH1 restriction enzyme. Products were electrophoresed on a 1.2% 
agarose ethidium bromide gel. The 400bp liberated from 4)31 can be detected. 
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Figure 5.6 Schematic diagrams illustrating phage ELISAs 
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5.6 The development of mimotope ELISAs to measure serum antibody 
responses to phage. 
Critical to our experiment is the measurement of serum antibody responses to 
the antigens used to immunise mice. ELISAs to measure serum antibody 
responses to phage mimotopes have not been previously documented. Initially 
a conventional ELISA protocol was adopted and phage were coated to 
polystyrene plates, however 3.83 mice, which have high levels of 3.83 antibody, 
specific for 031 as detected by ELISA with anti 3.83 Id 54.1 (Figure 5.6), do not 
bind to phage coating ELISA plates. Phage coating plates however was bound 
by serum from phage immunised BALB/c mice. We recognised that the 
response from BALB/c mice was polyclonal, and we were measuring the 
BALB/c response to all of the phage epitopes combined. 3.83 antibody only 
recognises the mimotope, a single epitope of the phage which is repeated 4 
times. 
The mimotope is expressed as a pill fusion, this is the minor coat protein 
and is only present in four copies per phage particle. To develop a way for the 
mimotope to be exposed to serum antibody, we tried lifting the phage off the 
plate by coating with anti M13 antibody; this did not improve 3.83 binding. 
However, if the ELISA is reversed, and serum placed on the bottom, bound to 
the plate with isotype specific antibodies, 3.83 binding to phage is possible. It 
emerged that the phage needs to be in fluid phase in the ELISA. This allows 
fixed antibody to bind the mimotope, if the phage is fixed, access to the 
mimotope by the antibody is hindered (Figure 5.6 and 5.7). 
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A ELISA illustrating poor binding of 3.83 serum antibody to phage coating 
Polystyrene plates.BALB/c (black) and 3.83(red) were immunised s.c. with phage 
in CFA and bled 14 days later.Serum responses to phage coating plates was 
measured by serially titrating serum down the plate and detecting it with anti lgG AP. 
Serum of a mouse immunised with an irrelevant antigen is used as a negative 
control (green) 
B Mimotope ELISAs were performed by coating polystyrene plates with anti lgG, 
serum was serially titrated down the plate starting at 1 in 500. Phage was added 
at 0.2mg/mI to all wells and detected with ant- M13 antibody followed by an 
anti-rabbit HRP secondary. BALB/c, 3.83 and irrelevant serum are represented by 
black, red and green lines respectively. 
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ELISAs performed in this way are very sensitive and require very little serum. 
In normal serum ELISAs serial dilution starting from 1 in 50 is usual. With 
mimotope ELISAs the serum needs to be titrated from 1 in 500 to prevent 
saturation. 
5.7 Transferred 3.83 cells divide in the chimaeric host and form germinal 
centres 
To investigate the response of 3.83 cells to antigens of different affinity, it was 
decided to use the same chimaeric adoptive host system that was used for the 
transfer of QM cells (see chapter 4). 3.83 KI mice, however, are on a BALB/c 
background. We needed CD407' mice and iMT mice on the same background. 
Both lines were crossed to BALB/c mice for 3 generations (referred to as 
j.tMT/BALB/c or CD40 /BALB/c mice for simplicity). Chimaeras were made 
using either tMT/BALB/c hosts or CD40" /BALB/c hosts and mice were 
reconstituted as described previously with 20% CD40" bone marrow and 80% 
tMT bone marrow. 
To confirm that sorted 3.83 B cells can divide when transferred to this 
adoptive host, sorted 3.83+  B cells were USE labelled and 1.5x106  cells 
transferred chimaeric mice. Mice were immunised s.c. in the hind legs with 31 
emulsified in CFA 24hr later and on day 7 spleens were harvested for FACS 
analysis. It can be seen from Figure 5.8 that many cells have undergone 5 or 
more cell divisions, indicating the antigen responsiveness of transferred cells. 
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Figure 5.8 Cell division and germinal centre formation of transferred 
3.83 cells 
lou 	to, 	10 	100  
CFSE 
B 
1.5X1 06  CFSE labelled sorted 3.83k B cells were transferred to chimaeric hosts 
and mice immunised s.c. with 431 in CFA 24 hr later. A Mays later splenocytes 
were analysed for division of transferred cells by FACS. The mouse shown is 
representative of 2 analysed. 
B Spleen sections were stained with PNA Texas red and anti 3.83 Id FITC to detect 
the presence of germinal centres, shown is one germinal centre representative of 1 
of —20 per section in 4 mice examined. 
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On day 17 spleens were harvested and sections analysed for GC 
formation by staining with fluorescently labelled PNA and anti idiotypic 
antibody. The anti idiotypic antibody, works poorly on sections and binds non- 
specifically to stromal cells making it impossible to distinguish GC from Id + or 
Id - cells, however, in 4 mice analysed GC numbers were the same as those in 
immunised BALB/c mice (18 +/- 4.2sd) (Figure 5.8). No GCs were detected in 
immunised chimaeras in the absence of transferred cells indicating that host 
cells are not responsible for GC detected. 
5.8 All mice generate an lgG response to phage 
A similar strategy to that described for the QM system was adopted for 3.83 cell 
transfers. B cells were enriched by CD43 depletion of splenocytes, 3.83 + cells 
were then sorted from Id - cells. Sorting 3.83 cells proved more accurate as they 
have more B cells and a higher percentage of them are Id positive. Purity of 99% 
was attained for Id positive cells, with only 0.2 to 0.4 % Id negative B cell 
contamination. The same emphasis was placed on controlling for sort accuracy 
and an equal number of mice received sorted 3.83 - cells as received positive 
cells. Control mice that received no cells were also immunised with each of the 
three phage. 
Mice received between 2 and 3x106 3.83 Id + B cells, a small number of 
negative cells to match the contamination level in the positive sorted cells, or no 
cells. 24 hr later mice were immunised s.c. in the hind leg with either of 431, 011 
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or Owt emulsified in CFA, they were boosted s.c. in the back on day 21. Blood 
samples were taken weekly for analysis of serum antibody responses and 
spleens harvested on day 28 for FACS analysis of the composition of transferred 
cells. Antibody responses of all IgG subtypes were measured by ELISA at each 
of 5 time points (Figure 5.9). 
All immunised mice produced an IgG response to 031011 and 4wt, even 
those that received negative cells or no cells, although in these cases the titres 
were lower (Figure 5.9). This IgG response is comprised of IgG2b and IgG3 
isotypes. (Anti-IgG2a did not work in this assay). We propose that in this 
system the phage induces a TI response leading to IgG2b and IgG3 production 
by host CD40 deficient cells as in a TD response only CD40 positive cells should 
provide a class switched response. 
In this experiment, IgGi is only detectable in mice that received 3.83 
transferred cells and were immunised with 031. Mice that received 3.83 cells 
and were immunised with either 0 11 or 4 wt do not make IgGi. In this case 
IgGi is the only subclass not made by host CD40' cells. We had thought that 
we might be able to use IgGi production as an indicator of the response of 
transferred cells. However, following further investigation, it became apparent 
that some CD40 deficient mice are able to make IgGi responses to phage. 
Therefore measuring IgGi production as a read out of the response of 
transferred cells is not robust enough and we are unable to make conclusions 
about the nature of the response of transferred cells to the phage in this system. 
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Figure 5.9 Relative titres of the response to phage 
4)31 	 4)11 	 4)wt 
Mice received either -2x1 06  3.83 positive cells (red) or sorted negative cells (blue). 
There are at least 3 mice per group. Mice were immunised 24hr later with one of the 
three phage, boosted on day 21 and blood samples taken weekly. Serum ELISAs 
for the mimotope were performed for lgG, lgG2b and IgGi. Titres are shown relative 
to the response of a phage immunised BALB/c mouse (black). The 3.83 response 
to 431 is shown in yellow and the negative control is in green. From left to right are 
the responses of mice immunised with 31, 11 and 4w1 respectively. From top to 
bottom are lgG, lgG2b and lgGl responses respectively. 
Arrows indicate primary immunisations and boosts. 
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5.9 Mice that received 3.83-RAG cells make antibody of all lgG subclasses 
To make a comparison between cells that can undergo rearrangement of their 
BCR and those that cannot, 5x10'3.83 RAG cells were transferred to chimaeras 
and mice immunised 24hr later with one of the phage emulsified in CFA. 
Serum responses were measured by isotype specific ELISA. Almost all mice, 
except 2, made antigen specific IgGi (Figure 5.10), this does not come from 
transferred cells as 3.83RAG cells do not make antibody responses to 011 or 4)wt 
(not shown). This response must come from host CD40 deficient B cells possibly 
responding in a TI fashion (see section 5.13). 
In the QM system, host cells did not contribute to the response to NP-
OVA indicating that this result was specific to some component of the 3.83 
experimental system. A thorough investigation of this result follows in section 
5.11, examining the possibilities of the source of this response focussing on 
differences between this experiment and the successful QM experiment. 
5.10 Transferred cells can be detected in the spleen after 4 weeks. 
On day 28 post cell transfer, mice were sacrificed and splenocytes stained with 
antibodies to B220, CD40 and the 3.83 Id to detect the presence of transferred 
cells. Gating on B220 cells to eliminate DC, B cells were analysed for CD40 
and Id expression. Unlike host cells, transferred cells express CD40 and 
consequently can be segregated allowing analysis of Id expression (Figure 5.11). 
However, background CD40 staining and the presence of autofluorescent cells 
complicate enumeration of Id + and negative cells. 





47 	414 	421 





V 	d14 	d21 	d28 
Figure 5.10 Responses of mice that received 3.83 RAG cells 
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Mice received 5x106 3.83 RAG cells (red). The negative control is in green. 
There are 2 (4)31) or 3 (4)11, 4)wt) mice per group. Mice were immunised 24hr later 
with one of the three phage, boosted on day 21 and blood samples taken weekly. 
Serum ELISAs for the mimotope were performed for lgG, lgG2b and IgGi. Titres 
are shown relative to response of a phage immunised BALB/c mouse (black). 
From left to right are the responses of mice immunised with 4)31, 4)11 and 4)wt 
respectively. From top to bottom are lgG, lgG2b and IgGi responses respectively 
Arrows indicate boosts. 
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Figure 5.11 Transferred cells can be detected on day 28 
On day 28 post cell transfer spleens were harvested and splenocytes stained with 
antibodies to B220, CD40 and the 3.83 Id. Plots above are gated on live 
lymphocytes and B220 high cells to exclude CD40 DC. From top to bottom are 
CD404- control mouse, mice that received 3.83 positive cells, negative cells, 
or 3.83 RAG-1- cells respectively. From left to right are mice immunised with 4)31, 
4)11 and 4)wt respectively. Mice shown are representative of 3 mice per group 
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Despite this we see no evidence for expansion of Id - cells in this system. This 
may reflect the absence of receptor revision. 
Activation of transferred cells was analysed by gating on CD40 positive 
cells and analysing forward scatter profiles (Figure 5.12). The Forward scatter 
profiles represent the hierarchy of binding with cells from 431 immunised mice 
being largest followed by those from ti 11 and 0 wt cells indicating that 
transferred cell were activated by antigen in this system. 
5.11 uMT mice on a BALB/c background but not on a C57BL16 background 
make serum IgG 
Although we became aware that the source of IgG in this system was from TI 
class switched CD40 1  B cells, initially other sources were investigated. Firstly 
the jtMT BALB/c mice were investigated. The QM experiment had been 
performed on the C57BL/6 background and host mice had not produced any 
IgG. As the p.MT BALB/c mice had been newly generated for this experiment 
we checked the authenticity of these mice. Despite confirming the absence of B 
cells by flow cytometry we also measured the serum Ig levels in these mice. 
p.MT mice on BALB/c and C57BL/6 background were immunised i.p. with 
100pg of alum precipitated DNP-KLH with iO Bordetella pertussis, mice were 
boosted on day 10 and antigen specific IgG production measured on day 14. 
None of the mice had any DNP specific antibodies, phage immunised [tMT 
BALB/c also failed to produce an antigen specific response. 
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Figure5. 12 Forward scatter profiles of transferred cells 
Key 	Name 
CD40+ wt B cells 
Wt 1mm cells 
- 	111mm cells 
- 	311mm cells 
Gating on CD40 cells, forward scatter profiles of cells in mice immunised with the 
3 phage were compared. As a comparison CD40 B cells from an unimmunised 
wt mice were also analysed. 
In purple is the forward scatter profile of B cells from a wt mouse, overlayed with 
cells transferred to a 431 immunised mouse (blue), 411 immunised mouse(pink) 
and wt immunised mouse (green). Mice shown are representative of 3 per group 
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However, tMTs on the BALB/c background did have significant levels of total 
serum IgG but not 1gM (Figure 5.13). This result was obtained at the same time 
as reports were made at the Immunology conference at Les Embiez. Rajewsky 
and co workers reported a phenomenon that occurs when tMT mice, are 
backcrossed to BALB/c. Due to differences in the genetic background there is a 
leak in the developmental block that halts B cell development and the BALB/c 
mice are able to produce IgG expressing plasma cells. 
5.12 pMT serum IgG does not account for the IgG detected in this system 
Given that pMT mice can produce IgG, albeit not antigen specific, we thought 
that in the context of a chimaera, tMT B cells might be able to account for the 
phage specific response detected by ELISA. We could think of 3 reasons for this: 
1) jtMT T cells, which have not been exposed to B cells, have been shown 
to have different characteristics to normal T cells (202, 203). They might lack the 
ability to provide the help required for B cells to make an antigen specific 
response. To assess this, 1x107 T cells (>99.5% pure) were transferred to tMT 
BALB/c mice to provide a source of normal T cells. Mice were immunised and 
boosted with DNP-KLH to see if the secretion of antigen specific antibody could 
be restored. No antigen specific 1gM or G response was detected (not shown). 
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!.LMT Balb/c and .tMt C57BL16 mice were immunised ip with DNP-KLH alum and 
boosted on day 10 before analysis of serum antibody levels on day 14. Although 
no antigen specific antibody was detected (A )Total serum lgG was present in 
the BALB/c Mt mice, but not in the C57BL16 RMt mice(B). 
In both figures [tMT Balb/c mice are represented by red lines and !.tMT C57BL/6 
mice by blue lines, positive and negative controls are black and green respectively. 
There are 10 mice per group 
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2) B cells in the .tMT mouse might differentiate into plasma cells due to 
the absence of other B cells. This phenomenon was discovered when B cells 
were transferred to lymphopeonic animals and may result from pressure to 
make protective antibodies (182). A similar finding has been reported in a 
mouse with an inducible mutation in the RAG gene (184). Plasma cells, being 
terminally differentiated are unlikely to be able to produce a de novo antigen 
specific response. In the presence of other B cells the leaky iMT B cells, might 
be arrested at naïve B cell stage and be able to provide an antigen specific 
response. To assess this, 6x106 CD40' splenocytes were transferred to gMT 
BALB/c mice. In this case immunisation with DNP-KLH was performed one 
week later to allow potential leaky B cells to build up in the spleen. Again, 
although 1gM was detected from the transferred CD40' B cells, no antigen 
specific IgG was produced (not shown). 
3)1gM, which is lacking in tMT B cells is known to aid IgG production 
(204) through the production of immune complexes, 1gM produced by CD40 
deficient B cells in the chimaeric host, might induce the production of antigen 
specific IgG by tMT B cells. 150t1 of serum from an immune CD40' mouse 
was transferred to mice, as a source of 1gM to aid the IgG response. Mice were 
immunised with DNP-KLH, but again no antigen specific IgG response was 
detected (not shown). 
Despite the fact that tMT/BALB/c mice have serum IgG they fail to 
make antigen specific responses even in the presence of normal T cells, CD40' 
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B cells and serum 1gM, we conclude that these mice are not the source of antigen 
specific IgG in our system. 
5.13 Immunisation with phage induces a T independent response resulting 
in the production of all antibody isotypes. 
Having ruled out the pMT BALB/c mice as a source of antigen specific IgG in 
this system, further investigation was performed into the nature of the response 
induced by the phage antigen. A panel of CD40' mice and xMT/CD40 
BALB/c chimaeras were immunised with all three phage to determine the 
nature of the IgG response induced (Figure 5.14). MT/CD40" C57BL/6 
chimaeras were also immunised with the wt phage. All mice made antigen 
specific IgG2b and IgG3, however, some mice also produced IgGi. The IgGi 
response proved very inconsistent with only about 1 in 2 mice making a 
response, however we believe that this IgGi response, produced by CD40 
deficient B cells accounts for the IgGi detected in the adoptive transfer system. 
Due to the formation of GCs in phage immunised BALB/c mice and in 
chimaeras with transferred 3.83 cells we had thought that a TD response was 
generated. But it appears that there is also a TI aspect to the phage response. To 
confirm this result 3.83 RAG mice were immunised with 0 31 to see if they 
produced IgGi. These mice have no T cells and should not make class switched 
responses to TD antigens, however class switched antibodies of all types were 
detected, indicating a TI response. 
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CD40' (top) and 1.tMT CD40 BALB/c chimaeras (middle) were immunised with 
the 3 phage and antigen specific serum antibody levels measured by mimotope 
ELISA. Titres relative to the day 14 response of a phage immunised BALB/c 
mouse are shown as dots for lgG, IgGi and lgG2b from left to right. Yellow dots 
represent 431 immunised mice, red dots 11, blue dots 4wt, pink 3.83 RAG -/-
mice immunised with 31, black and green lines represent BALB/c and negative 
controls respectively 
The bottom plot shows IgGi and lgG2a responses in CD40 Balb/c mice as 
measured by anti IgHa antibodies. Mice are p11 immunised. 
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We then questioned whether CFA, which contains bacterial antigens, 
might be responsible for the production of IgG by CD40 deficient B cells. To 
investigate this CD40' mice were immunised with myelin oligodendricyte 
glycoprotein (Mog) in CFA. IgG was not produced ruling out CFA as the cause 
of the IgG detected. BALB/c mice immunised with phage in PBS instead of 
CFA also produced IgG of all types and had GCs. 
To confirm that what we were detecting was not an artefact of the 
complex mimotope ELISA system CD40' BALB/c mice were immunised and 
anti allotype subclass ELISAs performed. We had feared that the ELISAs, due 
to their inverted orientation, had lost specificity for isotype and that there was 
now cross reactivity between antibodies. Anti IgHa  antibodies, however are 
unlikely to cross react as they are mouse anti-mouse antibodies and the antigen 
on each subclass is different. The same results were obtained with IgGi being 
detected in some of these mice. This leads us to the conclusion that phage can 
induce antigen specific IgGi in CD40' mice. Given that the basis of our 
detection strategy was IgG production we do not feel that we can attribute the 
response detected solely to transferred cells. 
5.14 Development of a system to allow distinction of transferred cells on 
the basis of expression of allotype marked antibody 
We had decided to use a chimaeric system, which allowed the detection of the 
response of transferred cells due their IgG response. Given that this is not 
possible due to the production of antigen specific IgG by CD40 deficient B cells 
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we developed another system which allows the distinction of the response of 
transferred cells due to their production of 19H  antibodies. 3.83 mice express 
antibody of the IgHa  allotype and are backcrossed to BALB/c, CB20 mice are on 
a BALB/c background but carry a congenic heavy chain of the IgHb  allotype. 
This means that the response of transferred cells can be detected using anti IgHa 
antibodies in ELISAs. 
It was determined that for transferred cells to survive and divide, host 
mice need to be irradiated for 10mm. However the same level of cell division of 
transferred USE labelled cells was not detected. Despite detecting ELISA 
responses in preliminary experiments (Figure 5.15), in two repeated 
experiments, although cells were detected, ELISA responses to phage were not. 
This system remains to be properly optimised. 
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Figure 5.15 CB20 system. 
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A CB20 mice irradiated for 10mm (R) or unirradiated (L)received 3x106 sorted 
3.83 ld cells and were immunisd with 431. On day 14 splenocytes were analysed 
by FACS for the presence of transferred cells. 
B 1gM, IgGi and lgG2a responses were measure by ELISA on day 14. Balck lines 
represent BALB/c responses, yellow 3.83, green negative control. Red lines 
represent the responses of 2 irradiated mice. 
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Discussion 
Background 
Receptor revision has been detected in splenic B cells by Nemazee and co-
workers in the 3.83 mouse (137). It was initiated only in response to antigen 
recognised with low affinity by the BCR and not by high affinity or non-binding 
antigen. In the 3.83 transgenic mouse, secondary rearrangement results in the 
rearrangement of endogenous loci that are not normally expressed due to 
phenotypic exclusion by the pre-rearranged transgene. Rearrangements in the 
endogenous antibody light chain gene were detected by expression of the 
lambda light chain; the transgene encodes a kappa light chain. De novo V(D)J 
recombination was proven by the detection of lambda excision products by PCR 
in mice immunised with low affinity antigen only. 
It has been suggested that this secondary V(D)J recombination of 
peripheral B cell might contribute to affinity maturation of the antibody 
response (157). Our experiment to test whether mature B cells can rearrange 
their receptors and subsequently gain affinity for poorly bound antigen was 
based on the findings of Hertz et cii. (137). 
In this chapter the transfer of a pure population of 3.83 B cells to CD40 
/jtMT mixed bone marrow chimaeras is described. This was done so that any 
affinity matured IgG response detected could be attributed to transferred cells 
alone. This has not been possible in experiments performed in intact mice as all 
mice possessing BCRS encoded by transgenes or site directed Ig insertions have 
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small populations of B cells with non-transgenic specificities that might be 
responsible for the response detected. 
The adoptive transfer strategy selected had proven successful in allowing 
the distinction of the response of transferred QM B cells (described in chapter 4). 
However, as the QM mice only possess a targeted heavy chain they require 
RAG expression to rearrange the endogenous light chain and create functional 
antibody. This means that affinity matured responses can be caused either by 
somatic hypermutation or receptor revision. 3.83 KI mice were crossed onto a 
RAG deficient background ruling out the contribution of receptor revision as 
secondary rearrangements are not possible in RAG deficient mice. We planned 
to compare the responses of transferred 3.83 KI cells, which can both mutate and 
revise their BCRs, with transferred 3.83 KI/RAG cells, which are only able to 
undergo mutation. This should allow the dissection of the contribution of both 
of these processes to affinity maturation. In using mice possessing the 3.83 
receptor we also have the advantage of being able to use antigens of known 
affinity for the BCR. The low affinity antigen (411) has been shown to induce 
receptor rearrangement whereas the high affinity (03 1) and non-binding 
antigens (4wt) do not. 
Firstly, as in the QM system, viability and division of transferred cells 
was confirmed by analysis of USE labelled cells after transfer to adoptive hosts. 
The formation of CC was also confirmed by immunofluorescent analysis of 
spleen sections, indicating the activation of transferred cells and their 
recruitment into the immune response. 
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Development of mimotope ELISAs 
The development of an ELISA system to detect serum antibody responses to 
mimotopes expressed on the surface of phage was critical to the success of this 
experiment. The recombinant phage used to immunise mice in this system 
express 12 or 15 amino acid insertions in the pIll gene. This protein is present in 
4 copies on the surface of recombinant M13 phage. Mimotope ELISAs for the 
detection of serum antibody responses have not been previously documented 
and is a significant new development in this project. 
Access to the mimotope appears to be hindered when phage are fixed on 
the surface of polystyrene plates used for ELISAs. Detection of serum antibody 
specific for the mimotopes requires that phage is free floating. This means that 
serum antibodies have to be fixed to the plate using anti mouse isotype 
antibodies, phage is then bound by any mimotope specific antibodies present in 
the serum. Bound phage is subsequently detected with a polyclonal rabbit anti 
M13 phage antibody and an anti rabbit secondary antibody conjugated to HRP. 
T independence of the response to phage 
Once the detection system had been developed, serum antibodies to phage 
mimotopes could be detected in chimaeras. This led to the discovery of an 
unforeseen problem; M13 phage elicit a TI response in this system that results in 
the secretion of all antibodies isotypes. This makes distinction of the response of 
host CD40 deficient cells from the response of transferred cells impossible as we 
rely on CD40 being required for class switching in a TD response. 
The recombinant M13 phage employed in this experiment has been 
reported to behave as a TI-2 antigen if the phage were crosslinked with anti- 
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phage antibodies (205). Polysaccharide antigens on the surface of bacteria are 
examples of TI-2 antigens; they possess multiple repeating epitopes that can 
activate B cells in an antigen specific fashion in the absence of cognate 
interaction with T cells. This distinguishes TI-2 antigens from TI-1 antigens 
exemplified by bacterial LPS, that induce a polyclonal, B cell response (39). The 
PITT protein is present in 4 repeats, which may explain its ability to induce TI-2 
responses, although normally a valency of 10 or more is required. 
Phage antigens, however, also initiate TD responses in vitro in the 
presence of anti-CD40 antibody (201). We have also discovered that BALB/c 
mice immunised with phage in either CFA or PBS elicited normal GC formation. 
Also, 3.83 cells transferred to chimaeras form plentiful GCs. This is a classic 
indicator of a TD response, therefore we thought that in the presence of T cells a 
TD response was elicited. T 1-2 antigens can elicit class switched responses of all 
isotypes in the absence of CD40 (44). In the chimaera system both CD40 
deficient and transferred CD40 sufficient B cells are present. The phage 
activated the former in a TI fashion and the latter in a TD fashion and the 
response elicited from these 2 subsets cannot be distinguished on the basis of 
isotype as had been planned. 
IgG production by uMT BALB/c mice 
We can now attribute the IgG response to phage in chimaeras to a TI response 
by host, CD40 deficient cells. Initially we had thought that pMT/ BALB/c mice, 
which reconstitute the chimaeras, might have been responsible. These mice had 
been newly generated and we feared an error in breeding was responsible. 
Although this was not the case MT mice crossed onto a BALB/c background 
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did possess significant levels of serum IgG but not 1gM. The production of 
antigen specific IgG was not detected. We investigated whether, in the context 
of CD40 deficient B cells, normal T cells or serum 1gM present in bone marrow 
chimaeras, these cells might behave differently and produce the antigen specific 
IgG we were detecting. MT BALB/c mice were supplemented with CD40 1  B 
cells, T cells from a normal mouse or serum 1gM from an immune mouse. None 
of these factors allowed the production of antigen specific antibody in this 
system, further elucidating this interesting phenomenon. 
We know that the IgG detected in MT BALB/c mice is caused by the 
presence of plasma cells but not normal B cells. The fact that an antigen specific 
response cannot be induced is probably due to the fact that these cells are 
terminally differentiated. To make an antigen specific TD response, B cells need 
to interact with T cells in B cell follicles, some of them then proliferate and form 
GC, and others form plasma cells and secrete high levels of antigen specific 
antibody. The plasma cells detected by Rajewsky and co-workers probably 
were not selected in antigen specific manner. 
B cells transferred to RAG deficient hosts quickly secrete high levels of 
1gM and serum levels approach normal (182). j..tMT mice have no membrane t 
gene but the gene for secreted 1gM and other isotypes is still present, however 
they still fail to secrete 1gM. The serum IgG detected, however, is probably 
caused by a similar phenomenon. Class switching to IgG is normally a TD 
phenomenon, however in the absence of the !t gene a small number of B cells 
appear to be able to rearrange the Ig locus so that a functional antibody of the G 
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isotype is formed. Rearrangement of a functional heavy chain gene is required 
for cells to pass from the early pro B cells stage and undergo positive selection. 
It is unknown why jtMT mice on the BALB/c background and not j.xMT 
mice on the C57BL/6 background can undergo this phenomenon. However, it 
has been previously reported that Ig-p—deficient/LPR mice on the C57/BL6 
background do secrete IgG but not 1gM (206). LPR mice lack functional FAS 
expression, which is important in the control of activated mature cells. It is 
postulated that lack of functional FAS may allow maturation of defective B cells 
in pMT/lpr mice accounting for the detection of serum 1g. It may be that 
p.MT BALB/c mice do not regulate the development of B cells as tightly as j.iMT 
C57BL/6 mice, this could be due to heterogeneity in FAS function or expression 
or may be caused by something else. 
The fact that the addition of normal T cells or immune serum 1gM do not 
allow antigen specific IgG production adds strength to the argument that this is 
due to the terminal differentiation of these cells. We might, however have 
expected that the addition of other B cells would allow the production of 
antigen specific IgG. If the MT B cells only become plasma cells due to the 
absence of other B cells as is the case in transfers to RAG deficient hosts, we 
might expect that in the presence of B cells and serum 1gM from these cells, that 
differentiation would be halted at a stage where leaky cells could respond to 
antigen. Either this is not the case or the design of our small experiment did not 
allow it. One week after transfer of CD40 deficient B cells mice were immunised 
with DNIP - KLH, this may not have allowed sufficient time for IgG expressing 
B cells from pMT mice to come out of the bone marrow. We do not know what 
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the frequency of the rearrangement event is, which allows cells to express 
surface IgG and undergo positive selection in the bone marrow. 
No evidence for expansion of Id negative cells 
Despite the fact that we were unable to discern whether affinity maturation 
occurred in this system due to an unfroseen TI response, we were still able to 
detect transferred cell after 28 days. Anti-Id staining, although complicated by 
high background from the anti CD40 antibody and autofluorescent cells, gave 
us no reason to believe that receptor revision had occurred in this system. 
Numbers of Id negative cell were not above background in any of the mice 
investigated. 
Hybridomas were generated from spleen cells of all mice in this 
experiment and analysis of these for gene rearrangement by sequencing will 
give conclusive evidence of the presence of absence of rearrangements in 
transferred cells, however, this could not be performed in the allotted time. 
Development of an allotype transfer system. 
We had selected an adoptive transfer system, which allowed the distinction of 
the response of transferred cells on the basis of class switched antibody 
production. Due to the unusual properties of the phage antigen this proved 
impossible. A final system was developed to resolve this problem. CB20 mice 
have an MHC H2 d  background, which makes them compatible with BALB/c 
mice, but express an IgHb  allotype. In 3.83 mice the transgene bears the IgHa 
allotype, allowing the response of these cells to be detected with allotype 
specific antibodies. 
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Although CB20 mice have the advantage of expressing a different 
allotype, transfers to these mice were unreliable. In some cases grafts did not 
survive, this is known to be a problem when transferring to immunocompetent 
hosts (186). Although some transfers were successful and IgHa antibodies were 
detected from transferred 3.83 cells, we failed to get consistent responses from 
transferred cells, even if grafts were detected by FACS. 
Conclusion 
Despite our considerable efforts to determine whether 3.83 cells are able to 
undergo secondary V(D)J recombination, and provide affinity matured 
responses to low affinity antigen, we were unable to do so in this system. We 
were unable to distinguish the antibody response of transferred cells from that 
of the host due to the production of IgG in a TI fashion by CD40 deficient B cells. 
However, analysis of the Id expression of transferred cells by FACS gave no 
evidence for the expansion of cells that had lost Id expression by receptor 
revision. This could be due to the fact that the phage induced a polyclonal 
response in all cells in the mouse and therefore there was not a strong selective 
pressure for the expansion of revised cells. However, this may give some 
insight into that fact that this phenomenon may only be readily detectible if 
selective pressure is strong. 
One of the initial arguments against receptor editing in the bone marrow 
was that it was an artefact of transgenic systems, which could only be detected if 
no other B cells were able to respond. This was addressed by Retter and 
Nemazee (28) by examining the frequency of functional rearrangements that 
had been inactivated by recombining sequence (RS) rearrangement. If the 
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antibody rearrangement in the bone marrow results in the production of non-
functional antibody it is normal to rearrange the other allele. However if 
functional antibody was generated the only reason to rearrange the other allele 
is if the antibody had an auto reactive specificity. The functional antibody is 
shut: down by recombination with the down stream RS sequence. In normal B 
cells 47% of RS-inactivated VKJK joins were in frame, suggesting that receptor 
editing occurs at a high frequency in normal mice. 
A similar argument could be wielded for the case of receptor revision; 
that it is only detectible in the case of mice with a limited B cell repertoire. 
However, heavy chain V gene replacement has been documented in rheumatoid 
arthritis synovial tissue B lymphocytes in humans (153) and in normal B 
lymphocytes from human tonsils (155). It has been reported that the frequency 
of such events is low (<3%) and unlikely to play a major role in the shaping of 
the repertoire as revised B cells are most likely counter selected (156). It is now 
believed that secondary rearrangements may contribute to the development of 
autoreactive specificities, rather than useful specificities as we hypothesised 
(150, 154). However, one recent study has documented the contribution of 
peripheral light chain rearrangement to the generation of high affinity 
antibodies and stated that receptor revision can contribute to affinity maturation 
(176). This was in a mouse where the diversity of the repertoire was limited due 
to the presence of a site directed transgene specific for the hapten NP. However, 
the fact remains that revised B cells can be detected in normal systems where the 
repertoire is already diverse. 
Receptor revision may be a rare event in organisms with a normal 
repertoire. Its effect may only be noticeable in cases where the either the 
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repertoire is limited by the presence of a transgerdc receptor, where selection of 
a rare cell of another specificity is strong or in cases of abnormalities in B cell 
regulation; patients with autoimmune disorders. We were unable to distinguish 
the response of transferred cells due to an unforeseen TI response. However, the 
presence of cells with altered specificities was not detected by FACS implying 
that receptor revision does not play a major role in a situation where other cells 
are capable of providing a suitable immune response. 
Chapter 5 	 206 
Conclusions 
The aim of this study was 2 fold: to investigate triggers of somatic 
hypermutation and to investigate the contribution of receptor revision to affinity 
maturation. 
We have initiated somatic hypermutation in vitro, using defined 
molecular stimuli. Stimulation of naïve B cells with antibodies to slg, CD40 and 
CD38 induced high level mutation with hallmarks of that induced in vivo. 
Studies in vivo using mice deficient in CD40 and CD38, confirmed the 
importance of stimulation through CD40 for the induction of mutation. This is 
the first formal proof of the absence of somatic hypermutation in CD40 deficient 
mice. The role of CD38 has been shown to be non-specific and its importance is 
most likely as a powerful B cell mitogen, allowing fixation of the mutations 
introduced in vitro during cell division. 
Our investigations into the role of receptor revision in affinity maturation 
proved less conclusive. In 3 chapters, I have outlined: 1) the development of an 
adoptive transfer system to facilitate detection of the affinity maturation of 
adoptively transferred transgenic B cells; 2) Experiments investigating affinity 
maturation using B cells from the QM mouse, which undergo secondary 
rearrangements at the heavy chain locus; 3) Experiments using B cells from the 
3.83K1 mouse, which undergo receptor revision at the light chain locus. These 
studies had varying degrees of success due to problems encountered at late 
stages in the experiments. 
Previous studies into receptor revision have not investigated its role in 
affinity maturation. We have employed an adoptive transfer system where only 
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newly introduced changes in the BCR of a pure population of B cells will 
facilitate affinity maturation. The response to antigens recognised with low 
affinity by 2 different transgenic BCRs has been investigated in the same 
manner. 
The development of a suitable host for the adoptive transfer of transgenic 
B cells was critical for the success of this experiment. The formation of CC by 
transgenic cells is critical for their affinity maturation as GC are the site of both 
somatic hypermutation and selection of high affinity mutants. Peripheral RAG 
expression has also been associated with CC (130, 133, 134) intimating that they 
are the location of secondary V(D)J rearrangement. We use a novel chimaeric 
mouse as an adoptive host in which we can be assured that only adoptively 
transferred cells can form CC and undergo affinity maturation therein. This 
system allows the selective expansion of transferred cells in a CD40 dependent 
fashion, giving them an advantage over host CD40 deficient cells. The presence 
of the host cells provides a physiological environment for this to occur. 
In the 2 experimental systems described different problems were 
encountered making it difficult to come to firm conclusions about receptor 
revision and affinity maturation. In the QM system the use of well-
characterised TD antigens resulted in an IgC response, which could be 
attributed to transferred cells alone. This assay demonstrated a small affinity 
matured response to TNP, an antigen to which no binding was detected in the 
primary response. However, we are unable to attribute this to receptor revision 
alone, as somatic hypermutation may be responsible. Analysis of Id expression 
by FACS should have elucidated whether cells had undergone receptor revision 
resulting in loss of Id expression. However, all transferred QM cells displayed 
diminished levels of Id expression making it difficult to discern whether these 
cells had lost Id expression. 
In the 3.83 system, similar analysis of Id expression by transferred 
transgenic cells demonstrated no evidence for the expansion of Id negative cells 
due to receptor revision or otherwise. However, due to the complex nature of 
the immune response elicited by the phage antigen both TD and TI antibody 
responses were detected. Class switching in response to TD antigens in this 
system would have identified the response of donor (3.83K1) cells, as host cells 
were CD40 deficient and cannot class switch. However, the unanticipated TI 
response could have given rise to IgG from either donor or host cells. 
More information could be obtained from the QM system if clearer data 
could be obtained about the Id expression of transferred cells by FACS. The 3.83 
mice, however, proffer a better-defined system in which to investigate receptor 
revision and affinity maturation. We have crossed these mice to a RAG 
deficient background providing a source of B cells in which secondary 
rearrangements are impossible. This allows a direct comparison to be made 
between B cells that can or cannot undergo this process, allowing us to 
distinguish the contribution of somatic hypermutation from that of receptor 
revision. We have already developed an Ig allotype detection system for the 
analysis of the response of 3.83 cells transferred to Ig congenic hosts. This 
circumvents the problem caused by the detection of a TI response in chimaeras 
as it does not rely on the production of class switched isotypes. However, this 
system still needs to be optimised. 
Future analysis of hybridomas generated from both QM and 3.83 systems 
will also enable the makeup of the Ig  locus to be examined for secondary 
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rearrangements and point mutations, revealing precisely the contribution of 
both of these processes to the affinity maturation of Ig responses. 
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Materials and Methods 
Animals 
All mice were maintained under specific pathogen free conditions at the 
Ashworth Laboratories, University of Edinburgh. C57BL/6, BALB/c and CBA 
mice were bred in house. CD40' (44) and pMT mice (207) on both BALB/c and 
C57BL/6 backgrounds were also bred in house and maintained in filter topped 
cages. RAG-/-  2 deficient mice (7) on both backgrounds were maintained in 
isolators. CB20 mice were a gift from Dr Neil Mabbott (Institute of Animal 
Health, Edinburgh University, UK). QM (178) mice were kindly donated by Dr 
Peter Lane (University of Birmingham, UK) with the permission of Dr. Mattias 
Wabi (UCSF, San Francisco). 3.83K1 mice (177) were the gift of Dr Roberta 
Pelanda (Denver, Colorado, USA). ELK mice (89) were kindly provided by Dr. 
Michael Neuberger (LMB, Cambridge, UK). CD38 knockout mice (B6x129 F2) 
were provided by Dr. Maureen Howard (Anergen, Redwood City, CA). Mice 
were used at 8-12 weeks of age and sex matched as closely as possible. 
Protein Antigens 
Ovalbumin (OVA, Sigma, Dorset, UK)), bovine serum albumin (BSA, Sigma) 
and keyhole limpet haemocyanin (KLH, Calbiochem, San Diego, California, 
USA) were used as protein antigens. These were coupled to dinititrophenyl by 
reacting with 23p1 of dinitrofluorobenzene (DNFB, Sigma) solution in oil in 0.1M 
sodium borate buffer, pH 8.4 (Sigma) per mg of protein. OVA and BSA were 
coupled to nitrophenyl (NP) by reacting with 200tg of NP-O-Suc (Biosearch 
Technologies Inc. Novato, CA, USA.) in dimethylformamide (Sigma), in 0.2M 
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carbonate /bicarbonate buffer pH9.0. Following coupling hapten—protein 
conjugates were dialysed extensively against PBS to remove free hapten. TNP-
OVA and TNP-BSA were purchased from Biosearch technologies. 
Phenyloxazolone Ph-OX-CSA was a gift from Dr. Harry White (UCL, London, 
UK). Alum precipitation of antigens was performed in 4.5% potassium alum 
(Sigma) solution. 
Preparation of recombinant M13 phage to be used as antigen 
XL 1-Blue bacteria, which contain the F plasniid (possessing a tetracycline 
resistance gene) required for phage infection, were grown overnight in the 
presence of tetracycline (Sigma). Bacteria were infected with phage by 
inoculating a 1/100 dilution of an overnight culture with phage from a single 
plaque. Following a 3hr incubation cultures were then grown overnight in 
300m1 2xYT culture medium (Sigma). The next day bacteria were removed by 
centrifugation for 15min at 8000rpm. Phage was precipitated from the 
remaining supernatant on ice for lhr by the addition of polyethylene glycol 
(final concentration 5%) (PEG, Sigma) and NaCl (0.5M). Precipitated phage was 
centrifuged for 15min at 8000 and PEG precipitated a second time. Following a 
final centrifugation phage particles were washed in PBS to remove bacterial 
debris and remaining PEG before quantitation by spectophotometry. 
Immunisations 
Mice were immunised i.p. with 100tg of alum precipitated protein antigen with 
109 killed Bordetella Pertussis (Calbiochem). Boosts where performed were with 
1O0.tg of soluble antigen except for QM transfer experiments where boosts were 
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the same as primary immunisations. Phage immunisations were performed sub 
cutaneously (s.c.) in the hind flank with 100tg of phage emulsified in CFA 
(Sigma), boosts if required were s.c. in the back. 
Cell preparations 
Single cell suspensions of spleens and lymph nodes were prepared in Hank's 
balanced salt solution (HBSS, Sigma) supplemented with 2% foetal calf serum 
(FCS, Labtech, Andover, Massachusetts, USA), by pressing lymphoid tissue 
through nylon gauze with forceps. These were further prepared by flushing 
through a 25 gauge needle (Becton Dickinson, San Jose, CA, USA). Red blood 
cells were removed by incubation in red blood cell lysing solution (Sigma) and 
washed in PBS. 
Bone marrow cells were flushed from femurs with a syringe containing HBSS. 
Peripheral blood mononuclear cells were prepared by layering blood samples 
collected from mice in heparin over lympholyte-M (Cedarlane Laboratories, 
Hornby, Ontario, Canada). White cells were removed using a Pasteur pipette 
and washed in PBS. 
Analysis of cell division by CFSE 
Cells were loaded with the dye CFSE (Molecular Probes Inc., Eugene, Oregon, 
USA) at a concentration of lOnM for 10 minutes at 37°C. The number of cell 
divisions undergone by cells was measured at the appropriate time using FACS 
analysis (Becton Dickinson, FACS Calibur running CellQuest). 
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B cell stimulations 
B cells were prepared by negative selection using anti-CD43 MACS microbeads 
(Miltenyi Biotech, Bergisch Gladbach, Germany) according to the manufacturers 
instructions. 1x106 B-cells/well were plated out in 24 well tissue culture plates 
(Costar, Corning, New York, USA) in Iscove's Modified Dulbecco's Medium 
(IMDM, Sigma) supplemented with 5% FCS (Labtech), 2mM L-Glutamine 
(Gibco-BRL, Paisley, Scotland), 50mM 2-mercapto-1ethanol (2-ME,Sigma) and 
penicillin-streptomycin (50mg/mi, Sigma). The cultures were maintained at 
37°C in a humidified 5% CO2 atmosphere. The following stimuli were added, 
singly or in combination: LPS (S. typhosa 0901) at 5,tg/ml (Difco Labs, Detroit, 
Michigan, USA) anti-CD38 supernatant at 1/200, (NIMR-5 (167) provided by Dr. 
Michael Parkhouse, IAH, Pirbright, Surrey, UK), anti-CD40 (FGK-45 (208)) at 
10jtg/ml and anti-kappa light chain (187.1) at 10tg/m1. Supernatants from 
alloreactive Th2 clone (209) produced as described previously were used at a 
1/10 dilution. The cells were harvested after 7 days 
PCR amplifications and sequencing 
Total RNA was prepared using RNAzo1 B (AMS Biotechnology, Oxon. UK) and 
then cDNA was made using a Promega Reverse Transcription kit (Promega 
Corporation, Madison, Wisconsin, USA) containing all the reagents for synthesis 
of single-stranded cDNA; both according to manufacturers instructions. The 
VKOx1 transgene (600 bp ) was amplified from the cDNA using the following 
primers: 
EK16 - 5'-GCCGGAATTCCCAGAGGACAAATTGTTC-3' (VKOx1) 
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RtCk- 5'-GCCCGGATCCGACGGGTGAGGA-3' (ratCK) and the following 
protocol: 
95°C for 5 mm. and then 30 cycles of 95°C 1 mm, 53°C 1 mm, 72°C 1min and then 
a 72°C extension for 10 minutes. The PCR product was purified using QlAquick 
PCR purification kit (Qiagen, Chatsworth, CA), ligated into P-Gem-T easy 
vector (Promega) before transforming competent JM109 bacteria. Colonies were 
picked and minipreps made (QiAprep spin plasmid miniprep kit; Qiagen). 
Colonies containing the correct insert were selected by digestion with Apal and 
Pstl (New England Biolabs, Beverly, Massachusetts USA). Sequencing was 
performed by MWG Biotech (Ebersberg, Germany). 
For analysis of the J-C intron flanking the 3' border of V1J558 genes, the method 
utilised was essentially that described by Jolly et al. (161). Briefly, genomic DNA 
was isolated using a QlAprep tissue kit (Qiagen). The JH4  intron was amplified 
using a primer specific for FR 3 of JH558  family of VH  genes 
(5'-GGAATTCGCCTGACATCTGAGGACTCTGC-3') and the Tend of the 
intronic enhancer (5'-GACTAGTCCTCTCCAGTTTCGGCTGAA-3') using a 2 
stage protocol: 10 cycles of 94°C 15 seconds, 64 °C-55 °C (reducing 1°C per cycle) 
15 seconds, 72°C 4 minutes and then 25 cycles of 94°C 15 seconds, 63°C 15 
seconds and 72°C 4 minutes. The JH4  rearrangement gives a product of 1200bp 
and this was excised, extracted from the gel using Qexil (Qiagen,), cloned into 
pBluescript at the EcoRV site and sequenced using a primer specific for J4 (5'-
TATGCTATGGACTACTGG-3'). The polymerase error rate was calculated by 
sequencing 20 clones derived after RT-PCR of message from a hybridoma 
expressing germline VKOxl. This error rate was 1/1200. 
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Cell proliferation assays 
B cells were prepared by negative selection using anti-CD43 MACS microbeads 
(Miltenyi Biotech, Bergisch Gladbach, Germany) according to the manufacturers 
instructions. 2x105 B-cells/well were plated out in 96 well tissue culture plates 
(Costar, Corning, New York, USA) in IMDM (Sigma) supplemented with 5% 
FCS (Labtech), 2mM L-Glutamine (Gibco-BRL, Paisley, Scotland), 50mM 2-ME 
(Sigma) and penicillin-streptomycin (50mg/mi, Sigma). The cultures were 
maintained at 37°C in a humidified 5% CO2 atmosphere. The following stimuli 
were added, singly: LPS (S. typhosa 0901) at 51ig/ml (Difco Labs), anti-CD38 
supernatant at 1/200, (NIMR-5 (167) provided by Dr. Michael Parkhouse, IAH, 
Pirbright, Surrey, UK), purified anti-CD38 at 10pg/m1, anti-CD40 (FGK-45 (208)) 
at 10tg/ml, IL-4 supernatant at 1/100 (from cell line X63). Polymyxin B was 
used at a range of concentrations up to lOOjig/mi. 
After 48 hrs in culture 1ttCi 3H thymidine in 10 Itl complete medium was 
added to each well, and plates were incubated for 16-18 hr at 37°C prior to 
harvesting and counting using a Top Count Microplate Scintillation Counter 
(Canberra Packard). 
Cell sorting 
B cells isolated from mouse spleens by MACS were washed and adjusted to 
1x108 /ml in HBSS (Sigma) supplemented with 2% FCS (Labtech). Cells were 
then incubated at 4°C for 20 min with FITC conjugated anti-Id antibody (for QM 
mice clone R2.438.8 at 1.54g/ml (178) supplied by Dr Peter Lane, Birmingham; 
for 3.83 clone 54.1 at 1.6 4g/ml (15) supplied by Dr David Nemazee, Scripps 
Institute, San diego, USA) and PE-conjugated anti-B220 monoclonal antibody 
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(clone RA3-6B2 Becton Dickinson at 0.4 g/ml) Id positive and negative cells 
were sorted using a FACS Vantage flow cytometer (Becton Dickinson running 
CeliQuest software). Sorted cells were then washed and resuspended in PBS. 
Purity was assessed using a FACS Calibur Flow cytometer and cells were 
counted using trypan blue (Sigma) and a Neubauer haemocytometer 
(Marienfeld, Laud a-Konigshofen, Germany). 
In vitro generation of bone marrow derived dendritic cells 
DCs were derived from bone marrow cells according to the procedure 
developed by Inaba et al. (210). In brief, bone marrow cells were cultivated in 
RPMI (Sigma) supplemented with 10% FCS (Labtech), 2mM L-Glutamine 
(Gibco-BRL), penicillin-streptomycin (50mg/mi, Sigma), sodium pyruvate 
(1mM, Sigma), granulocyte-monocyte colony stimulating factor supernatant 
1/20 (GM-CSF; cell line X63 (211)). On the third day, non-adherent cells were 
washed away and remaining cells were cultivated in the same culture medium 
supplemented with 1.5% mouse serum instead of FCS. An additional wash was 
performed on day 6. By day 7 cultures typically contained >90% DC and were 
pulsed with antigen at 100.ig/m1 for 3 hours before being harvest and washed 
in preparation for injection into mice. 
Generation of chimaeric hosts 
Recipient mice were lethally irradiated (dose dependent on strain used see 
results chapters 3, 4 and 5; irradiation delivered from caesium source) on day 0. 
On day 1 bone marrow cells were flushed from femurs with a syringe 
containing HBSS (Sigma) and passed through a 25 gauge needle (Becton 
217 
Dickinson) to generate a single suspension. They were depleted of T cells by 
negative selection using anti-Thy-1(T24)-biotin, streptavidin microbeads 
(Miltenyi Biotec, Bergisch Gladbach, Germany) and separation on a MACS 
magnetic column (Miltenyi Biotec) according to the manufacturers instructions. 
Cells of donor origin were mixed at the required ratio and 5x106 bone marrow 
cells injected i.v. into the irradiated recipients. The chimaeras were left for 8 
weeks to allow reconstitution of the immune system before use. 
To construct bone marrow chimaeras in which gene expression was restricted to 
defined cell populations, the host haemopoietic system had to be completely 
replaced with donor bone marrow cells. To ensure that there was no out growth 
or retention of host cells fully allogeneic chimaeras were tested 8 weeks after 
reconstitution. When bone marrow from BALB/c mice (H2d)  is transferred to 
lethally irradiated C57BL/6 mice (H2") greater that 99% of the peripheral B cells 
and DC are of donor origin as assessed by FACS staining with anti-CD19 (clone 
11)3, Becton Dickinson) and anti-CD11c (clone HL3 Becton Dickinson) and with 
antibodies to IA   (clone AF6-120.1) and IA   (clone MKD6). Furthermore 
essentially all of the DC generated in vitro from culture of bone marrow cells 
and non- adherent bone marrow precursors, are of the donor origin. 
The bone marrow chimaera used in these experiments has CD40 
expression on DC but not B cells. Irradiated mice were reconstituted with bone 
marrow from 2 sources: 80% from pMT and 20% from CD40 mice. To ensure 
that all the B cells were CD40 deficient B cells from these mice were stimulated 
with anti-CD40 (clone FGK-45) and proliferation measured. No proliferative 
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response was detected from these cells. This result was confirmed by FACS 
staining of spilenocytes with anti-CD40 antibody (clone 3.23 Becton Dickinson) 
and anti 1gM (polyclonal goat anti mouse, Southern Biotech, Birmingham, 
Alabama, USA) 
Adoptive transfers 
For transfers of QM and 3.83 B cells, between 1 and 3x106 sort purified Id 
positive cells were transferred to adoptive hosts. To account for the small 
amount of contamination in the Id positive population the requisite number of 
Id negative cells were transferred to control mice. 5x106 cells were used in 
adoptive transfers of 3.83RAG cells. In preliminary experiments to assess 
survival of transferred cells 1x107 splenocytes were transferred. 
Mice were immunised 24 hours after cell transfer. 
Measurement of antigen specific serum Ig by ELISA 
Blood collected from tail veins of mice was allowed to coagulate at room 
temperature, then centrifuged twice and serum collected. 96 well microtitre 
plates (Dynex Technologies Inc, Chantilly, Virginia, USA) were coated with 
antigen at 50tg/ml in O.1M carbonate /bicarbonate buffer, pH 9.6 overnight at 
4°C. Plates were washed with PBS and blocked with PBS 1% BSA or PBS 1% 
dried milk powder for one hr at room temperature (RT). Plates were washed 
and serum added in 2 fold dilutions in PBS 1% BSA for 2hr at RT. Plates were 
washed in PBS 0.05%Tween 20 (Sigma) and incubated with alkaline 
phosphatase (AP) conjugated polyclonal goat, anti-mouse 1gM or IgG or IgG 
subtypes (Southern Biotech) in PBS 1% BSA for 2h.r. Following a final wash 
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plates were developed with p-nitrophenyl phosphate, disodium salt (pNPP, 
Southern Biotech) in substrate buffer (10% diethanolamine, 5% MgCl6H0 pH 
9.8). The optical density was measured at 405nm. 
Mimotope ELISAs 
96 well microtitre plates (Dynex Technologies Inc. Chantilly, Virginia, USA) 
were coated with isotype specific antibody at 10tg/m1 in 0.1M 
carbonate /bicarbonate buffer, pH 9.6 overnight at 4°C. Plates were washed 
with PBS and blocked with PBS 2.5% dried milk powder (mPBS) for one hr at 
room temperature (RT). Plates were washed and serum added in 2 fold 
dilutions in 1% mPBS for 2hr at RT. Plates were washed in PBS 0.05%Tween 20 
and incubated with phage at 0.1mg/mu in 1% mPBS for 2 hrs. Free phage was 
washed away and bound phage detected with polyclonal rabbit anti-Fd (Sigma) 
for lhr at RT. Following a wash, anti-rabbit horseradish peroxidase (Dako, 
Glostrup, Denmark) was added for one hr at RT. Plates were developed using 
10%w/v Tetramethylbenzidine (TMB) substrate (Sigma) diluted in substrate 
buffer (0.05M Sodium Phosphate, 0.025M Citrate pH 5) with 0.03% Hydrogen 
peroxide. The reaction was stopped after 3-5 min with 2M sulphuric acid and 
the optical density measured at 450nm. 
Histology 
Spleens were harvested, embedded in Cryo-M-Bed embedding compound 
(Bright Instrument Company, Huntingdon, UK) and frozen at -80°C. Frozen 
sections (5tM thick) were fixed in cold acetone and dried extensively. Sections 
were stained with FITC conjugated anti-Thyl (clone T24) for T cells and Texas 
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Red conjugated anti 1gM for B cells (Southern Biotech). CC were stained with 
either FITC or biotin conjugated PNA (Vector Labs. Burlingame, California, 
USA). Primary stains were for 2 hr, where required secondary stains were 
performed with streptavidin Texas Red (Southern Biotech) for 1 hr. After 
staining, sections were washed extensively in PBS before mounting and analysis 
using an Olympus BX50 microscope under reflected fluorescent light. Images 
were captured using a Hamamatsu digital camera and Openlab image analysis 
software (Improvision, Coventry, UK 
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Signals That Initiate Somatic Hypermutation of B Cells 
In Vitro' 
Sigridur Bergthorsdottir,* Aoife Gallagher,2* Sandra Jainandunsing,* Debra Cockayne,t 
James Sutton,*  Tomas Leanderson, and David Gray23* 
Somatic hypermutation is initiated as B lymphocytes proliferate in germinal centers. The signals that switch on the mutation 
process are unknown. We have derived an in vitro system to define signals that will initiate mutation in normal, naive splenic B 
cells. We find that three signals are required to allow detection of somatic mutation in vitro; these are anti-Ig, anti-CD40, and 
anti-CD38. If any one of these is omitted, mutation remains off. We show that CD40 is obligatory in vivo, as CD40 knockout mice 
exhibit no Ag-driven mutation. In contrast, CD38 is not, as CD38 knockout mice mutate normally. We believe that, in vitro, CD38, 
in combination with other stimuli, drives extensive cell division, allowing the detection of mutated sequences. However, in germinal 
centers in vivo, proliferative activity is instigated by a different molecule. This is the first demonstration of the initiation of 
hypermutation in vitro with normal splenic B cells using defined stimuli. The Journal of Immunology, 2001, 166: 2228-2234. 
A ffinity maturation of the Ab response occurs largely as a result of selection of the Ig V gene products that have undergone a process of somatic hypermutation. The vast 
majority of late primary and secondary response Abs exhibit 
changes from the germline V sequence (1, 2), and most memory B 
cells carry somatically mutated B cell receptors (BCR)4 (3). In 
generating the repertoire for affinity selection to act upon, somatic 
hypermutation forms an integral part of the process of memory B 
cell development, and the two processes seem to be intimately 
linked, both occurring in the same anatomical site. Germinal cen-
ters (GC) are necessary for the generation of memory B cells (4) 
and are sites in which B cell hypermutation is switched on (5). 
Under normal, physiological circumstances GC appear to be the 
only sites of mutation (6), although, if pushed to the extreme by 
repeated immunization with enormous amounts of Ag, mutations 
can be detected in lymphotoxin-a' mice that lack GC (7). 
B cell memory development, GC reaction, and somatic hyper-
mutation occur only during responses to T-dependent Ags (gener-
ally proteins), suggesting that signals from T cells are necessary at 
some point in all of these processes. The exact molecular identity 
of the signals driving these processes is still unknown. We do not 
know what initiates the GC reaction, what drives GC B cell pro- 
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liferation, or what causes differentiation within the GC (e.g., the 
transition of centroblast to centrocyte). CD40 is implicated in the 
first two functions as CD40 knockout mice develop no GC (8, 9); 
however, its role in GC induction may be an indirect one as rudi-
mentary GC can be regenerated in these mice simply by injection 
of CD40-Ig (10). However, CD40 signals do seem to be crucial 
during the final stage of memory differentiation in GC; the final 
rescue of mutated GC B cells from apoptosis (11) and entry into 
the memory pool (12). Signals via the BCR are clearly also crucial, 
as without recognition and uptake of Ag the B cell would be un-
able to elicit T cell help. Whether the BCR signals generated by 
small protein Ags have any role to play in driving the cell through 
cell cycle is not known. Ag uptake and subsequent processing for 
presentation is important at two stages of the B cell response: the 
Initiation and for the selection of mutants in the GC for survival in 
the memory pool (13). So we know that the processes involved in 
memory generation require signals via surface immunoglobulin 
and signals derived from T cells; indeed, we have shown that so-
matic mutation could be maintained (although not initiated) by 
culturing B cells with anti-Ig and helper T cells (14). This has since 
been supported by similar findings using human B cell lines (15, 
16) and tonsillar B cells (17). The exact identity of these T cell-
derived signals is still mysterious. 
In this study we have set out to find the signals that initiate 
somatic mutation of B cells in vitro. To do this we have stimulated 
B cells from a transgenic mouse carrying a VKOxI gene with all of 
the upstream elements required to target somatic mutation to the V 
gene (18). As this VK is rearranged to a rat CK the transgene is 
readily identified, avoiding the problem of unequivocal identifica-
tion of the germline equivalent of a mutated Vic that is often dif-
ficult in normal mice due to close similarities within V gene fam-
ilies. B cells from these mice were stimulated and maintained in 
culture under a number of conditions. These included BCR cross-
linking in combination with the various effector molecules of T 
cell help (i.e., CD40 ligand and cytokines). B cells stimulated us-
ing anti-Ig together with anti-CD40, and supernatants from Th2 
clones did not accumulate somatic mutations in the VKOxJ trans-
gene. However, the replacement of cytokines with an Ab to CD38 
led to the detection of somatic mutation in vitro. 
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FIGURE 1. Mutation initiated in vitro. Sequences of the VKOx] transgene from B cells cultured with LPS (A) and anti-K, anti-CD40, and anti-CD38 






























FIGURE 1. Continu 
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Anti-CD38 + anti-CD40 + anti-Ig 20 9 20 1/290 0.016 
Anti-CD38 + anti-CD40 IS 6 6 11725 0.73 
Anti-CD38 + anti-Ig 14 4 6 1/676 0.52 
Anti-CD40 + anti-Ig 22 9 10 1/627 0.56 
Anti-CD38 + anti-CD40 + anti-Ig + Th2 supernatant 6 1 1 1/716 0.75 
Anti-CD38 8 0 0 <1/2320 0.65 
LPS 12 3 3 1/1140 - 
Cultures are the same as those from which the sequences in Fig. I were derived. 
Number of independent sequences used for analysis. 
Total number of mutations in all mutated sequences. 
Number of mutations in all sequences divided by the total number of base pairs sequenced. 
Probability using Fishers exact test that the difference in mutation frequency between LPS and triple stimulus is due to chance 
Materials and Methods 
Mice and immunizations 
ELK mice, carrying a transgene incorporating VKOx] and upstream regu-
latory elements (18), were provided by Dr. Michael Neuberger (LMB, 
Cambridge, U.K.). CD38 knockout mice (B6X 129 F2) (19) were provided 
by Dr. Maureen Howard (Anergen, Redwood City, CA) and CD40 knock-
out mice (8), originally made by Dr. Hitoshi Kikutani (Osaka, Japan) have 
been maintained in our laboratory for some time and backcrosued to 
C57BL(6 for seven generations. Wild-type mice were C57B1J6 strain. All 
mice were bred and maintained under standard laboratory conditions in the 
animal facilities of Imperial College School of Medicine, Hammersmith 
Hospital and later at the Ashworth Laboratories, University of Edinburgh. 
Mice were used at 8-12 wk of age. Mice were immunized via the i.p. route 
with 100 tig of alum-precipitated phenyloxazolone-chicken serum albumin 
together with 10 killed Bordetella pertussis and then boosted 3 wk later 
with 100 jig of soluble phenyloxazolone-chicken serum albumin. 
B cell stimulations 
In early experiments B cells were prepared from spleens by the depletion 
of T cells using 1gM Abs against Thyl, CD8, and CD4 and lysis with 
mouse-absorbed young rabbit complement (C-Six Diagnostics, Mequon, 
WI). Residual T cells were depleted using Dynabeada (Dynal, Oslo, Nor-
way) coated with IgG Abs to the same surface markers (Abs and procedure 
are described in Ref. 20). In more recent experiments B cells have been 
prepared by negative selection using anti-CD43 MACS microbeads (Milte-
nyi Biotech, Bergisch Gladbach, Germany) according the manufacturer's 
instructions and described in Skok et al. (21). Using both methods, B cell 
preps were routinely >95% pure with <1% contamination with CD3 * T 
cells. One million B cells/well were plated out in 24-well tissue culture 
plates (Costar, Coming, NY) in IMDM supplemented with 5% FCS, 2 mM 
1.0 	2.0 	3.0 
Mutation frequency (x10 3 per base pair) 
FIGURE 2. Mutation frequency in B cell cultures. The frequency of 
mutation obtained in the VKOxI transgene following 7-day culture of B 
cells with combinations of anti-K (anti-1g), anti-CD40, and anti-CD38. 
Only the combination of all three stimuli was statistically, significantly 
different from the LPS control (using Fisher's exact test). This result is 
representative of three other experiments 
L-glutamine (Life Technologies, Paisley, Scotland), 50 MM 2-ME, and 
penicillin-streptomycin (50 mg/ml). The cultures were maintained at 37°C 
in a humidified 5% CO2 atmosphere. The following stimuli were added 
singly or in combination: LPS (Salmonella typhosa 0901) at 5 yeg/mI (Difco, 
Detroit, Ml), anti-CD38 supernatant at 1:200 (NIMR-5, Ref. 22, provided by 
Dr. Michael Parkhouse; IAH, Pirbright, Surrey, U.K.), anti-CD40 (FGK-45, 
Ref. 23) at 10 .cg/m1, and anti-K light chain (187.1) at 10 gug/mI. Supernatants 
from alloreactive Th2 clone (20) produced as described previously were used 
at a 1:10 dilution. The cells were harvested after 7 days. 
Analysis of cell division 
The number of cell divisions undergone in culture was measured using 
FACS analysis (FACSCaliber running CellQuest; Becton Dickinson, 
Mountain View, CA) at appropriate times of cells loaded with the dye 
CFSE (Molecular Probes, Eugene, OR) at a concentration of 10 nM for 10 
minat 37°C as previously described (24). 
PCR amplifications  and sequencing 
Total RNA was prepared using RNAzoI B (AMS Biotechnology, Oxon. 
U.K.), then eDNA was made using a Promega Reverse Transcription kit 
(Promega, Madison, WI) containing all the reagents for synthesis of single-
stranded eDNA (both according to manufacturer's instructions). The 
VKOxI transgene (600 bp) was amplified from the eDNA using the fol-
lowing primers: EKI6, 5'-GCCGGAATFCCCAGAGGACAAATrGT 
TC-3' (VKOxI); and RtCk, 5'-GCCCGGATCCGACGGGTGAGGA-3' 
(ratCK); and the following protocol: 95°C for 5 min and then 30 cycles of 
95°C for 1 mm, 53°C for I mm, 72°C for 1 mm, and then a 72°C extension 
for 10 mm. The PCR product was purified using a QiAquick PCR purifi-
cation kit (Qiagen, Chatsworth, CA) and ligated into P-Gem-I easy vector 
(Promega) before transforming competent JMI09 bacteria. Colonies were 
picked and minipreps made (QlAprep spin plasmid miniprep kit; Qiagen). 
Colonies containing the correct insert were selected by digestion with ApaI 
and Pstl. Sequencing was performed by MWG Biotech (Ebersberg, 
Germany). 
For analysis of the J-C intron flanking the 3' border of V0J558 genes, 
the method used was essentially that described by Jolly et al. (25). Briefly, 
genomic DNA was isolated using a QlAprep tissue kit (Qiagen). The JH4 
intron was amplified using a primer specific for framework region 3 of 
H58 family of V genes (5'-GGAAlFCGCCTGACATCTGAGGAC 
ICIGC-3') and the 3' end of the intronic enhancer (5'-GACTAGIC 
CTCTCCAGT17CGGCTGAA-3') using a two-stage protocol: 10 cycles 
of 94°C for 15 s, 64°C-55°C (reducing 1°C per cycle) for 15 a, 72°C for 4 
mm, and then 25 cycles of 94°C for 15 a, 63°C for 15s, and 72°C for  mm. 
The 2H4  rearrangement gives a product of 1200 bp; this was excised, ex-
tracted from the gel using QexIl (Qiagen), cloned into pBluescript at the 
EcoRV site, and sequenced using a primer specific for 3H4  (5'-TATGC 
TATGGACTACTGG-3'). The polymerane error rate was calculated by 
sequencing 20 clones derived after RT-PCR of message from a hybridoma 
expressing germline VscOxI. This error rate was 1:1200. 
Results and Discussion 
Experimental system 
All in vitro experiments were conducted with B cells from a trans-
genie mouse (ELK) expressing VKOX1 linked to a rat CK. The 




SIGNALS THAT INITIATE HYPERMUTATION IN B CELLS 
Table II. Summary of mutation frequencies obtained in four separate in vitro experiments 
Stimulus 	 Eupt. I 	 EXPI. 2 Expi. 3 Expt. 4 
Anti-CD38 + anti-CD40 + anti-Ig 	 1/363" (8/10)b 	1/410 (12117) 1/399 (24/33) 1/290(20/20) 
Anti-CD38 + anti-CD40 	 ND' ND 1/580(5/10) 1/725 (6/15) 
Anti-CD38 + anti-Ig ND 	1/653 (7/16) 1/967 (3/10) 1/676 (6/14) 
Anti-CD40 + anti-Ig 	 1/580 (6/12) 1/628 (6/13) 1/773 (6/16) 1/627 (10/22) 
Anti-CD38 + anti-CD40 + anti-Ig + Th2 supernatant 	ND 	 ND 1/870(216) 1/1716 (1/6) 
LPS 	 1/1740 (2/12) 1/1450(4/20) 1/1160 (5/20) 1/1140 (3/12) 
p valued 0.015 	 0.02 0.02 0.016 
Frequency of mutation = number of mutations in all sequences divided by the total number of base pairs sequenced. 
Total number of mutations in the sequences analyzed/number of independent sequences analyzed. 
ND, Not done. 
d Probability using Fisher's exact test that the difference in mutation frequency between LPS and triple stimulus is due to chance. The value for all other stimulations conditions 
are >0.4. 
enhancer that together facilitate targeting of somatic mutation to 
the transgene (18). The gene product is expressed at the cell sur-
face and is secreted into the serum; however, as far as this exper-
iment is concerned, it is used as a passenger transgene in that we 
do not analyze Ag-driven responses. It has the advantage that we 
can readily identify the mutated transgene by amplifying with a 
PCR primer for the rat CK together with a VKOx 1-specific primer. 
This is important as the unequivocal identification of mutated V 
genes in mice is complicated by the close homology within fam-
ilies and the possibility that not all the members of that family are 
yet cloned. Thus, splenic B cells were purified (>98%) and placed 
in culture under a variety of conditions for 7 days. The culture 
medium and stimuli were replenished after 4 days (see Materials 
and Methods). After harvesting cells, RNA was prepared and the 
VtdJxI transgene was amplified by RT-PCR, cloned, and 
sequenced. 
Initiation of somatic mutation in vitro 
The stimuli used in the cultures were designed to mimic signals 
delivered to B cells during T-dependent responses, i.e., antigen 
(anti-1g), CD40 ligand (anti-CD40), and cytokines (delivered as a 
mixture of Th2 cytokines contained in a supernatant from an ac-
tivated Th2 clone). We also tested an Ab to CD38 that has strong 
mitogenic properties on mouse B cells (22). As previous studies 
had indicated that mutation did not occur during culture of B cells 
following LPS stimulation (26), we used LPS as a negative con-
trol. As demonstrated in Fig. IA, the B cells cultured with LPS for 
7 days exhibited no mutation of the VicOxl transgene above the 
Tag error rate (- 1:1200). Somatic hypermutation was found under 
only one culture condition, containing three stimuli together: anti-
Ig, anti-CD40, and anti-CD38. Fig. lB shows a significant number 
of point mutations scattered through the Vi<Oxl transgene from B 
cells cultured in this way. Approximately half (9 of 20) of the 
sequences analyzed contained mutations (see Table I), and most 
had two or more mutations per sequence. Both Table I and Fig. 2 
indicate that the difference in mutation frequency between LPS 
(1:1140) and the triple stimulus (1:290) is statistically significant. 
Table I and Fig. 2 also show that mutation can only be initiated if 
all three stimuli are present; omission of any one results in loss of 
significant mutation. A very striking result is the observation that 
the addition of Th2 cytokines to the anti-Ig, anti-CD40, anti-CD38 
culture inhibits the accumulation of somatic mutations, we think 
because they drive differentiation of B cells to plasma cells. In 
Table II we show data from four independent experiments that 
confirm that the triple stimulus of anti-Ig, anti-CD40, anti-CD38 
reproducibly induces mutation in vitro. This culture condition is 
the only one tested in which the difference in mutation frequency 
compared with the LPS control, which could not occur due to 
chance, according to Fisher's exact test. The frequency of muta-
tions observed with dual stimuli was greater than that in the LPS 
controls but did not reach statistical significance. For stimulation 
conditions involving anti-CD40 this increase was consistent in 
four independent experiments; for anti-Ig plus anti-CD38 the in-
crease was seen in only two of the three experiments. This could 
indicate that CD40 signals are sufficient on their own to switch on 
mutation that is detectable only when other stimuli are present to 
enhance cellular proliferation. 
Naive B cells have been stimulated to accumulate mutations in 
vitro previously either within a splenic fragment assay (27) or in 
coculture with an activated T cell clone (17). Neither of these 
studies revealed which signals were involved in the process. Here 
we identify three signals that can initiate mutation in vitro and may 
be crucial in vivo. It is interesting that CD40 was reported not to 
induce mutation in the study of Razanjaona et al. (17); however, 
the cultures reported in that study included CD40 ligand transfec-
tants plus a mixture of cytokines. We also find no mutation when 
cytokines are added to our "mutation stimuli". 
We have analyzed the mutations incorporated into the VKOxl 
transgene in B cells stimulated with anti-Ig, anti-CD40, anti-CD38 
for hallmarks of Somatic mutation. The point mutations detected 
are scattered throughout the V region, with more than half in the 
framework regions; however, there does seem to be an accumula-
tion in complementarity-determining region 2 (Fig. 1B). This pat-
tern of mutation in sequences from triple stimulation cultures was 
similar in four independent experiments (80 sequences). It may be 
that the complementarity-determin jog region targeting of muta-
tions observed previously is related to antigenic selection, of which 
Table III. Nature of base substitutions observed in cultured B cells 
Mutations" Observed (%) Expected' (%) 
Transitions 
Total 56.3 33.3 
C—sT 18.8 9.3 
A—aG 25.0 8.0 
G—aA 6.3 7.4 
T—aC 6.3 7.0 
Tranaversions 
Total 43.7 66.6 
A—sT 12.5 8.0 
G—aT 25.0 7.4 
0—aC 6.3 7.4 
Mutations found in the elite mutated sequences derived form the anti-1g, anti-
CD40, anti-CD38 cultures. 
Expected number of mutations was calculated by multiplying the frequency of a 
particular nucleotide (mutation target) in the germline sequences by the total number 
of observed mutations and dividing this by 3 (as mutation to any of the other three 
nucleotides has the same theoretical probability). 
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FIGURE 3. Proliferation of B cells in culture. Flow cytometric analysis 
of CFSE labeling of B cells cultured for 7 days with various stimuli (A—E, 
as indicated). These data are representative of four such experiments. 
there is none in this system. As expected, for this reason, the ratio 
of the number of replacement mutations compared with the num-
ber silent mutations is little different from the predicted value (data 
not shown). Table III shows that there is an over-representation of 
transitions compared with transversions in the set of mutations 
from the triple stimulation culture. A preference for transitions is 
an intrinsic feature of the hypermutation machinery. Transitions 
should make up only 33% of the mutations; however, in this data 
set 56% of the mutations are transitions. We have to keep in mind 
that up to 25% of the mutations we see could be taq-induced (our 
taq error rate = 1:1200) and these would also be biased toward 
transitions. If we take away 25% of the observed transitions, the 
proportion of such mutations is, at 43%, still some 10% greater 
than the expected frequency. Some changes are particularly prev-
alent, such as C—s.T, A—G, and G—sT; these have been noted 
previously in a study of mutation in a cell line (16). Mutation in the 
intrinsic mutational hotspots is not observed in the sequences il-
lustrated here (Fig. 1); thus we see no mutation of the serine 26, 31, 
or 77 codons (28, 29). Moreover, these mutations were not ob-
served in the larger data set (Table H) above the frequency ex-
pected by chance. 
Calculation of the rate of mutation in this culture is in the range 
previously estimated for somatic hypermutation in vivo. The mu-
tation frequency in the triple stimulation culture is 3.4 X iO per 
base pair. We estimated, using the halving of USE fluorescence 
with each cell division (Fig. 3), that the cells in this culture pass 
through six generations. Thus the rate of mutation is 5.8 X iO 
per base pair per generation. This is 10-fold lower than the max-
imum quoted rate in vivo of 5 X 10— (30). It has been argued that 
a rate of 3 3< iO per base pair per generation is more accurate. 
Most calculated figures are, in fact, below 10 — (31, 32). It is also 
worth remembering that the rate varies throughout the response, 
such that it is low to start with and increases at the height of the GC 
(33). On this basis and given the fact that the in vitro culture may 
lack the optimal microenvironment, we are gratified that the mu-
tation rate is of the correct order of magnitude. 
Is mutation related to number of cell divisions? 
CD38 might play one of two roles in the initiation of somatic 
mutation in vitro. First, it could provide a specific signal to start 
mutation or second, it could drive proliferative expansion of mu-
tated cells to a level within the cultures at which they are readily 
detectable. We analyzed the proliferative activity of B cells stim-
ulated in various ways by labeling the starting population with 
USE and counting the number of cell divisions (by halving of 
USE fluorescence) at the end of 7 days. Fig. 3C shows that anti-
CD38 and anti-Ig cause the majority of cells to enter cell division 
and proceed to the maximum number of six divisions. This con-
firms what we already know (Table I and Fig. 2), that CD38 is not 
an "on switch" for somatic mutation, at least, not in the absence of 
CD40 signals, as even with maximal cell division no mutation is 
seen. Anti-CD38, in combination with anti-CD40 and anti-Ig, in-
creases the number of cells proceeding through the maximum six 
divisions (compare Fig. 3, D and E) and as such may well be 
working to drive expansion of mutants to a detectable level. It 
should also be noted that, in the anti-CD38 stimulations, the ma-
jority of cells enter the cell cycle (98.7 vs 93.9%; Fig. 3, D and E), 
and so no subpopulation of B cells is left at the proliferative start-
ing gate as happens with LPS or anti-CD40 (see Fig. 3, B and D). 
We have found no other stimulation conditions that have such a 
broad and powerful mitogenic/proliferative effect. Although we 
cannot rule out absolutely the possibility that some of the muta-
tions we see in our cultures derive from the expansion of pre-
existing memory cells, the proliferation data suggest otherwise. 
Anti-CD38 plus anti-Ig seem to push most cells into cycle (Fig. 
3C), but mutation is not significantly enhanced. We also have in 
excess of 40 ELK transgene sequences from splenic B cells, which 
Table IV. Frequency of somatic mutation sin the VHJ5581 VC intron in immunized CD40 and CD38 
knockout mice 
No. of 
No. of 	 Mauled 	No. 	of Frequency of 
Miceflmmunizations 	Sequences" Sequences Mutations" 	Mutations 
Wild-type/nonimmune 	13 	 12 	 24 	 1/4660 
Wild-type/immune 11 8 53 1/169 
CD40'jimmune 	 13 	 3 	 5 	 1/1820 
CD38'/immune 12 7 38 1/198 
"Number of independent sequences used for analysis. 	 256 Total number of mutation sin all mutated sequences. 
Number of mutations in all sequences divided by the total number of base pairs sequenced. 
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SIGNALS THAT INITIATE HYPERMUTATION IN B CELLS 
exhibit no evidence of mutation despite the presence of ongoing 
'irrelevant' immune responses (e.g., splenic GCs) in the mice. 
In relation to the cell proliferation it is clear that none of the 
sequences obtained from these cultures are clonally related, i.e., no 
sequential accumulation of mutation during culture could be de-
tected. This is not unexpected given the cell input number and the 
relatively small sample size. We are currently trying to extend the 
useful life of the cultures in the hope of achieving a larger clone 
size and observing such clonal development. It might then also be 
possible to introduce selection into the system. 
Somatic mutation in CD40 and CD38 knockout mice 
To see whether CD40 and CD38 play a role in hypermutation in vivo 
we immunized CD40- and CD38-deficient mice (19) and analyzed the 
accumulation of mutations in their V regions. To do this we se-
quenced the J-C intron flanking the 3' border of VreJ558 genes in B 
cells from immunized mice, as described by Jolly et al. (25). The data 
are summarized in Table IV. As expected, in the light of the absence 
of (IC in CD40 	mice (8, 9), no somatic mutation was found. This 
may not be surprising, however, it is the first formal demonstration of 
impaired somatic mutation in these mice. The role of CD40 in the 
mutation process is obligatory in vitro and in vivo. The obvious in-
terpretation is that CD40 directly initiates the mutation process by 
inducing expression of one of the components of the "mutator com-
plex"; however, it might act indirectly following induction of other 
costimulatory receptors on the B cell surface. The latter possibility is 
indicated by the report that an EBV-negative Burkitt's lymphotna 
(BL2) mutates following anti-Ig stimulation and interaction with T 
cells, independently of CD40 (34). 
In contrast, the J-C intron in B cells from CD38 knockout mice 
was heavily mutated. Our conclusion must be that CD38 is not 
necessary in vivo for the initiation or maintenance of somatic by-
permutation. Although the proliferation it drives in vitro is crucial 
for the outgrowth and detection of somatic mutants, it appears that 
in vivo CD38 is not required for proliferation of mutating cells in 
GC, and that some other molecule performs this function. We can-
not rule out that CD38 causes clonal expansion of selected cells 
following mutation, we have not analyzed the clone size of the 
mutated cells from CD38' mice compared with wild type. 
Concluding remarks 
Our data suggest that resting B cells require nothing other than Ag 
and CD40 ligand as a donor of T cell help to initiate the hyper-
mutation process. We found that CD38 signaling was required in 
our in Vitro model before mutations were evident, but its role was 
to enhance proliferation rather than to act as a specific on-switch: 
This pro-proliferative role for CD38 was dispensable in vivo. We 
propose that, in addition to CD40, another, still unidentified, mo-
lecular signal drives proliferation of centroblasts in GC. 
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